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ABSTRACT 
Studies on the Oxidative Degradation of Fluphenazine 
Decanoate in Oily Solution 
William F. Heyes 
Oxidation of fluphenazine decanoate, a member of the neuroleptic pheno-
thiazine drugs, is believed to occur in oily solution via the hydroperoxides formed 
as a result of autoxidation of the oil. Synthesis and characterisation of the 
expected oxidation products of the drug was undertaken so that the formation of 
these degradation products in oily solution, could be accurately determined. By 
this means the rate of oxidation of fluphenazine decanoate by various hydro-
peroxides was determined. Only in the case of the C-IB unsaturated fatty esters 
did the overall oxidation process obey simple kinetics (2nd order) enabling values 
for the respective rate-constants to be calculated. The presence of acid was 
clearly demonstrated to catalyse oxidation of the tertiary amine centres in the 
molecule, a finding contrary to reports in the literature. In addition, the catalytic 
effect was shown to be related to the pKa value of the acid. 
Benzyl alcohol is commonly added as a preservative to oily formulations and 
thus the effect of this material on the rate of fluphenazine decanoate oxidation 
was investigated. Evidence for the enhanced oxidation of the drug in the presence 
of benzyl alcohol in a naturally ageing formulation was obtained and a plausible 
mechanism for this phenomenon was sought. Autoxidation of the benzyl alcohol 
was deemed a likely explanation and since little information on this aspect of 
benzyl alcohol chemistry could be found in the literature an extensive study of 
benzyl alcohol autoxidation was conducted. It was finally concluded that 
autoxidation of benzyl alcohol leads directly to hydrogen peroxide offering one 
viable explanation of the enhanced degradation of the drug observed in the 
presence of the preservative. 
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1.1. The Phenothiazines 
CHAPTER 1 
INTRODUCTION 
1.1.1. Historical Development 
Phenothiazine (I) was first synthesised by Bernthsen1, nearly 100 years ago 
during studies aimed at elucidation of the chemical structure of methylene-blue 
(II). Subsequently, phenothiazine formed the basis of the chemistry of the 
important thiazine dyes2• 
(I) 
+ 
CI (II) 
The anthelmintic properties of phenothiazine were noted during the 1930's3 
and it has since been extensively used in veterinary medicine4• 
The origins of the modern phenothiazine drugs may be traced to the mid 
1940's when a series of phenothiazine derivatives containing an amino-alkyl 
substituent at the 10-position were synthesised independently in France5 and the 
U.S.A. 6• By varying the nature of the amino-alkyl side chain, modification of the 
therapeutic activity was achieved culminating in patent rights being granted to 
the French group in Britain 7 (1948) and the USA 8 (1950). Included amongst the 
-1-
compounds listed in the patents were diethazine (III) and promazine (IV) which 
were destined to become highly successful products, both commercially and 
therapeutically. 
Additional substitution at the 2-position (aromatic ring) further modifies the 
pharmacological properties of the molecule, eg chlorpromazine (VII) which was 
first synthesised9 in 1952 and revolutionised the therapy of the mentally ill. 
During the ensuing decade intensive activity in the field of phenothiazine 
chemistry produced literally thousands of related derivatives. Schenker and 
Herbst10 reviewing the literature in 1963 listed some 3957 individual compounds. 
Unfortunately, because of the labile nature of chloro group in chlorprom-
azine59, the compound exhibited acute phototoxicityll thus limiting its 
therapeutic potential. Yale successfully overcame this problem by replacing the 
I bOI hI h I th 0 0 12 a I e c oro group with the stable trifluoromet y group syn eSlsmg 
triflupromazine (VIII) in 1957. The discovery that the trifluoromethyl group 
conferred increased neuroleptic activity upon the molecule was an obvious 
additional advantage. Further development of the trifluoromethyl phenothiazine 
derivatives eventually led to the synthesis of fluphenazine13 (XVII) which has a 
side chain containing the piperazine-ethanol moiety. The final stage in the 
development of the phenothiazine drugs was the preparation of the long-acting 
ester forms (1963), made possible by the presence of the alcoholic hydroxy group 
in fluphenazine. By esterification with decanoic acid Yale14 produced a 
compound which had a duration of activity of 21 days following I.M. injection as 
compared with 1.5 days for unesterified fluphenazine15• Further discussion of 
this phenomenon is included in Section 1.1.2 below. 
1.1.2. Structure - Activity RelationShips. 
1.1.2.1. Effect of Structure on Pharmacodynamic Properties 
Table 1.1 lists the chemical structures of some commonly 
encountered phenothiazine derivatives and compares their medical 
uses. 
-2-
Table 1.1 
Some Commonly Encountered Phenothiazine Drugs 
r0(S~ 
V"N~R I 2 
R1 
Rl R2 Generic Name Medical use 
I -CH2CH2N(C2H5)2 H Diethazine (III) anticholinergic; anti-parkinsonian w 
I 
-CH2CHN(C2H5)2 H Ethopropazine (IV) anticholinergic;antiparkinsonian I 
CH3 
-CH2CHN(CH3)2 H Promethazine ( V) antihistamine; antiemetic I 
CH3 
-CH2CH2CH2N(CH')2 H Promazine (VI) tranquilliser 
-CH2CH2CH2N(CH,)2 CI Chlorpromazine (VII) tranquilliser 
-CH2CH2CH2N(CH')2 CF3 T ri flupromazine (VIII) tranquilliser 
-CH2CHCH2N(CH3)2 H Trimeprazine (IX) antipruritic I 
CH3 
Table 1.1 (Contd •• ) 
Some Commonly Encountered Phenothiazine Drugs 
Rl R2 Generic Name Medical use 
-CH2CHCH2N(CH3)2 OCH3 Methotrimeprazine ( X) analgesic I 
CH30 I -CH2CH2 N SCH3 Thioridazine (Xl) tranquilliser oil> 
I 
I 
CH31\ 
-CH2CH2CH2N NCH3 H Perazine (XU) tranquilliser 
"-' 
1\ 
-CH2CH2CH2N NCH3 CI Prochlorperazine (XIII) tranquilliser 
"-' 
r-\ 
-CH2CH2CH2N NCH3 
"-' 
CF3 Tri fluperazine (XIV) tranquilliser 
Table 1.1 (Contd •• ) 
Some Commonly Encountered Phenothiazine Drugs 
R1 R2 Generic Name Medical use 
r\ 
-CH2CH2CH2N NCH3 SCH2CH3 Thiethylperazine ( XV) antiemetic 
'--.J 
I 
U1 
I 
r\ 
-CH2CH2CH2N. NCH2CH2OH Cl Perphenazine (XVI) tranqui lliser 
'--.J 
r\ 
-CH2CH2CH2N NCH2CH2OH CF3 Fluphenazine (XVII) tranqui lliser 
'--.J 
r\ 
-CH2CH2CH2N NCH2CH20H 
'--.J 
COCH2CH3 Carphenazine (XVlll) tranquilliser 
The type of pharmacological activity shown by the compounds can 
be seen to vary with the nature of the substituents at both the 2 
and 10 positions. A phenothiazine with an aminoalkoxy carbamate 
side-chain at the la-position has ANTITUSSIVE activity, ego 
dimethoxanate (XIX).23 
r7'yS~ 
~N;V 
I 
COCH zCH zOCH zCH z N(CH 3) II z 
° 
nux) 
For a phenothiazine derivative to possess strong ANTIHISTAMINE 
activity two fundamental requirements must be satisfied10• 
a) the molecule should contain an aliphatic tertiary amino group 
in the side-chain (lO-position). 
b) the side-chain should contain two carbon atoms between the 
phenothiazine ring N and the aliphatic amine N atom. 
Even if the above requirements are met, the extent of antihist-
amine activity may be altered by changing the sUbstituent groups 
R 1 and R 2 in the general structural formula: 
A branched-chain Cie. Rl = CH3) increases antihistamine activity 
whereas changing R 2 from methyl to ethyl reduces antihistamine 
-6-
activity. Adding a 2-substituent to the aromatic ring (at R3) also 
reduces antihistamine activity. Replacement of one R2 group by a 
2nd aliphatic tertiary amine group destroys the antihistamine 
action of the moleculelO• Inclusion of a heterocyclic N wi thin the 
side-chain renders the structure-activity relationship less predict-
able. Antihistamine activity ceases to be a function of the carbon-
chain length between the two N atoms; thus each of compounds 
XX, XXI and XXll below exhibit antihistamine propertieslO • 
.rI', I""'" .rI', ~ .rJ', I""" .rI', I~ 
N N N N 
I I I I 
CH z 
0 
CH z b I b CH z I LJ N I H I CH 3 CH 3 
(XX) (XX1) (XXlll (XXlll) 
Although compounds XXll and XXlll each possess a similar C-chain 
length between the two N atoms, their pharmacological properties 
are totally different. Compound XXll is an antihistamine whereas 
compound XXlll is a neuroleptic. 
Lengthening the carbon chain between the ring N atom and the 
amino side-chain N to three carbon atoms results in CNS effects 
replacing antihistamine activityl6. The 3-C chain is optimal for 
TRANQUILLISING activityl7. Enhancement of CNS activity may 
be gained by inclusion of an electronegative substituent in the 
-7-
aromatic ring at the 2_position18,19. In this respect tranquillising 
activity decreases in the order CF 3>CI>S02N(CH3)219. Hence 
triflupromazine (Vlll) has about five times the tranquillising activ-
ity of chlorpromazine20(VU). The discovery concerning the effect 
of the trifluoromethyl group was contrary to indications given in 
the literature describing the structure-activity relationships of 
other drug molecules21• A further improve..:nent in tranquillising 
activity may be achieved by including a piperazine-ethanol moiety 
in the side-chain (fluphenazine XVU). Fluphenazine has been shown 
to possess fifteen to thirty times the tranquillising activity of 
chlorpromazine(VII)22. 
1.1.2.2 Effect of Structure and Route of Administration on 
Duration of Activity 
Of the many phenothiazine derivatives devised over the last 25 
years, fluphenazine (XVII) has been shown to be the most potent 
neuroleptic22• By esterification of the alcoholic hydroxy group of 
fluphenazine with fatty acids14, Yale demonstrated the prolonged 
activity of these novel compounds1S• However, another equally 
important criteria for prolonged activity is the route of adminis-
tration. Intraperitoneal injection of the hydrochloride salts of 
fluphenazine and fluphenazine enanthate(XXIV) results in similar 
potencies and duration of activity of both compounds (about 1.S 
days)lS. 
In order to prolong the duration of activity it is necessary to 
administer a sesame oil solution of the ester by intramuscular 
injection. By this means the duration of activity was extended to 
between twelve and fifteen days15. In control tests, similar 
experiments with fluphenazine showed a duration of activity of 
only 1.5 days ie. the same as obtained by intraperitoneal injections. 
-8-
R = C6Hl3 fluphenazine enanthate (XXlV) 
R = C9Hl9 fluphenazine decanoate (XXV) 
The length of the ester C-chain is also important. The decanoate 
ester (C-IO) migrates from the site of injection at about a half the 
rate of the en ant hate (C-7) ester24• Thus fluphenazine decanoate 
administered I.M., as a sesame oil solution, normally has a duration 
of activity of about three weeks though reports of therapeutic 
effects lasting as long as three months have been published25• 
Hungarian workers have recently reported a new series of fluphen-
azine esters26, of which the 3, 4, 5-trimethoxybenzoate ester was 
shown to possess a duration of activity greater than that of 
fluphenazine decanoate as measured by the Conditioned Avoidance 
Test. 
1.1.2.3. Activity of Phenothiazine N- and S-Oxides 
y y z 
(IC~)[) ° sulphoxide ~ I N I ~ °2 sulphone 
I ...... R N-oxide (CHz)-N ...... R ° 3 I (t-amine oxide) 
Z 
-9-
Oxidation of amino-alkyl phenothiazines can give rise to sul-
phoxides, sulphones or amine oxides, depending on the choice of 
reaction conditions (See Section 1.3 below for further details) and 
these compounds have been assessed for pharmacological activity. 
a) Sulphoxides 
In general the sulphoxides are less active than the parent com-
pounds. Chlorpromazine sulphoxide has been shown to be inactive 
( I t ' t"): . t 27, 43, 57, 84 H . I h . de neuro ep IC ac IVlty in VI ro • owever, su p OXl S 
which have lost the tranquillising effect of the parent still retain 
the lactogenic activity28. 
b) Sulphones 
Sulphones possess no tranquillising activity but promethazine sul-
phone and the sulphone of 10-(3-dimethylamino-2-methylpropyl) 
phenothiazine both exhibit strong antihistamine properties29, 30. 
Because of the lack of tranquillising activity and much reduced 
CNS activity, the sulphones have fewer associated side-effects and 
have been proposed as improved antihistamines. 
c) N-oxides 
The antidepressent properties of the N-oxide chlordiazepoxide 
(XXVI) are well-known and it might thus be expected that alkyl-
amino phenothiazine N-oxides may also be pharmacologically 
active. Indeed, Yale has described the N-oxides of fluphenazine as 
having a similar tranquillising activity to the parent3l• However, 
the N-oxide of chlorpromazine has been shown to be inactive in-
vitr032,33. The neuroleptic activity found for these oxides in 
pharmacological test systems is therefore probably due to an 
enzymatic conversion to the parent compound in_viv032,34. 
-10-
(XXV1) 
CI 
1.1.3 Oxidative Degradation 
1.1.3.1 Electrochemical Oxidation - Generation of Radicals 
and Cations 
Anodic oxidation of unsubstituted phenothiazine 
results in two distinct oxidation steps with half-wave potentials of 
+ 270mv and + 750 mv respectively, measured against a Ag/AgCI 
reference electrode35• The reaction may be represented by the 
following equation: 
-11-
phenothiazine, R 
semiquinone; 
radical cation, s+ 
(orange) 
phenazathionium ion, T+ 
(red) 
The notations used to denote the various forms of the pheno-
thiazine ring are those proposed by Cymerman-Craig39 and 
Tozer45• 
Although the existence of the radical cation was 
postulated by Michaelis as early as 194136, it was not until the 
development of ESR spectrometry that Billon and coworkers were 
able to conclusively demonstrate the existence of the S+ 
species37,38. Either of the S+ or T+ species may be quantitatively 
prepared by electrolysis of a solution of phenothiazine in aceto-
nitrile at the necessary potential. 
The redox potentials of individual phenothiazine deriv-
atives show a pronounced dependance on the nature and position of 
substituent, groups39. Substitution at the phenothiazine ring N 
atom renders oxidation of the molecule more difficult40,41. 
Following acylation this phenomenon would be expected, but with 
alkyl grOlJps at position 10 the observation is contrary to expec-
tation42 as similar substitution at C atoms leads to easier ox ida-
tion. The effect can only be explained if a steric factor is taken 
into consideration (See Section 1.1.4). For the 10-alkylamino 
phenothiazine series the number of C atoms between the two N 
atoms is also of importance, as exempli fied by the effect of pH on 
the redox potentials of these types of phenothiazines. Derivatives 
with three C atoms between the two N centres show little or no 
change in redox potential with pH but for similar compounds with 
only two C atoms the redox potentials show a strong pH depend-
ance
40
, due to the electron withdrawing effect of the protonated 
exocyclic N atom. 
-12-
The influence of acidity on the stabili ty of the cation 
radical (S+) has been investigated polarographically44; an increase 
in pH stabilises S+. A similar effect has been noted by other 
workers45• 
1.1.3.2 Chemical Oxidation - Generation of Radicals and 
Cations. 
An alternative approach to the investigation of the 
radical species and the reaction mechanisms involved in the 
oxidation of phenothiazine derivatives had been adopted by Shine 
who generated the radical species by chemical means. Working 
with solutions of phenothiazine in concentrated sulphuric acid two 
distinct colour changes were observed46 (Yellow to golden-orange 
to green) and were shown to result from the successive loss of 
electrons resulting in the following species: 
R 
+ S 
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phenothiazine 
semiquinone; 
radical cation 
protonated phenazathionium 
cation, m 2+ 
(green) 
The TH2+ species exists only in a strongly acidic 
anhydrous medium. In other media, the phenazathionium 
cation(T+) is present, because of the prototropic equilibrium which 
exists between TH2+ and T+ 43. 
Gilbert et al47 have also utilised chemical oxidation to 
study the generation of radicals and cations from phenothiazine. 
These workers generated the cation radical,S+, with perchloric 
acid and then demonstrated the conversion of this species to the 
neutral radical,S, by treatment with triethylamine or 020. 
~s~ ~N--V 
H 
cation+radical 
(S ) 
neutral radical 
(S) 
The neutral radical has been prepared in the form of 
an N-oxide (XXVII) by treating phenothiazine with hydro per-
oxides91• 
(](I S)1)"" ~ . h N. 
I 0-
(XXVll) 
Other reagents which may be employed for the chemi-
cal generation of oxidised forms of phenothiazine are: 
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Cerric ammonium sulphate 45 
Iron(III) salts 48 
n 3+ and hydrogen peroxide49 
Ce 4+ and dilute sulphuric acid50 
Fe3+ and dilute sulphuric acid51 
Potassium dichromate and glacial acetic acidS2 
Using chemical methods, the effect of substituent 
groups of the phenothiazine molecule on radical or cation 
formation and stability and their relationship to the pharmaco-
dynamic properties of the compounds have been studied. Original 
attempts to measure the rate of formation of the cation radical 5+ 
with cerric ammonium sulphate in dilute sulphuric acid were 
unsuccessful because of the rapid decomposition of the species4S• 
However, in recent studies Gasco and Carlotti50, again using a 
Ce4+/dilute sulphuric acid system, determined the kinetics of 5+ 
formation as 2nd order when the reactants were present in 
equimolar concentrations, and also demonstrated a pseudo 1st order 
formation rate when one of the reagents was present in excess. 
These authors were able to show a correlation between the rate 
constant (decay of 5+) and the reduction potential of some 
phenothiazine drugs. Moreover, the neuroleptic and antihistamine 
groups of compounds could be di fferentiated into two groups on the 
correlation plot. The same authors have also employed ferric 
perchlorate as oxidising agentS3 in order to study the overall rates 
of oxidation of promazine (VI) and promethazine (V). 
The processes involved in the decay of the cation 
radical 5+, leading to oxidation products, has been shown to obey 
2nd order kinetics 45. The influence of substituent groups was 
studied and, in general, it was shown that N-substitution reduced 
-15-
the rate of decay of 5+. Increasing the acidity of the solution had 
a similar effect. Further investigations of the kinetics of 5+ decay 
have been considered by Levi et a154, particularly the influence of 
the disproportionation reaction with respect to lO-alkyl pheno-
thiazines: 
2S+~ R + T2+ 
Decay of 5+ obeyed 2nd order kinetics and the rate determining 
step was postulated to be the hydrolytic decomposition of T2+ 
leading to sulphoxide (See Section 1.1.3.5.below) because dispropor-
tionation and its reverse appeared to be instantaneous reactions. 
Phenothiazine is a good electron donor therefore oxi-
dation may also be achieved by interaction with suitable electron 
acceptors. Foster and Hanson55 postulated that oxidation to the 
cation radical occurred on mixing phenothiazine with the powerful 
electron acceptor 2,3-dicyano- p -benzoquinone. Tsujin056 subse-
quently demonstrated that more moderate electron acceptors, such 
as iodine, were sufficient to cause oxidation of phenothiazine to 
the S+ species in dimethylsulphoxide solution. 
1.1.3.3. Photochemical Oxidation - Generation of Radicals and 
Cations. 
The cation radical (S~ of phenothiazine has been 
generated photochemically with UV radiation in aqueous acetic 
acid media46• However, in 95% aqueous ethanol solution, the 
neutral radical, S, was obtained. Identification of 5 was made on 
ESR evidence. 
A re-evaluation of the reaction in ethanol has been 
conducted by Iwaoka et a158• These workers confirmed that 
photochemical oxidation of phenothiazine in ethanolic solution 
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yields the neutral radical S. The process was shown to be a one 
photon process and the mechanism of formation was postulated to 
be via a molecular phenothiazine/02 complex of the charge-
transfer type. 
Phenothiazine derivatives containing a 2-chloro sub-
stituent are particularly susceptible to photo-oxidation as these 
molecules readily lose the chloro group via free radical form-
t " 59 a Ion • By comparison, derivatives containing alternative 2-
substituents are relatively stable. 
1.1.3.4 Autoxidation 
The ease with which phenothiazine may be oxidised by 
atmospheric oxygen has been known for many years and one of the 
most important early industrial applications of phenothiazine was 
its use as an antioxidant for preventing oxidative changes in 
lubricating oils. 
By bubbling air through an oily solution of la-methyl 
phenothiazine, Brown et al60 were able to isolate the resulting 
sulphoxide (l0-methyl-phenothiazine-5-oxide). Colclough and 
Cunneen61 subsequently demonstrated the capability of pheno-
thiazine to react with hydroperoxides and postulated that the 
antioxidant action of phenothiazine involved both interference with 
the propagation step of the oxidative chain-reaction and decom-
position of the olefinic hydroperoxide. 
The direct photosensitised (UV) autoxidation of the 
pharmacologically important phenothiazine derivatives in aqueous 
acidic solution was originally demonstrated using chlorprom-
azine62(VU). Twelve degradation products were observed of which 
three were identi fied as chlorpromazine N-oxide, chlorpromazine 
sulphoxide and hydroxychlorpromazine. Solution colour changes 
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were noted during the oxidation and are undoubtedly due to the 
formation of free radicals63,64. The radical formed has been 
shown to be a cation radica16\ 
The role of free radicals in the oxidative degradation of pheno-
thiazines is discussed below in Section 1.1.3.5. 
The autoxidation of numerous phenothiazine drugs has 
since been investigated under a variety of conditions. In general, 
the compounds yielded the 5-oxide, together with other degrada-
tion products, often unidentified. Eg. promethazine66, methopro-
mazine67, levopromazine67• tri fluperazine68 and thioridazine69• 
Of particular interest are the results concerning thioridazine. 
Degradation in the influenc·~ of UV irradiation produced a pattern 
of degradation products similar to that reported for other pheno-
thiazine drugs, but under conditions of total darkness only one 
major degradation product was noted. This compound was identi-
fied as a sulphoxide, but was not the expected 5-oxide. Attack of 
the 2-methyl thio ether occurred yielding the following compound: 
(XXV111) 
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In addition, the authors also claimed to have isolated 
an N-oxide species in which the phenothiazine ring N was oxidised: 
(XX1X) 
Oxidation of the phenothiazine ring N in preference to the side-
chain N is contrary to expectation, as substitution of an alkyl 
group at the 10- position causes oxidation at this point to be more 
difficult42• The absence of other literature reports concerning the 
preferential oxidation of the phenothiazine ring N together with 
the knowledge that the position of oxidation was assigned on I R 
evidence alone renders the structual identity of this compound 
suspect. The N-O band observed in the I R spectrum is more 
likely to arise from oxidation of the piperidine (side-chain) nitrogen 
atom. 
A detailed investigation of phenothiazine oxidation in 
an oxygen-saturated acidic media protected from light has been 
conducted by Roseboom and Perrin. The major degradation 
products were identified70 (Fig. 1.1) and 1st order kinetics demon-
strated71 with respect to the disappearance of phenothiazine. 
Furthermore, by kinetic means, the authors were able to demon-
strate that XXX and XXXI were formed by parallel reactions, but 
XXXlll was produced independantly. Hence a mechanistic pathway 
for the formation of the degradation products of phenothiazine was 
postulated 72. By contrast, N-methyl-phenothiazine (XXXV) 
-19-
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phenothiazine-S-oxide 
(XXX) 
3S-phenothiazine-3-one 
(phenothiazinone, XXX1) 
7-hydroxy-3a-phenothiazine 
3-one (XXXll) 
7-(lO'-phenothiazinyl)-
3H-phenothiazine-
3-one (XXXlll) 
formed only two degradation products 71, phenothiazine sulphoxide 
(XXX) and N-methyl-phenothiazine sulphoxide, which were shown 
to be produced by parallel reactions. 
In an extension to the above study, degradation of the 
la-acetyl derivative of phenothiazine under acid conditions 73 was 
studied (again in the dark). This compound was considered as a 
model for phenothiazines possessing a carbonyl group adjacent to 
the ring N, compounds which exhibit antiarrythmic properties74• 
None of the observed degradation products contained the acetyl 
group, and were identified as identical to those reported previously 
for phenothiazine 70 (Fig. 1.1). Kinetic investigations in the 
presence and absence of oxygen, together with the fact that the 
acetyl group was absent from all degradation products, indicated 
that la-acetyl-phenothiazine degraded via a specific hydrogen -ion 
catalysed hydrolysis, followed by subsequent oxidation of the 
phenothiazine so formed. 
Underberg has extensively studied the degradatic n of 
promethazine. An aqueous oxygen-saturated solution of prometh-
azine hydrochloride was allowed to degrade in the dark, and the 
resulting major oxidation products were isolated and identified. 
Fig. 1.2 shows the identity of the compounds. Disappearance of 
the parent compound followed 1st order kinetics 7 6 • The influence 
of Fe and Cu ions on the degradation process was demonstrated76 
and a mechanism by which the ions could affect the degradation of 
the drug was postulated. 
Further work aimed at correlation of the oxidative 
degradation pattern with the nature of the 2-substituent has been 
reported by Underberg et a1 77 • After comparing the degradation 
patterns of 2-methyl promazine, triflupromazine and cyanopr,m-
-21-
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(XXX) 
Fig. 1.2 - The Major Degradation Products of Promethazine 
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azine the authors postulated that with an electron-withdrawing 
group at the C-2 position, an interaction with the N-10 side-chain 
is possible, leading to demethylated degradation products; thus 
. explaining the formation of demethy lated products from 
triflupromazine and cyanopromazine, and not from 2-methyl 
promazine. 
1.1.3.5. Reaction Mechanisms - The Role of Radicals and 
Cations 
The majority of products formed during the oxidative 
degradation of phenothiazine derivatives may be explained in terms 
of free-radical and cation intermediate species. Three types of 
reaction may be distinguised: 
a) oxidative coupling(resulting in dimers) 
b) hydrolysis of cations yielding 5-oxides 
c) hydrolysis leading to 3-oxo substi tuents 
a) Oxidative Coupling; Dimer Formation 
ESR studies have shown that the greatest spin-density in the 
unsubstituted phenothiazinyl free radical is concentrated at the N, 
5, C-J and C-7 atoms78• The sulphur atom in the sulphide bridge 
shows no tendency to form a third covalency42 and hence no 5-
linked dimers have been reported. Dimers linked via a· N-N 
. 79 80 81 
couplIng have been prepared ' , , but have not been reported 
as oxidative degradation products. Formation of a C-C linked 
dimer at C-3 has been claimed by Fujisawa82, by the action of 
white fluorescent light on an aqueous acid solution of 
methoxypromazine: 
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(XXXV1) 
The most commonly encountered dimers occurring as degradation 
products are the N-C linked compounds. 7-(lO'-phenothiazinyI)-3-
H-phenothiazine-3-one (XXXlll, Fig. 1.1) has been identified in an 
ageing solution of phenothiazine 70. 
When dissolved in a mixture of DMSO and acetic anhydride 
(deoxygenated) phenothiazine is slowly converted into two dimers 
(XXXVll and XXXVlll) and certain higher polymers (proposed as a 
trimer and tetramer)83. The reaction was postulated to proceed 
via the neutral free radical, 5·. In DMSO/iodine solution the 3,10' 
dimer (XXXVlll) is formed in 64% yield56• 
O S ~I N 
H 
~N~ ~S~ 
1,10' biphenothiazine 
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(XXXVll) 
o:so~ ~ I I /:: N 
H 
(XXXVIII) 
3, 10' biphenothiazine 
b) Hydrolysis of Intermediate Cations; Formation of Sulphoxide 
Electrochemical generation of the phenazathionium cation (T+) 
from phenothiazine followed by treatment with hydroxylated bases 
results in the formation of phenothiazine-5-oxide40,85,. 
-2e 
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H 
N-substituted phenothiazine derivatives, however, form the 5-oxide 
wi th such ease that the traces of water present in the solution are 
sufficient to hydrolyse the intermediate cation species generated. 
In this latter case, the lack of a H atom in the 10 position (i.e. the 
ring N) prevents the elimination of H+ and thus a highly reactive 
bivalent cation (XXXIX) is produced which is immediately hydro-
lysed to the 5_oxide86• 
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(XXX1X) 
Intermediate cation formation during the chemical oxidation of 10-
alkylamino phenothiazines to the corresponding sulphoxide (5-
°d ) dOh h t b 0 87 OXl e has been demonstrate Wit suc reagen s as romme , 
lead tetra acetate88 and sulphuric acid89• 
An alternative reaction mechanism via the radical cation, 5+, 
leading to production of the 5-oxide has been described85,86. 
Instead of the direct oxidation of phenothiazine to the phenaza-
thionium cation T+ (loss of two electrons), the intermediate radical 
cation 5+ (loss of one electron) is formed which then dispropor-
tionates, particularly in alkaline solution, resulting in the forma-
tion of T+. Hydrolysis of the T+ species to the 5-oxide may then 
take place. The reaction pathways are summarised in Fig. 1.3 • 
• + C6H4SNHC6H4 
(phenothiazine) 
-8 
• C6H4SNHC 6H4 
, 
, 
, 
, 
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, 
, 
, 
, 
hydrolysis "-
5-oxide ~4~--------------
(S=O) 
(two moles) 
(S+) 
(phenothiazine) 
(T+) 
Fig. 1.3 - Reaction Pathways for 5=0 Formation 
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Hydrolysis of the phenazathionium cation (T+) has been further 
investigated90 by tracer experiments using H20
18
• Photoxidation 
of chlorpromazine (Vll) in H20
18 
and ethanol/H20
18 
solutions 
resulted in a 5-oxide product that did not contain 0 18• Thus in the 
case of photoxidation, hydrolysis of T+ does not appear to be the 
mechanistic pathway. The authors postulated a peroxyl radical 
(XL) as precursor to the sulphoxide on the basis of flash-photolysis 
experiments. 
(XL) 
c) Hydrolysis Leading to 3-oxo Substituents 
Nucleophilic attack by water on the T+ ion yields phenothiazine-3-
one 46. The reaction is concurrent wi th that of 5-oxide formation 
and dependant on the acidity of the solution. Strongly acid 
conditions favour 3-one formation because protonation of the 5-
oxide leads to S+ 46 i e. sulphoxide formation is acid reversible. 
Fig. 1.4 summarises the competing reactions. 
1.1.3.6. Biological Oxidation 
Over the past 30 years considerable effort has been devoted to the 
investigation of the metabolic changes undergone by phenothiazine 
drugs. The majority of reports concern chlorpromazine (VU) which 
has become the accepted model for such investigations. A recent 
estimation of the number of chlorpromazine metabolites observed 
-27-
OH 
I 
~~~ ~N~ 
H 
en 
-
.., 
o 
::::J 
(Q 
i» (') 
-Q. 
+ 42 
Fig. 1.4 - fompeting Reactions in Hydrolysis of T 
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since the discovery of the drug94 totalled some 168. However, 
many of the observed compounds have not yet been fully identified. 
In general, metabolic transformation of 10-alkylamino-
phenothiazine drugs leads most usually to the 5-oxide, the 7-hydroxy 
derivative, the side-chain N-oxide and demethylated products92• 
Further oxidation of the sulphoxide to sulphone may also take 
place. Fig. 1.5 shows the structures of typical compounds. 
Obviously, the chemical structure of the compound will ultimately 
determine the metabolic profile. Eg. phenothiazines substituted at 
the 2-position with a sulphur-containing group (thioridazine, Xl)_ 
can, and do, form the alternative sulphoxide93• The 
oxidoreductase enzymes present in the liver are believed to be 
responsible for the formation of the S- and N- oxides98 and have 
been utilised by some workers as a means of synthesizing these 
compounds (See Section 1.2.1.2). 
1.1.4. Molecular Configuration 
Conflicting accounts of the molecular configuration of pheno-
thiazines are to be found in the literature. Some workers have 
interpreted the available evidence to indicate a planar structure 
whereas others believe a folded structure about the N-S axis to be 
the case. The folded structure is the more generally accepted. 
Malrieu and Pullman have considered the proposed tetragonal-
folded structure of phenothiazine in detail95• Two extremes of 
conformation are possible with the 10-hydrogen atom in either the 
intra (endo or quasi equatorial) position, or the extra (exo or quasi 
axial) posi tion - Fig. 1.6. 
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H·intra H-.extra 
Fig. 1.6 - Oonfiguration of Phenothiazine 
Unsubstituted phenothiazine was shown to adopt the H-intra con-
figuration by comparing the calculated and experimental values for 
the spin densities of the corresponding free radical. More recent 
considerations of dipole moments has indicated that 2-substituted 
phenothiazine may, in fact, exist in solution as a mixture of the 
conformers96• 
Substitution of an alkyl substituent at the ring N was postulated to 
result in formation of the 'extra' conformer because of the bulk of 
the substituent group95. The two forms 'intra' and 'extra' are not 
electronically equivalent because the proximity of the N lone-pair 
to the aromatic rings changes and thus alters the energy of the 
highest filled molecular-orbitaI42• It is for this reason that 
oxidation of N-substituted phenothiazines is rendered more diffi-
cult ie. the oxidation potential of N-substituted derivatives is 
increased. Following NMR experiments with S-oxidised pheno-
thiazines, Russian workers also concluded that lO-alkyl pheno-
thiazines adopt the 'extra' configuration205• 
Calculations by Reboul and Cristau97, based on previously publish-
ed crystallographic data, have demonstrated that the N-alkyl side-
chain does indeed stretch away from the ring system and that 
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introduction of a 2-substituent tends to increase the folding of the 
'butterfly' tricyclic system. 
1.2. Synthesis of N- and S-Oxides 
1.2.1 Practical Aspects(pertaining to tricyclic moieties) 
1.2.1.1. Chemical Methods 
Oxidation of substituted phenothiazine generally leads to a 
mixture of oxidation products42• Specific S-oxidation may be 
achieved with the hydroperoxides of tetrahydrofuran and di-
oxan99, compounds which are present in these solvents following 
autoxidation. Alternatively, the action of HN03/acetic acid on 
the protected N-benzyl phenothiazine yields the corresponding 
sulphoxide, which may then be converted to phenothiazine sul-
phoxide by removal of the benzyl substituent via alkaline hydro-
lysislOO (85% yield phenothiazine sulphoxide). Acetylation has 
also been utilised to protect the phenothiazine ring N during the 
preparation of the sulphonelOl ie. the 5, 5 dioxide. 
In the specialised case of lO-aminoalkyl phenothiazines, numer-
ous methods have been developed to allow the specific oxidation 
of either the ring S, or the side-chain N. (Oxidation of the 
phenothiazine ring N is unlikely because of the high value of the 
oxidation potential when substituted with an alkyl group - See 
Section 1.1.3) Specific S-oxidation is most commonly gained via 
an acetic acid/hydrogen peroxide system102• This procedure 
yields the 5-oxide in quantitative amounts on a semi-micro scale 
and has been applied to the detection of phenothiazines in 
biological fluids l02• It is also the basis of a quantitative 
fluorimetric assay for phenothiazines103• A similar preparative 
procedure has been reported for the selective synthesis of the 
sulphoxide of piperazino dibenzothiepines104( XLI). 
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(XU) 
The hydrogen peroxide/acetic acid system has the added advan-
tage that by raising the temperature to 70oC, the corresponding 
sulphone may be synthesised even in the presence of a side-chain 
containing tertiary amino groupsl05. 
Other reagents which have been reported to selectively oxidise 
the 5 atom in the presence of an amino-alkyl side-chain are: 
lead tetra_acetatel06,118 
periodic acidl07,109 
chromium trioxide/acetic acidl08 
potassium permanganate/acetic acidl08 
ozone
llO 
sodium nitrite/acetic acidlll 
. 1 h t 112 ammonium persu p a e 
perbenzoic acid(or itsm-chloro derivative)113,119 
The selective oxidation of the side-chain tertiary amino N 
centre(s) is less well defined. Numerous procedures exist but 
none has become universally accepted. A Japanese patent 
records. the use of Ca(OCI)2 for the preparation of chlorprom-
azine N-oxide1l4• An ethanoUc solution of hydrogen peroxide, 
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followed by a palladium/charcoal treatment has been employed 
by several workers1l5, 116 for the synthesis of N-oxides, al-
though use of ethanolic hydrogen peroxiqe alone apparently 
resulted in formation of the mixed N-oxide-sulphoxide of chlor-
promazine1l7• With piperazino dibenzothiepines however, 
ethanolic hydrogen peroxide alone yielded the N_oxidelOS (XLU). 
The use of m-chlorperbenzoic acid has been similarly describ-
ed120• 
(XLll) 
In contrast to the above direct oxidations, selective synthesis 
may also be accomplished by indirect procedures. Eg. to prepare 
the sulphoxide of chlorpromazine, phenothiazine sulphoxide is 
first synthesised then the required alkylamino side-chain is 
attached121• Many such procedures have been described in the 
literature, often as a means of avoiding the infringement of 
patent rights. 
1.2.1.2. Enzymic Methods 
Conversion of phenothiazine derivatives to the corresponding 
sulphoxide and N-oxide by the enzymes present in Ii ver micro-
somes is a well-documented feature of the metabolism of these 
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1.2.2. 
compounds98, 123. (See also 1.1.3.6). N-oxidation in particular 
is considered to be a major metabolic route of phenothiazine 
drugs124• Using pig-liver microsomes, Sofer and Zeigler125 have 
developed a novel procedure for the selective preparation of the 
N-oxide of such compounds as fluphenazine, thiopropazine and 
trifluperazine. In order to achieve a useful yield the stability 
and activity of the oxidases was enhanced by covalent bonding to 
glass beads126• By this means 500mg quantities of the N-oxide 
of each compound was synthesised. 
Kinetic and Mechanistic Aspects 
The oxidation of phenothiazines tosulphoxides by some chemical 
oxidising agents has been discussed previously (Section 1.1.3.5) in 
terms of a mechanism involving the phenazathionium cation and 
the phenothiazine cation radical. However, the reaction of 
peroxides with organic nitrogen and sulphur centres involves an 
entirely different mechanism and is fully discussed below. 
1.2.2.1 Organic Sulphides 
Oxidation of dialkyl sulphides with percarboxylic acids may be 
summarised by the following mechanism127 • 
., H, o , , 
I 0 
O 1/ 
...... C 
I, 
R 
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The reaction is usually fast and accelerated by electron-donating 
groups in the sulphide or electron-withdrawing groups in the 
peracid. The reaction shows no dependance on the presence of a 
strong acid128,129. A similar mechanism may be written for the 
reaction of dialkyl sulphides and hydroperoxides130• 
HX 
_~ H, Y'_y , R-~---O rX r.~ ~, \_ ~ I O---H 
/ R' 
, 
R2S=O + ROH + HX 
The reaction is.st order in both sulphide and peroxide (ie. 2nd 
order overall). n contrast to the reaction with peracid, hydro-
peroxide oxidations are strongly acid-catalysed. The role of the 
acid, HX, is to facilitate the loss of the leaving group ROH from 
the transition state. With the peracid the additional proton 
source is not required because the geometric characteristics of 
the molecule provide a low-energy cyclic transition state for the 
loss of RCOOH128• The nature of the protonic material HX can 
be any potential proton donor, such as the protic solvents alcohol 
and water. The effectiveness of HX is determined by its pKa. 
Work in aprotic solvents has shown that in the absence of other 
protonic material, the alkyl hydroperoxide can itself function as 
the proton donor. In this case, the oxidation rates are 2nd order 
in hydroperoxide The acid strengths of alkylhydroperoxides 
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have been found to correlate with the rate of oxidation of the 
I h'd 128 su pie • 
On addition of strong acid to the hydroperoxide however it is the 
acid which is preferentially involved (as HX) in the transition 
state. Eg. acetic acid added to hydrogen peroxide; acetic acid 
acts as the HX species. The very much lower pKa of acetic acid 
accelerates the reaction rate. Hence a mixture of acetic 
acid/hydrogen peroxide has an oxidation rate comparable to that 
of a peracid. The effect is believed to be catalytic rather than 
the 'in situ' generation of peracetic acid as oxidation usually 
occurs faster than the rate of formation of peracetic acid128• 
Sulphoxides may be further oxidised to sulphones by percarboxy-
lic acids or by hydroperoxides. With peracids, the conversion of 
sulphoxide to sulphone is slower by a factor of 100 to 1000 than 
the initial formation of sulphoxide from the dialkyl sul-
phide86,122,129,131,138. A reaction mechanism similar to that 
illustrated on p.35 was originally postulated for sui phone forma-
tion, but more recent reports indicate that the fQllowing mech-
anism may be more accurate132• 
o 
II _ 
+ RCOO 
OH 0 
I II 
~S-OOCR 
Conversion of sulphoxide to sulphone with hydroperoxides re-
quires elevated temperatures and/or the addition of a suitable 
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catalyst. Temperatures above 700 C are generally used and 
typical catalysts include the carboxylic acids133 and the salts of 
molybdenum134, zirconium135 and vanadium136• 
1.2.2.2. Tertiary Amines 
Publications concerning the oxidation of t-amines are relatively 
sparse in comparison to the literature describing the many 
aspects of S-oxidation. However, the following mechanism has 
been proposed137 for the reaction of alkylhydroperoxides with t-
amines. 
/H .~ ~/H + -~N-O 
.. 0 RaN---O r.d. RaN + I --. I~ .. + 0 I rI./ 0 R-OH ,/ R 
Aqueous hydrogen peroxide is sufficient to convert aliphatic t-
amines to the corresponding oxide but less reactive compounds, 
such as the heterocyclic t-amines, often require peroxy acids. 
m-chloroperbenzoic acid in chloroform solution has been re-
commended as a means of preparing tertiary amine 'N_oxides107 
in almost quantitative yields. 
As with the oxidation of dialkyl sulphides, the rate of the 
reaction increases with increasing nucleophilicity of the amine 
and electrophilicity of the peroxide. The reaction is not acid-
catalysed, indicating the decreased dependance on hydrogen-
bonding for loss of the leaving group R-O. A low pH is 
disadvantageous due to the decrease in effective concentration 
of the amine. Thus the attempted oxidation of t-amines with 
trifluoroperacetic acid results in the formation of the TFA salt 
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of the amine, no oxidation to the amine oxide being noted139• 
1.3. Analysis of N- and S- Oxides 
The occurrence of N- and S- oxides as degradation products, and as metabolic 
products, of tricyclic drugs requires that suitable analytical procedures be 
available for the quanti tation of the compounds. A variety of procedures have 
been reported for this purpose and are discussed individually below. 
1.3.1. Spectrophotometric Procedures 
Many of the colorimetric methods described for the quantitation 
of phenothiazines140 may be successfully applied to the determination of the 
corresponding N- and S- oxides. One notable exception is the procedure 
involving the chelation of phenothiazine with suitable metal ions (e.g. 
palladium141) forming a coloured complex. The metal chelates at the S atom 
of the tricyclic ring system and thus sulphoxides and sulph~:1es are not 
sensitive to this reagent. 
Most of the early spectrophotometric procedures tin respect of 
phenothiazine oxides) were developed in order to assay the sulph )xide present 
in biological samples. Thus, for example, Flanagan et al142 utilised a UV 
method, Hetzel143 nitrated the compounds forming yellow-coloured products, 
and Gothelf and Karczmar144 used ferric ammonium sulphate which produced 
a red colour. More recently Difference Spectrophotometry has been describ-
ed145 for the assay of the suJphoxide content of degraded phenothiazine 
formulations. The assay is speci fic for the suJphoxide moiety in the presence 
of the parent phenothiazine drug, but in order to avoid interference from 
other oxidation products, a selective alkaline extraction procedure was 
included. 
The speci fic determination of t-amine oxides may be achieved by 
an indirect colorimetric method146• The N-O is allowed to react with 502 
forming an adduct. Subsequent hydrolysis yields a secondary a .."ine and an 
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aldehyde, the latter of which can be determined calorimetrically. 
1.3.2. Fluorimetric Procedures 
Phenothiazines exhibit only a weak native fluorescence. How-
ever, on conversion to the sulphoxide an intensely fluorescent molecule is 
obtained103,14B. This phenomenon has been made the basis of an assay 
procedure for the determination of both phenothiazines149 and thioxan-
thenes150 in biological fluids. 
1.3.3. Chromatographic Techniques 
TLC systems have been extensively used for the separation of 
phenothiazine degradation products, including the sulphoxide, sulphone and 
side-chain N-oxide, from the parent compound140• Quantitation of the 
chromatograms may be achieved by densitometry151. Conversion of the 
parent compound to the sulphoxide on the surface of the TLC plate has been 
noted16B,169. Thus particular care must be exercised when examining 
phenothiazines by TLC in order to avoid erroneous results. 
Of the aminoalkyl phenothiazine oxides only the sulphoxide and 
sulphone are amenable to direct GC analysis since the N-oxide derivatives 
d th 1 " 152 "'ld" II I d "C 1" t' 153 un ergo ermo YSIS Yle mg an a y compoun via ope e Imma Ion 
However, this reaction has formed the basis of an indirect GC assay for 
hI "N 'd 152 c orpromazme -ox I e • The majority GC procedures in recent years 
have been applied to the determination of the metabolites of phenothiazine 
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drugs140• In order to improve the sensitivity of the GC procedure a 
combined GC - Mass Spectrometry method has been reported154• Similar 
procedures have been utilised for the identification of some phenothiazine 
metabolites155,156. 
In view of the problems encountered with the GC of the oxides, 
HPLC has proven to be the most useful of the chromatographic methods for 
the direct quanti tation of tricyclic N- and 5- oxides, particularly when a 
mixture of oxidation products is expected to be present. Eg. the separation 
of the oxides of thioridazinel57 (Xl). Examples of the application of both 
normal_phaseI57,158,159 and reversed_phase160,161,162 HPLC are apparent 
in the literature. UV detection is normally employed, but with sulphoxide and 
sulphone a fluorimetric detector has also been utilised157• 
1.3.4. Electrochemical Methods 
The use of electrochemical methods during the investigation of 
phenothiazine oxidation by Billon and co-workers has been referred to 
previously. However, cathodic polarography may be successively used to 
quantitatively determine sulphoxides in the presence of the parent com-
pound163• Beckett et al164 have determined the metabolic N-oxide, N-oxide 
sulphoxide and sulphoxide of chlorpromazine after prior separation by con-
ventional partition. German workers have adopted polarography as a means 
of assaying chlorpromazine tablets by first oxidising the phenothiazine to the 
polarographically reducible sulphoxide165• 
1.3.5. Radio-immuno Assay(RIA) 
Description of the application of RIA procedures to pheno-
thiazine oxides are restricted to the determination of the level of inter-
ference during assay of the parent166,167. In the majority of cases the 
sulphoxide is almost devoid of cross-reactivity, typically about 0.6%. No 
doubt, if required, a specific antibody for reaction with sulphoxide could be 
raised, but with the many alternative methods already available, an RIA 
method is unlikely to be developed in the near future. 
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CHAPTER 2 
FLUPHENAZINE DECANOATE INJECTION(MODECATE) 
2.1 Introduction 
Modecate injection is a depot-action phenothiazine formulation designed for 
the management of acute schizophrenia and marketed as a solution of the ester in 
sesame oil. The idea for such a novel product was conceived when Yale, working 
at the Squibb Institute for Medical Research in New Brunswick (USA), discovered 
the extended duration of activity associated with fluphenazine esters when 
formulated as a solution in sesame oil solution.15 
2.2 The Formulation 
The normal Modecate formulation is given below:-
Material 
Fluphenazine decanoate 
Benzyl alcohol 
Sesame oil 
Quantity 
25mg 
15mg 
q.s.lml 
Benzyl alcohol is included in the standard formulation, its original, purpose 
being a preservative for the multidose pack. 
2.3 Degradation Routes 
Numerous degradative pathways for fluphenazine decanoate formulated in 
sesame oil have been identified, all of which are predictable from a knowledge of 
the chemistry of the active. 
2.3.1 Hydrolysis 
Hydrolysis of the side-chain ester linkage in fluphenazine dec an-
oate yields fluphenazine and decanoic acid: 
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r-\. 
~-(CHz'-N N-(CHz) OH \: :13 "--I 2 
This reaction is particularly detrimental to the product as relative-
ly high concentrations of free fluphenazine are considered clinically undesir-
able and may lead to unacceptably high initial blood-levels 170. 
2.3.2 Transesterification 
Sesame oil consists of a mixture of triglycerides derived from oleic 
(45.4%), linoleic (40.4%), palmitic (9.1%), stearic (4.3%) and arachidic (0.8%) 
acids171• Hence interaction of fluphenazine decanoate with the oily vehicle 
can produce such esters as fluphenazine oleate, linoleate, palmitate and 
. 12 
stearate by transesterification. The trans-esters may be detected by GLC 
or HPLC173• 
2.3.3. Oxidation 
The phenothiazine ring may undergo a variety of oxidation re-
actions (Section 1.1.3), but the only ring-oxidation product reported to date in 
Modecate injection is the sulphoxide. This compound may be detected in 
aged formulations using a TLC procedure174• 
Oxidation of the side-chain will result in the formation of a t-
amine N-oxide. The occurrence of such a degradation product was confirmed 
in 1971174 when small amounts were isolated from an artificially aged 
formulation. Preparative layer chromatography was utilised for the 
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isolation of the degradation products which were then examined by mass 
spectrometry. Two independant interpretations174, 185 of the Ms data 
agreed that one particular isolated zone from the TLC plate was probably the 
N-oxide of fluphenazine decanoate, although the thermolabile nature of the 
species rendered an absolute identification impossible. Attempts to confirm 
the identity of the N-oxide by synthesis of a compound with the proposed 
. 174 175 
structure were, at that time, unsuccessful • Subsequent work by Heyes 
eventually led to the synthesis of a compound with an Rf value (TLC) 
identical to that of the compound believed to be the N-oxide. However, 
further structural investigations were not undertaken. 
2.3.4. Photolysis 
Storage of the product is usually in the dark, by virtue of the 
packaging; thus photolysis is a highly unlikely degradation route. If, 
however, opened packages were left exposed to light, production of the 
sulphoxide could be postulated by analogy with similar studies concerning 
chlorpromazine90• No investigations of this nature have been undertaken 
with the Modecate formulation. 
2.4 Factors Affecting Formulation Stability 
2.4.1 Water Content of Sesame Oil 
A study of the effect of water on the levels of free fluphenazine 
produced by hydrolysis of the active during storage of the formulation has 
conclusively demonstrated a positive relationship176. Increasing the amount 
of water added to a previously dried sesame oil containing fluphenazine 
decanoate and benzyl alcohol, resulted in a corresponding increase in free 
fluphenazine during accelerated stability tests. A ten-fold increase in water 
content (from ~.01 to 0.1%) caused a three-fold increase in free fluphenazine 
levels. Above 0.1 % added water, the sesame oil/water mixture 
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was immiscible. 
2.4.2 Effect of Hydroperoxide Content of Sesame Oil 
2.4.2.1 F ormation of Peroxide 
Reference has previously been made to the triglyceride constituents of 
sesame oil, the majority of which are derived from the unsaturated 
fatty acids (oleic 45.4%, linoleic 40.4%). 
CH3(CHZ)7 CH = CH (CH2)7COOH 
oleic acid 
(cis-9-octadecenoic acid) 
* CH3(CHZ)4 CH = CH CHZ CH = CH(CH2)7COOH 
linoleic acid 
(cis-9, cis-1Z-octadecadienoic acid) 
The presence of the C=C double bond renders these molecules 
susceptible to autoxidation. The linoleate moiety has been 
reported to autoxidise about eleven times faster than oleate 
because of the highly activated methylene group (shown starred 
above) in the centre of the 1:4 pentadiene systeml77• 
The early stages of autoxidation are characterised by the form-
ation of hydroperoxides via a chain reaction involving free radicals: 
Initiation: Initiator .. R· 
Propagation: R·+ O2 .. ROO· 
. 
.. ROOH + R· ROO + RH 
Termination: R· + R· .. R-R 
R·+ ROO· .. ROaR 
• • ROO + ROO ~ ROOR + O2 
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It has been suggested177 that the reaction may be initiated either 
by a photochemically activated oxygen molecule, or by the direct 
attack of oxygen on the more reactive linoleate system. The 
radicals obtained from the oleate chain are shown below: 
1 R - CH - CH = CH - CH2 - R 1~ 
• 1 
R - CH2 - CH - CH = CH - R 
1~ 
R - CH = CH·- C H CH2 _ R 1 1~ 
" 1 R - CH2 - CH = CH - CH - R 
These mesomeric structures account for the observed formation of 
the four hydroperoxides17S, the order of decreasing yield being 
C10>Cll > CS>C9" 
Similar structures may be written for linoleate: 
" 1 R - CH - CH = CH - CH = CH - R 
1~ 
. 1 
R - CH = CH - CH - CH = CH - R 
1~ · 1 
R - CH = CH - CH = CH - CH - R 
Again the structures explain the sequence of observed products. In 
the initial stages of oxidation, attack is almost entirely confined to 
Cll' because of the highly activated nature of this methylene 
group. However, the conjugated radicals are more stable than the 
non-conjugated form and ultimately the formation of the con-
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jugated hydroperoxides predominates (90% yield). 
The level of hydroperoxides in sesame oil depends on both the 
degree of refining and on the storage conditions of the refined oil. 
2.4.2.2. Reaction of Peroxides with Fluphenazine Decanoate 
The effect of increasing peroxide levels of sesame oil on the 
degradation of fluphenazine decanoate has been studied. A 
corresponding increase in the formation of the N-oxide degradation 
product was noted179 even in the absence of dissolved air or 
oxygen (See next section). 
The exact mechanism by which the N-oxides are formed from 
fluphenazine decanoate in the oily vehicle are unknown, although 
an interaction between the phenothiazine and the radical chain-
propagating peroxide species has been postulated61 in connection 
with the antioxidant activity of lO-methyl-phenothiazine. Alter-
natively, the drug may react with the true hydroperoxide(formed 
during the hydrogen-abstraction step) by a conventional nucleo-
philic/electrophilic reaction mechanism. 
2.4.3 Effect of Dissolved Oxygen 
Using a freshly refined sesame oil devoid of peroxide, the effect of 
dissolved oxygen on the formation of fluphenazine decanoate N-oxide has 
been investigated179• When compared with a deoxygenated control 
sample, the formulation containing dissolved oxygen was found to contain 
twice as much N-oxide after storage under identical conditions. 
By contrast, similar solutions of the drug in coconut oil containing 
dissolved oxygen (as air) showed little, if any degradation to the N-oxide 
following accelerated stability studies180, but the. possibility of a direct 
reaction between dissolved oxygen and fluphenazine decanoate via a free 
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radical mechanism cannot be entirely eliminated on the basis of the 
described experimental work. However, the results are sufficient to 
indicate that the most likely role of oxygen is to react with the 
unsaturated triglycerides of the oil prior to the formation of the N-oxides 
of the drug via the intermediate hydroperoxides. 
2.4.4 Effect of Free Fatty Acid Content of Sesame Oil 
An increase in the free fatty acids present in the sesame oil 
vehicle could contribute to the accelerated degradation of fluphenazine 
decanoate as both transesterification and hydrolysis are known to be acid-
catalysed reactions1B1• 
A factorial studylB2 has confirmed the expected catalytic effect 
for transester formation in a sesame oil solution of fluphenazine decan-
oate. The same study also demonstrated that production of N-oxide and 
free fluphenazine was subject to acid-catalysis but to a lesser extent than 
transesteri fication. 
2.4.5 Effect of Metal Ions 
Metal ions have been shown to exert a profound effect upon the 
stability hydroperoxides, inducing decomposition via free radical mechan-
isms1B3 Transition metals in particular have been investigated. The 
presence of trace metals in an autoxidising system results in a more rapid 
rate of chain initiation through the following reaction: 
+ 2+ 
2 ROOH M ; M., ROO· + H20 + ·OR 
Cobalt, copper, iron and lead compounds have been reported in this 
respect183• 
The influence of copper and iron on the degradation of fluphen-
azine decanoate in sesame oil solution has been studied. A preliminary 
study184 showed that both metals had little effect on the degradation 
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rate, but a subsequent factorial study182 indicated that the presence of 
Fe3+ ions caused an increase in the production of N- and 5- oxides. 
Choice. of metal ions used in the above investigation appears to 
have been arbitrary. An alternative, and perhaps more useful, approach 
would be to initially examine sesame oil by x-ray emission spectrometry 
in order to identi fy those metals most commonly present and to determine the 
approximate levels. 
2.4.6 Effect of Benzyl Alcohol 
Some loss of benzyl alcohol has been noted during stability studies 
in multidose vials (rubber stopper)180 and, more recently, in ~ealed glass 
vials184• A number of possibilities exist to account for the observed loss: 
a) a physical loss through the rubber vial closure, as described by 
Royce and Sykes186• 
b) an involvement in the degradative reactions. 
c) conversion of the benzyl alcohol to the corresponding ester by 
reaction with the free fatty acids present. 
Investigation of the above possibilities has not been undertaken. 
2.5 Selection of Topics for Investigation 
From the foregOing resume of work completed to date concerning 
the degradation of fluphenazine decanoate in sesame oil solution numer-
ous areas for further study can be identified. The general concept of 
oxidation of the phenothiazine derivative was chosen for investigation, 
particularly the aspects of N- and S- oxidation which is thought to occur 
in oily solution. Little has been reported in the literature concerning such 
reactions except for early references to the antioxidant action of 
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phenothiazine and some of its derivatives. Squibb in-house R&D reports 
have described the tentative identification of an N-oxide in degraded oily 
formulations and also the observation of a sulphoxide. 
Before investigations of the oxidation reaction(s) could be attempt-
ed, reference compounds of the individual oxides were required to act as 
markers for qualitative studies and as standards for quantitative investi-
gations. Establishing the identity of any synthesised compound is impera-
tive before using the material as a reference compound. Hence a full 
spectral characterisation of the synthesised oxides was proposed -
especially since previous attempts to identify the N-oxide of fluphenazine 
decanoate were never satisfactorily resolved. 
Studies at the Squibb Institute for Medical Research (International 
Development Laboratory, U.K.) have indicated that the oxidation of 
Modecate in sesame oil is due to the reaction of fluphenazine decanoate 
with the hydroperoxides formed during autoxidation of the oil. In order to 
gain further knowledge of the mechanism and kinetics involved it was 
proposed to study the reaction between fluphenazine decanoate and 
simplified systems of pure hydroperoxides and autoxidised olefines. 
Essential to the above proposal is the availability of a suitable 
analytical procedure for the determination of the oxides formed. HPLC 
offers the most flexibility in this respect with a variety of columns and 
detectors being available. The technique is ideal for the chromatography 
of N-oxides which are often thermolabile and therefore not amenable to 
direct GC analysis. Thus the development of an appropriate HPLC assay· 
procedure was required. 
The role of benzyl alcohol in the formation of N- and S-oxides of 
the drug has been investigated by the Squibb R&D Department, but was 
dismissed as being of little consequence. These studies however were 
originally conducted using a semi-quantitative TLC procedure for 
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estimation of the oxides and for this reason the conclusions of the study 
cannot be taken as absolute. Quantitative determinations using an HPLC 
procedure should produce reliable and meaningful data for interpretation. 
In addition, a reference to the direct reaction of benzaldehyde, (traces of 
which are present in benzyl alcohol as an impurity, B.P. limit 0.2%) with 
atmospheric oxygen forming the powerful oxidant perbenzoic acid187 is 
apparent in the Ii terature. 
Ph CHO + 02 • Ph eOOH 
II 
o 
Therefore, a study of benzyl alcohols of varying purity and their effect on 
the oxidative degradation of fluphenazine decanoate was proposed. 
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SUMMARY OF ASPECTS FOR STUDY 
1. Devise synthetic routes for the preparation of the N- and S-oxides of 
fluphenazine and its decanoate ester. 
2. Investigate the spectral properties of the synthesised oxides and conclusively 
identi fy the compounds. 
3. a) Develop an HPLC procedure for the assay of small amounts of N- and S-
oxides in the presence of the parent compound. 
b) Using this assay procedure, investigate the kinetics/mechanism of the 
reaction between fluphenazine decanoate and hydroperoxides. 
4. Investigate the role of benzyl alcohol and benzaldehyde in the oxidative 
degradation of fluphenazine decanoate. 
Each of the above aspects form the basis of a separate chapter. 
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CHAPTER 3 
OXIDA TION OF FLUPHENAZINE AND ITS DECANOATE ESTER; 
SYNTHESIS OF THE N- AND S-OXIDES 
3.1. Synthesis of the Oxides 
3.1.1 Introduction 
3.1.1.1 Theoretical Oxides 
The chemical structure of fluphenazine (and its decanoate ester) 
reveals four potential sites where N- or S- oxidation may take place: 
Oxidation at the ring N atom is unlikely to occur42 thus the 
remaining three sites offer the possibility of a total of eleven compouds, 
viz. two side-chain mono N-oxides, a side-chain di N-oxide, a sulphoxide 
and the corresponding series of mixed sulphoxide N-oxides, a sulphone and 
the corresponding series of mixed sulphone N-oxides. (See Fig. 3.1). 
Only two of the possible compounds have been reported previously. 
The preparation of a mono N-oxide of fluphenazine has been patented by 
Yale31• The synthesis of fluphenazine sulphoxide has also been describ-
d147 e • 
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Compound g, J. l. 
mono N-oxide A 1 
mono N-oxide B 1 
di N-oxide 1 1 
sulphoxide 1 
sulphoxide mono N-oxide A 1 1 
sulphoxide mono N-oxide B 1 1 
sulphoxide di N-oxide 1 1 1 
sulphone 2 
sulphone mono N-oxide A 2 1 
sulphone mono N-oxide B 2 1 
sulphone di N-oxide 2 1 1 
when R = H, fluphenazine series 
R= C C9H19, fluphenazine decanoate series. II 
0 
Fig.3.1 - Structures of Fluphenazine Oxides 
-54-
3.1.1.2 Choice of Oxidants 
Little information was available concerning the oxidation of flu-
phenazine except for two previously cited references (31 and 147). In 
order to gain an insight into the subject, an investigation of the oxidation 
of fluphenazine and its decanoate ester by selected oxidants was propos-
ed. Three reagents seemed to offer particular advantages and were 
therefore chosen for the initial survey: 
a) Ethanol/hydrogen peroxide - used by Yale for the synthesis of 
fluphenazine mono N-oxide B31 and for the specific N-oxidation of 
chlorpromazine1l5• 
b) m-chloroperbenzoic acid - Reacts with piperazino-dibenzthiapines 
forming specifically the 'B' mono-N-oxide120• Also recommended for the 
preparation of the N-oxides of t-amines such as codeine and morphine107• 
c) Hydrogen peroxide/acetic acid - At room temperature specifically 
forms the sulphoxide derivative of phenothiazines102• At increased 
temperatures may produce the corresponding sulphone. 
3.1.1.3 Choice of Analytical Methods 
Before investigations with the selected oxidising agents could 
begin, a suitable analytical procedure was required with which to monitor 
the progress of reactions. 
Chromatographic systems only were considered because of their 
ability to separate the potential mixture of oxidation products. Suitable 
TLC systems for examining fluphenazine and fluphenazine decanoate were 
readily available180 and were known to separate the sulphoxide from the 
parent compound. TLC however is a slow analytical technique and cannot 
provide information on the progress of a reaction within a short time, the 
TLC plates requiring approximately two hours development time in the 
mobile phases described in the references. 
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In this respect HPLC is particularly advantageous as the state of a 
reaction mixture can be determined within a few minutes. GC is highly 
unsuitable because of the thermolabile nature of N-oxides. Consequently, 
HPLC was adopted as the method of choice, with the TLC systems held in 
reserve. 
3.1.2. Experimental 
3.1.2.1 HPLC Method Development 
a) Columns 
An HPLC procedure for the separation of fluphenazine from 
fluphenazine decanoate has been described in the literaturel61• The 
system comprised of a reversed-phase column, Partisil-TMS (a lOu irreg-
ular-particle material) and a mobile phase of methanol/acetonitrile/l % 
aqueous ammonium carbonate. Since the publication of this method, an 
improved column packing material with a similar short-chain alkyl phase 
bonded to the silica had become available. The material (SAS-Hypersil) 
also had the added advantages of being spherical and of being a smaller 
particle size (5u) resulting in improved column efficiency. Initially, 
lOOmm x 4.6mm columns were slurry packed from a methanol/aqueous 
sodium acetate solultion, using a Haskel air driven fluid pump, at 4600 psi. 
However, in later stages of the project new batches of the packing 
material yielded columns with poor efficiency. Consultation with the 
manufacturers (Shandon Products Ltd) confirmed the problems exper-
ienced with the originally recommended slurry solvent. Substitution of 
isopropanol for the original slurry-solvent, followed by hexane wash was 
recommended and successfully resolved the problem. The new procedure 
also allowed the preparation of 200mm x 4.6mm columns. 
Use of columns with an octadecyl stationary phase bonded to the 
silica was also assessed. Of the many commercial brands of ODS-silicas 
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available, ODS-Hypersil (Shandon Products, Runcorn) was arbitrarily 
chosen. 200mm x 4.6mm columns were packed by a similar procedure to 
that described above, but with carbon tetrachloride as slurry solvent, 
followed by a methanol wash. 
b) Development of Mobile Phases 
Throughout all the HPLC work the following equipment was 
uitilised: 
u. V. detector 
Pump 
Injection mode 
Recorder 
Cecil 212, variable wavelength 
Altex ll0A(reciprocating) 
Syringe, SGE, lOul 
Perkin Elmer, Model 56. 
co Separation of fluphenazine decanoate oxidation products was 
attempted using a lOOmm SAS-Hypersil column. Without samples 
of the expected oxides the development work was always subject to 
uncertainty. However, as a convenient means of assessing the 
effectiveness of particular mobile phases, a mixture of fluphen-
azine decanoate andm-chloroperbenzoic acid in methanol solution 
was used. A mobile phase of methanol/acetonitrile!l % ammonium 
carbonatel6l separated a series of peaks from the mixture, all of 
which were more polar than the parent ester (Fig. 3.2). Such an 
increase in polarity may be expected upon formation of fluphena-
zine decanoate oxidation products. Removal of either the methan-
ol or the acetonitrile from the mobile phase caused considerable 
tailing of the peaks. Optimum chromatography was obtained with 
a 1:1 ratio of methanol:acetonitrile. When the same solution was 
chromatographed on an ODS column (200mm) tailing peaks were 
noted regardless of the composition of the mobile phase. 
Further refinement of the HPLC procedure was required before 
embarking upon the quantitative aspects of the study. A full 
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Fig. 3.2 - HPLC Chromatogram of Fluphenazine 
Decanoate following Oxidation with 
m -Chloroperbenzoi c Acid. 
1, 2, 3 and 4 = Oxidation products, 
5 = fluphenazine decanoate; mobile 
phase, methanol-acetonitrile-l% aqueous 
ammonium carbonate (1-1-1); column, 
SAS-Hypersil. 
-58-
description of this work is given in Chapter 5. 
(ii) HPLC system for the separation of fluphenazine oxidation products 
was sought in a similar manner to that described above using a 
solution containing fluphenazine and m-chloroperbenzoic acid. 
Again, satisfactory chromatography was obtained with a 100mm 
SAS-Hypersil column together with a mobile phase of methanol/ 
acetonitrile/l% aqueous ammonium carbonate and a series of peaks 
were separated following injection of the solution of fluphenazine 
and oxidant (Fig. 3.3) All peaks were eluted before the fluphenazine, 
indicating the increased polarity of the oxidation products present 
in the solution. One potential problem was noted from the 
chromatogram, namely that two of the observed peaks were only 
partially resolved. Increasing the column length to 200mm failed 
to overcome the problem. An improvement of the resolution of the 
two peaks was obtained by (i) removal of the acetonitrile compo-
nent from the mobile phase; (ii) replacing the ammonium carbonate 
solution with 10% aqueous ammonium hydroxide (Fig. 3.4). Pot-
assium chloride has b~en reported to improve the chromatographic 
resolution of phenothiazines189• The beneficial effect of incorpor-
ating potassium chloride in the proposed mobile phase is clearly 
demonstrated in Fig. 3.4. The resulting mobile phase, comprising of 
methanol/10% aqueous ammonium hydroxide containing 1% pot-
assium chloride (1-1) was found to be suitable for the majority of 
the subsequent experimental work. 
However, in the final stages of the work it became necessary to 
separate a complex mixture of seven fluphenazine oxides and, 
contrary to expectation, the reintroduction of acetonitrile was 
required for optimum resolution of the seven compounds. Thus in 
the presence of potassium chloride the originally noted detrimental 
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Following Oxidation with 
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effect of acetonitrile was negated. 
In view of the excellent chromatography attained using an SAS-
Hypersil column, use of the alternative ODS column was not 
investigated. 
3.1.2.2Experiments Withm-Chlorperbenzoic Acid 
a) Oxidation of Fluphenazine Decanoate 
In a preliminary experiment, m-chloroperbenzoic acid and flu-
phenzine decanoate were mixed in equimolar quantities in ethyl acetate. 
After heating the solution at 500 C for 2 hours, an aliquot of the reaction 
mixture was examined by TLC188• Amongst the zones observed on the 
TLC plate was one particular zone with an Rf value identical to that of 
the degradation product considered by Shand174 to be the N-oxide. 
Further work indicated that the reaction of fluphenazine decanoate with 
m-chloroperbenzoic acid was an almost instantaneous reaction; thus in a 
detailed investigation a solution of m-chloroperbenzoic acid of known 
concentration in ethyl acetate was added dropwise from a burette to an 
ethyl acetate solution of fluphenazine· decanoate (0.5g), at 200 e, with 
constant stirring. 20ul aliquots of reaction mixture were withdrawn at 
intervals, diluted with the HPLC mobile phase(methanol-acetonitrile-l% 
aqueous ammonium carbonate; 1-1-1) then 5ul injected onto the HPLC 
column. Monitoring the reaction in this manner revealed the formation of 
a series of compounds in the sequence: 
Fluphenazine 
decanoate fast., A + B + C fast., C slow ., E 
The sequence is illustrated in Fig. 3.5. All the products of the 
reaction were observed to be more polar than fluphenazine decanoate. 
The chromatograms also indicated that compounds C, 0 and E were 
produced in > 95% yield. 
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As the parent ester is readily hydrolysed to fluphenazine under acid 
conditions the compounds A-E could be hydrolysis rather than oxidation 
products. The carboxylic acid most closely related to the oxidant (rn-
chlorobenzoic acid) was used to demonstrate that none of the compounds 
A-D further reacted in the presence of the non-oxidising acid alone, 
establishing that the compounds were, as expected, oxidation products of 
the ester. 
The oxidation products of phenothiazines are many and varied in 
nature and in an attempt to discover which of the products observed 
above were likely to be oxides, solutions of the compounds were treated 
with zinc/methanolic hydrochloric acid. HPLC indicated that all of the 
compounds except E were reducible to the parent ester, suggesting that 
compounds A-D were N- or S_oxides42,190. Although compound E reacted 
with the zinc/HCl system this compound was converted to an unknown 
product F which was less polar than compound E. 
From the amount of oxidant consumed during the reaction withm-
chloroperbenzoic acid, compound C was calculated to be a dioxide and 
compound D a tri-oxide. Conversion of compound D to E was observed to 
be a slow reaction, whereas the other reactions in the sequence were 
virtually instantaneous. The rate of formation of sulphones via peracid 
oxidation is known to be 100 to 1000 times slower than sulphoxide 
formation86,122,129,131,138 thus implying that compound E may be a 
sulphone. Additionally, oxidation of the phenothiazine ring S atom causes 
a bathochromic shift in the wavelength of maximum absorption ( A max.) 
because of the extended conjugation of the aromatic ring system. Hence 
the ring-oxidised phenothiazines exhibit a A max. of 275nm in comparison 
to that of 260nm for the parent molecule. Comparing chromatograms of 
the reaction mixture determined at 260 and 275nm indicated that 
compounds D and E were ring-oxidised species. Compounds A, Band C 
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were almost undetected at 275nm, suggesting that the UV spectrum of 
each of these compounds was similar to that of the parent ester, as might 
be expected if oxidation had taken place in the N-IO side-chain. 
From the fragmentary evidence available at this early stage, it was 
concluded that compounds A, Band C were the side-chain piperazino N-
oxides, compound D was a sulphoxide and compound E was possibly a 
sulphone. 
Because compounds A and B were produced as a mixture at room-
temperature (200 e), the effect of conducting the oxidation at low-
temperature was investigated. In accordance with the literature120 the 
reaction with m-chloroperbenzoic acid was performed at _400 C using a 
cardice/acetone bath to cool the reaction mixture. Other experimental 
details were identical to those used in previous experiments. HPLe 
demonstrated that the ratio of A B produced at _400 e was little 
different from that formed at 200 e. 
Attempts to oxidise compound E by refluxing in ethyl acetate in the 
presence of excess m-chloroperbenzoic acid failed to produce any further 
change, as evidenced by the invariant chromatograms obtained throughout 
the duration of the experiment. 
b) Oxidation of Fluphenazine 
Before experiments with fluphenazine could be commenced, it was 
necessary to convert the fluphenazine. dihydrochloride salt (the normal 
commercial form) to the base since the salt is insoluble in ethyl acetate. 
Performing a similar investigation to that described above for the 
decanoate ester, an almost identical sequence of events was witnessed ie. 
Fluphenazine ~fa;.;st~ .... ~ A' + B' + C' fast C' fast.. 0' slow.. E' 
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Once again, refluxing compound E' with excess m-chloroperbenzoic 
acid did not produce any further reaction. 
The most noticeable di fference between the oxidation of fluphen-
azine and of the decanoate ester was the ratio of the A' and B' 
components formed. At 200 C the ester produced an approximately I : I 
mixture throughout addition of the oxidant (Fig. 3.5a), but with fluphen-
azine compounds A' and C' appeared to be formed at the expense of B' 
(Fig. 3.6). 
This observed di fference in the behaviour of the two forms of 
fluphenazine withm-chloroperbenzoic acid was investigated at a later 
stage in the project. The work is fully described in section 3.2. 
3.1.2.30xidation with Ethanolic Hydrogen Peroxide Solution 
Yale's patent for the preparation of fluphenazine N-oxide31 claim-
ed the selective formation of the '8' mono N-oxide (Fig. 3.1) using an 
ethanol/hydrogen peroxide mixture. The reaction of this reagent with 
fluphenazine decanoate was therefore investigated to determine if a 
similar selectivity was apparent. 
0.5g Fluphenazine decanoate was dissolved in 25ml ethanol, 1.5ml 
hydrogen peroxide (30%) added and the mixture heated under reflux for 2 
hours. HPLC examination of the reaction mixture indicated that com-
pounds A, 8 and C were produced simultaneously (Fig. 3.7). Subsequent 
treatment of the reaction mixture with Pd/charcoal had no effect on the 
ratio of A : 8 : C present in the solution. 
3.1.2.40xidation with Hydrogen Peroxide in Glacial Acetic Acid 
a) Fluphenazine Decanoate 
Fluphenazine decanoate reacts with hydrogen peroxide in glacial 
acetic acid solution to form the corresponding sulphoxide at room 
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temperature147• Thus 0.5g of the ester was dissolved in glacial acetic 
acid, 0.5ml of hydrogen peroxide (l00 vol.) added and the mixture allowed 
to react at 200 C. Using HPLC, the progress of the reaction was 
monitored by withdrawing 10ui aliquots of the reaction mixture at 
intervals, diluting with 0.2ml of mobile phase and injecting 5ul onto the 
HPLC column. The resulting chromatography showed that, after an hour, 
one major product (compound Z) was present together wi th small quant-
ities of two other compounds (X and V). The reaction was allowed to 
continue at room temperature and compound Z was observed to be 
replaced by compounds X and Y and a fourth compound, W. After 16 
hours reaction, compound W was the only component of the solution. 
Refluxing the solution of compound W at 600 C for 5 hours converted W 
into a fifth compound V. Comparison of chromatograms determined at 
260 and 275nm suggested that all of the observed compounds were ring-
oxidised. 
Thus to summarise: 
Fluphenazine 
decanoate HAc 
16hr Z+X+Y+W ---. W 
RT 
HPLC retention times for the observed compounds indicated that 
compound W was equivalent to the compound 0 formed with -chloroper- A~­
benzoic acid, and also that compound V was the equivalent of compound E 
formed similarly. 
Treating the solutions of compounds Z, X, Y and W with zinc! 
methanolic hydrochloride acid (following destruction of the excess 
peroxide with caustic soda) reduced the oxidation products to the parent 
ester, again indicating that the compounds were N- or S- oxides. Com-
pound V however, behaved in a similar manner to the compound ~ formed 
with m-chloroperbenzoic acid,· and was converted to an unknown 
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compound of lesser polarity. 
b) Fluphenazine 
An identical reaction sequence was observed with fluphenazine, ie. 
fluphenazine ----I .. ~ Z' + X' + V' + W' --.... W'-....V' 
Compound W' had an HPLC retention time equal to that of the 
compound D' formed wi th -chloroperbenzoic acid. Compound V' also 
appeared to be equivalent to compound E'. 
c) Effect of Hydrochloride Salt 
Conflicting recommendations are apparent in the literature con-
cerning the form of the phenothiazine most suitable for selective oxida-
tion to the sulphoxide; Turner102 used the phenothiazines as bases, 
whereas Shand191 and Clarke147 preferred to use the hydrochloride salt. 
The difference between the oxidation of the two forms of the pheno-
thiazine in glacial acetic acid solution was therefore investigated. The 
reaction sequence pertaining to oxidation of the base is described above. 
With the hydrochloride salt of fluphenazine, however, compound Z' was 
produced in almost 100% yield (Fig. 3.8). The extra components formed 
when using the base as starting material were noted to be absent. In 
addition the reaction proceeded at a faster rate in the presence of the 
hydrochloride salt. A similar selectivity and increased rate of formation 
of compound Z was observed with the dihydrochloride of fluphenazine 
enanthate (the only fluphenazine ester readily available in the form of the 
salt). 
Both of the above observations are consistent with the findings of 
other workers. The catalytic effect of acids on the oxidation of dialkyl 
sulphides by hydrogen peroxide is a well documented fact. Formation of a 
purer product Z can be explained if the impurities X and V represent the 
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further oxidation of Z (probably the sulphoxide) to the sulphoxide-N-oxide, 
as the formation of N-oxides by t-amines is dependant upon the basicity 
of the amine190,192. A reduction in basicity reduces the prQbability of 
N-oxide formation, and in the presence of a strong acid oxidant(eg. 
tri fluoroperacetic acid), N-oxidation of t-amines does not occurl39. 
In order to oxidise the hydrochloride salt beyond the formation of 
compound Z' (or Z) it was necessary to reflux the reaction mixture at 
600 C. At this higher temperature the reaction proceeds via compounds X' 
and Y' producing compound W' after approximately 5 hours. 
3.1.2.5 Combined Use Hydrogen Peroxide/Glacial Acetic Acid and m-
Chloroperbenzoic Acid 
Oxidation of the compound Z (formed initially with hydrogen 
peroxide in acetic acid) by either m-chloroperbenzoic acid or hydrogen 
peroxide in glacial acetic acid resulted in the formation of the same 
sequence of compounds, as indicated by HPLC retention times. That is, 
Z W ---i"~ V 
However, as the reaction withm-chloroperbenzoic acid is almost 
instantaneous, formation of X, Y and W is more easily controlled by use 
of this particular reagent. 
HPLC comparison of the oxidation products A, B, C and D (formed 
by m-chloroperbenzoic acid alone) with the products Z, X, Y and W 
established that compounds D and W have identical retention times and 
are therefore probably the same chemical entity. Compounds A, B, C, Z, 
Wand Y were shown to be individual oxidation products. (Fig~ 3.9). 
3.1.2.6Development of Procedures for the Preparation and Isolation of the 
Oxides 
The above description of the oxidation of fluphenazine and its 
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and WXYZ (from Fluphenazine Decanoate) 
-73-
decanoate ester has shown that the selective synthesis of oxidation 
products C,D,E,F ,Z, Wand V may be achieved, yielding compounds of 
>95% purity, as evidenced by the HPLC chromatograms. Only com 
pounds A, B (A I, B') and X, V (X', V') were formed as mixtures and 
therefore required a means of separation from the starting material and 
other oxidation products. 
a) Isolation of Compounds A, B from the Reaction Mixture 
A column chromatographic procedure has been described for the 
quantitative separation of fluphenazine decanoate from its degradation 
products and this procedure was adapted for the isolation of compounds A 
and B from the reaction mixture. The suitability of the chromatographic 
system(methanol/cyclohexane/methyl acetate; 40-70-100) for the separa-
, 
tion of A and B from the starting material, fluphenazine decanoate, and 
from the compound C which is also present in the reaction mixture, was 
confirmed by thin layer chromatography on silica gel GF 254' TLC of the 
reaction mixture indicated that the compounds A and B, although separat-
ed from the parent ester and compound C, were not completely separated 
from each other. (Fig. 3.10). Hence, a more efficient means of separating 
these two materials was required. Preparative HPLC was eventually 
chosen for this purpose, allowing 20mg each of pure compound A and B to 
be isolated. 
The subsequent discovery that compound B was hydrolysed at a 
faster rate than compound A (Chapter 4) provided a means whereby larger 
quantities of compound A could easily be prepared. Hydrolysis of the 
mixture of compounds A and B separated from the oxidation reaction 
mixture by column chromatography yielded a mixture of compound A, the 
hydrolysis products of A and B (ie. fluphenazine derivatives) and decanoic 
acid. Compound A was separated from this mixture by repeating the 
column chromatographic procedure described previously. 
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Fig. 3.10 - TLC Separation of Some Fluphenazine Decanoate 
Oxidation Products 
IOObile phase, methanol-cyclohexane-methyl acetate (40-70-100); 
layer, silica gel GF254 • 
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b) Isolation of Compounds X, V from Reaction Mixture 
The methanol/cyclohexane/methyl acetate mobile phase (40-70-
100) proved to be a suitable system for the separation of X and V from 
the reaction mixture. Again TLC indicated that these two compounds 
were not resolved from each other (Fig. 3.10). Therefore, after prior 
isolation by normal mode column chromatography, small amounts of each 
of compounds X and V were separated by preparative HPLC for charac-
terisation. 
c) Isolation of Compounds A' and 8' from Reaction Mixture 
For isolation of the compounds- A' and 8' obtained from the 
oxidation of fluphenazine it was necessary to revert to a mobile phase of 
acetone/cyclohexane/ammonia (80:30:5). The A' component in the reac-
tion mixture can be reduced to a negligible level by conducting the 
oxidation at -400 C enabling pure compound 8' to be isolated. 
d) Preparation of Compound A' 
As compound A' is not easily formed by the direct oxidation of 
fluphenazine (See Section 3.2) an alternative procedure was sought. The 
simple~t method of obtaining A' was found to be via hydrolysis of the 
corresponding decanoate ester oxide (ie. compound A). 
The hydrolysis reaction yields a mixture of compoundA' and dec an-
oic acid which may be satisfactorily separated on a silica gel column with 
a mobile phase of the same composition as that used for the separation 
compound 8 above. 
e) Preparation of Compound V' 
Isolation of compound V' was a particularly difficult task, due 
mainly to the apparent instability of this compound. The method used 
previously for the preparation of the equivalent ester oxide (V) proved to 
be impractical for preparation of V' and it was necessary to reverse the 
sequence of oxidation. ie. m-chloroperbenzoic acid oxidatio" was per-
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formed first (at -400 C) and following the conversion of the resulting 
mixture of products to the hydrochloride salts, the mixture was treated 
with hydrogen peroxide in glacial acetic acid. The result of this exercise 
was to produce a mixture comprised of compounds Z' V' and W'. The high 
polarity of WI enabled this compound to be separated by partition into 
aqueous sodium hydroxide solution leaving compounds Z' and V' in the 
organic phase for subsequent separation by preparative layer chromato 
graphy using the mobile phase of acetone/cyclohexane/ammonia (80-30-5). 
Elution of compound V' from the silica gel was achieved with methanol, 
but isolation of the compound from solution caused considerable problems. 
Application of any degree of heating during evaporation of the solvent 
instantly degraded compound V' to a red/brown syrup. Evaporation of the 
methanol under vacuum was found to be the most satisfactory procedure. 
Last traces of methanol were removed from compound V' by addition of 
dichloromethane and further evaporation to dryness. 
f) Isolation of Oxidation Products from Solution 
The original isolation of fluphenazine N-oxide by Vale31 was 
achieved by precipitating the hydrochloride salt from ethereal solution, 
and a similar method was proposed for the isolation of the synthesised 
compounds from solution. 
PreCipitation of the hydrochloride salts was found to be possible 
only if solutions of the oxidation products had not been treated with 
water, or the compounds exposed to the atmosphere (eg. on a chroma-
tography plate), at any stage during the preparation. Treating the 
solutions of the oxidation products with desiccants such as anhydrous 
sodium sulphate or dried magnesium sulphate failed to dry the solutions 
sufficiently to allow the hydrochloride salt to precipitate. 
The moat likely explanation of thia phenomenon is that the 
oxidation products readily form stable hydrates which are not converted 
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to the anhydrous form by the normal non-reactive desiccants commonly 
used in preparative organic chemistry. Such behaviour has been reported 
previously for aliphatic N_oxides190• 
An alternative salt used commercially for many phenothiazine 
derivatives is the maleate. This too proved to be useless in those cases 
where water had been used at some stage in the preparation/isolation. 
When precipitation of either the hydrochloride or maleate salts 
could not be aChieved, the oxidation product was isolated as the base (or, 
possibly, hydrated base) from an organic solvent by rotary evaporation. In 
only one case did this procedure prove to be unsuitable - that of compound 
V', after preparation with hydrogen peroxide. Compound V' was found to 
be preferentially soluble in the resulting aqueous solution and could not be 
extracted into an organic solvent. The product was therefore isolated 
from the aqueous solution by adsorption onto a resin, Amberlite XAD2, 
which was subsequently eluted with methanol. 
g) P lri fication by Recrystallisation 
R )crystallisation was successful only with compound C (and C') in 
the form of the hydrochloride salt. For this purpose a solvent mixture of 
ethanol/ether was used. The hydrochloride salts of other compounds, ego 
D and E, could not be recovered from solution as either crystalline or 
amorphous solids. These compounds produced a sticky semi-solid mass, 
possibly due to their hygroscopic nature. 
Because of these problems, the preparative reactions were care-
fully controlled and monitored to ensure a yield of product with a purity 
of not less than 95%, as shown by HPLC. By this means the need for 
purification via recrystaUisation was avoided. A purity of 95% should be 
adequate for the spectral characterisation of the material, as 5% impurity 
would be unlikely to be detected by the majority of spectroscopic 
techniques. In addition, the impurity present in any of the synthesised 
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oxidation products represents a known entity in the form of one of the 
other compounds under investigation. Possible interference from the 
impurity could therefore be taken into account during the interpretation 
of the spectra. 
If for any reason the purity of the isolated compound was insuffi-
cient for characterisation, preparative layer chromatography was employ-
ed to purify the material. 
Full practical details of the procedures used for the preparation 
and isolation of each of the compounds A, S, C, 0, E, F, Z, X, V and W 
are given in Appendix I. Similar details concerning the compounds A', B', 
C', 0', E', F', Z', V' and W' are given in Appendix II •. 
3.2. Oxidation of Fluphenazine, Fluphenazine Esters and Related Compounds 
3.2.1 Introduction 
Fluphenazine and fluphenazine decanoate each react withm-chloroperben-
zoic acid forming a mixture of three compounds during the initial stages of 
the reaction. However, a difference in the ratio of products (arbitrarily 
labelled A, B, C and A', B', C' with respect to the decanoate ester and 
fluphenazine respectively) was noted. Compounds A and B were formed in 
approximately equal amounts, but compound B' was produced only in minor 
quantities at room temperature and in negligible amounts at _40oC. (Figs. 
3.5 and 3.11). 
The phenothiazine N-IO side-chain of fluphenazine is composed of 4-
propyl-piperazine-ethanol and the above compounds were identified (Chapter 
4) as the piperazino N-oxides following isolation. 
H 
~-CHrCHrCHrN4 t N-CHz-CHrOH 
'---J 
5 • 
Fluphenazine side-chain 
Compound A (A') was identified as the 4-oxide, compound B (B') as the 1-
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oxide and compound C (CI) as the 1,4-dioxide. 
Oxidation of fluphenazine with ethanolic hydrogen peroxide has been 
reported to selectively form the l_oxide31• Using a purified' microsomal 
mixed-function amine oxidase, Sofer and Zeigler also reported the selective 
oxidation of fluphenazine to the l_oxide125 whereas an unpurified microsomal 
liver extract has been shown to oxidise trifluperazine forming a mixture of 
the I-oxide and the 4_oxide196• In contrast to these reports, no information 
concerning the oxidation of the esterified piperazine-ethanol moiety was 
found in the literature. Thus a comparitive study of the oxidation of 
fluphenazine, fluphenazine esters and other closely related phenothiazines 
was undertaken. 
3.2.2 Choice of Compounds 
Compounds were chosen to represent: 
a) variation of the phenothiazine ring 2-substituent 
b) variation of the ester chain-length 
c) variation of the piperazine I-substi uent 
The piperazine 4-substituent (propyl) was kept constant throughout. Table 
3.1 lists the compounds investigated. 
All compounds except fluphenazine acetate were obtained from the 
manufacturers and were of pharmaceutical grade. Those compounds supplied 
as salts were converted to the equivalent bases. Fluphenazine acetate was 
prepared from fluphenazine and purified to >99% (HPLC assay). 
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Table 3.1 
Compound X R 
Fluphenazine CF3 -CH2CH2OH 
Fluphenazine acetate CF3 -CH2CH2OCOCH3 
Fluphenazine enanthate CF3 -CH2CH20COC6H13 
Fluphenazine decanoate CF3 -CH2CH20COC9H19 
Perphenazine Cl -CH2CH2OH 
Perphenazine acetate Cl -CH2CH2OCOCH3 (Thiopropazate) 
Trifluperazine CF3 -CH3 
Perazine H -CH3 
3.2.3 Experimental 
3.2.3.1 Conversion of Salts to Bases 
The compounds received as salts were treated with 10M sodium 
hydroxide and the resulting base extracted with diethyl ether. The 
ethereal solution was dried over magnesium sulphate and then the solvent 
evaporated to dryness on a rotary evaporator. Finally, the isolated base 
was dried overnight in a vacuum oven at 600C. 
3.2.3.2 Preparation of Fluphenazine Acetate 
The preparative method was adapted from the general procedure 
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for esterification of fluphenazine described by YaIe194• 
2.5g Fluphenazine hydrochloride was dissolved in 20ml pyridine and 
diluted with 100mI trichloroethane. 10ml Acetyl chloride were then 
added and the mixture heated under reflux for 5 hours. HPLC (SAS-
Hypersil column; mobile phase, methanol-acetonitrile-1 % aqueous 
ammonium carbonate, 1-1-1; detector 260nm) of the solution showed that 
the reaction was essentially complete after 2! hours, little further 
esterification occurring after this time. Excess acid chloride was 
destroyed by treating the trichloroethane solution wi th SOml of 1M sodium 
hydroxide and, after washing free from sodium hydroxide with successive 
quantities of water, the trichloroethane solution was dried over mag-
nesium sulphate. Crude ester was isolated by evaporating the organic 
solvent to dryness. In order to remove residual pyridine it was necessary 
to perform repeated addition and evaporation of aliquots of trichloro-
ethane. By this means pyridine may be azeotroped from the residue195• 
HPLC examination of the isolate indicated that' the material 
contained about 8% unreacted fluphenazine. (Fig. 3.12) Purification of 
the ester was achieved by passing the crude product through a silica gel 
column (Merck, Kieselgel 60, 70-230 mesh) using a mobile phase of 
methanol - cyclohexane - methyl acetate (40 - 70- 100). With this system 
fluphenazine is retained on the silica gel whilst the ester is eluted. HPLC 
of the ester, isolated from solution by rotary evaporation, verified that 
the final material obtained was of acceptable purity (less than 1% 
fluphenazine, Fig. 3.12). 
3.2.3.3HPLC Systems for Monitoring Oxidative Reactions 
The molecules chosen for study (Table 3.1) show widely differing 
polarities. It was therefore necessary to adjust the HPLC systems 
previously devised for fluphenazine and fluphenazine decanoate oxidation 
products in order to accommodate these di fferences. In general, the 
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mobile phase of methanol - acetonitrile -1% aqueous ammonium carbon-
ate was utilised for esters and that containing 10% ammonia and 1% 
potassium chloride for all other compounds. Altering the ratio of 
organic/aqueous phases produced suitable systems, details of which are 
summarised in Table 3.2. 
Table 3.2 
Mobile Phases for ChromatograE!h~ of Phenothiazines 
and Related Oxidation Products 
Column: SAS-Hypersil, 20 cm 
Compound Methanol! 1% aqueous 10% aqueous Flow 
acetoni tri Ie ammonium ammonia + rate 
(50:50) carbonate 1 % potassium (ml/min) 
chloride 
Fluphenazine 1 1 2 
acetate 
Fluphenazine 2 1 2 
enanthate 
Fluphenazine 2 l. 2 
decanoate 
Perphenazine 1 1.25 2 
acetate 
Fluphenazine 1 1 1 
Perphenazine 1 1.5 1.5 
Trifluperazine 1 1 1.5 
Perazine 1 2 1.5 
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3.2.3.4 Oxidation Procedure 
0.5g of each compound was dissolved in 50ml ethyl acetate and a 
solution of m-chloroperbenzoic acid in ethyl acetate added dropwise at a 
suitable temperature (usually 20oC) with constant stirring. When a low 
temperature (-40oC) was required, the reaction vessel was cooled in a 
cardice/acetone bath. The concentration of the m-chloroperbenzoic acid 
solution was adjusted in accordance with the M.W. of the compound being 
oxidised, such that addition of 50ml of oxidant was equivalent to a molar 
ratio, oxidant: phenothiazine of 1:1 (Table 3.3). 
Table 3.3 
Reaction Conditions for Oxidation 
Compound M.W. mM taken Oxidant 
(0.59) 9/l00ml 
Fluphenazine acetate 479.5 1.043 0.360 
Fluphenazine enanthate 549.5 0.091 0.314 
Fluphenazine decanoate 591.8 0.085 0.292 
Perphenazine acetate 446.0 1.121 0.387 
Fluphenazine 437.5 1.143 0.394 
Perphenazine 404.0 1.238 0.427 
Tri fluperazine 407.5 1.227 0.423 
Perazine 339.5 1.473 0.508 
3.2.3.5 Quanti tation of Oxidation Products 
Samples of the reaction mixture were examined at intervals during 
the addition ofm-chloroperbenzoic acid using the HPLC systems described 
in Table 3.3. Quantitation of the components present in the solution was 
accomplished by integration of the detected peaks, using a Spectra 
Physics (Minigrator) integrator. Normalisation of the resulting integrals 
gave the relative proportions of N-oxides produced. 
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3.2.3.6 Preparation of Fluphenazine Mono N-Oxide Mixture 
An approximately equimolar mixture of the two fluphenazine mono 
N-oxides (A and B) was prepared by alkaline hydrolysis of the correspond-
ing ester N-oxides. 
0.25g Fluphenazine decanoate mono N-oxide mixture (prepared as 
described in Appendix 1) was dissolved in 10m I of methanol and 1ml of 
ammonia (SG 0.88) was added. The reaction was allowed to proceed at 
room temperature (200 e) and when complete the resulting fluphenazine 
mono N-oxides were isolated as a mixture by the procedure described in 
Appendix 2. 
3.2.3.70xidation of Fluphenazine Mono N-oxide Mixture 
O.lg of fluphenazine mono N-oxide mixture was dissolved in 25ml 
ethyl acetate and oxidised withm-chloroperbenzoic acid according to the 
procedure described in Section 3.2.3.4. 
3.2.3.80xidation of Fluphenazine in Presence ofm-Chlorobenzoic Acid 
0.5g Fluphenazine base was dissolved in 50ml of ethyl acetate, 19 
of m-chlorobenzoic acid added and the solution oxidised with m-chloro-
perbenzoic acid according to the procedure described in Section 3.2.3.4. 
3.2.4 Results 
The ratio of oxides (A, Band e ie. l-piperazino oxide, 4-piperazino oxide 
and 1,4 piperazino dioxide) formed by each phenothiazine examined are given 
in Tables 3.4 to 3.13. The same results are expressed graphically in Figs. 3.13 
to 3.22. 
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Table 3.4 
Relative Proportions of N-oxides Formed 
by Fluphenazine Acetate at 200 e 
m-chloroperbenzoic Mono N-O A Mono N-O B 
acid added 
(molar eguiv.) 
0.30 
0.40 
0.60 
0.80 
1.00 
1.30 
1.80 
(%) (%) 
50.0 43.4 
48.4 42.3 
45.4 39.S 
42.1 36.8 
38.2 32.8 
31.8 27.0 
IS.2 12.1 
Table 3.S 
Relative Proportions of N-oxides Formed 
by Fluphenazine Enanthate at 200 e 
m-chloroperbenzoic Mono N-O A Mono N-O B 
acid added (%) (%) 
(molar eguiv.) 
0.20 49.3 43.7 
0.40 47.4 41.9 
0.60 43.9 38.7 
0.80 41.1 36.1 
1.00 38.0 33.1 
1.22 33.9 29.3 
1.60 24.2 20.5 
-88-
di N-O 
(%) 
6.6 
9.3 
IS.1 
21.1 
29.0 
41.2 
72.7 
di N-O 
(%) 
7.0 
10.7 
17.4 
22.8 
28.9 
36.8 
55.3 
Table 3.6 
Relative Proportions of N-oxides Formed 
by Fluphenazine Decanoate at 200 e 
m-chloroperbenzoic Mono N-O A Mono N-O B 
acid added 
(molar eguiv.) 
0.20 
0.40 
0.60 
0.80 
1.00 
1.30 
1.60 
(%) (%) 
50.7 43.9 
47.3 42.3 
44.4 39.6 
41.1 36.4 
37.3 33.1 
30.8 26.4 
21.4 17.9 
Table 3.7 
Relative Proportions of N-oxides Formed 
by Perphenazine Acetate at 200 e 
m-chloroperbenzoic Mono N-O A Mono N-O B 
acid added (%) (%) 
(molar eguiv.) 
0.19 50.5 41.9 
0.36 49.4 40.7 
0.58 47.3 38.5 
0.74 45.1 35.7 
0.93 42.3 32.5 
1.11 38.9 28.8 
1.48 29.3 19.3 
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di N-O 
(%) 
5.4 
10.4 
16.0 
22.5 
29.6 
42.8 
60.7 
di N-O 
(%) 
7.6 
9.9 
14.2 
19.2 
25.2 
32.3 
51.4 
Table 3.8 
Relative Proportions of N-oxides Formed 
by Perphenazine at 200e 
m-chloroperbenzoic Mono N-O A Mono N-O B 
acid added 
(molar eguiv.) 
0.19 
0.36 
0.58 
0.74 
0.93 
1.20 
1.57 
(%) (%) 
16.9 68.2 
13.0 66.3 
9.7 64.6 
6.9 62.4 
4.6 60.6 
2.2 55.5 
0.7 41.7 
Table 3.9 
Relative Proportions of N-oxides Formed 
by Trifluperazine at 200 e 
m-chloroperbenzoic Mono N-O A Mono N-O B 
acid added (%) (%) 
(molar eguiv.) 
0.20 14.2 79.1 
0.40 13.2 76.8 
0.60 12.0 74.8 
0.80 10.3 72.9 
1.00 8.4 69.9 
1.22 5.7 64.4 
1.30 4.8 61.1 
1.60 1.3 42.2 
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di N-O 
(%) 
14.9 
20.7 
25.7 
30.7 
34.8 
42.3 
57.6 
di N-O 
(%) 
6.7 
10.0 
13.2 
16.8 
21.7 
29.9 
34.1 
56.5 
Table 3.10 
Relative Proportions of N-oxides Formed 
by Perazine at 200 C 
m-chloroperbenzoic Mono N-O A Mono N-O B 
acid added (%) (%) 
(molar eguiv.) 
0.19 16.6 76.1 
0.38 15.9 73.6 
0.57 14.9 71.3 
0.76 13.5 69.1 
0.93 12.0 66.8 
1.20 8.8 61.0 
1.48 4.8 51.3 
Table 3.11 
Relative Proportions of N-oxides Formed by Fluphenazine 
in the Presence ofm-chlorobenzoic Acid at 200 C 
m-chloroperbenzoic Mono N-O A Mono N-O B 
acid added (%) (%) 
(molar eguiv.) 
0.21 12.3 69.1 
0.43 8.6 65.7 
0.74 4.8 62.1 
1.10 2.6 55.8 
1.52 43.7 
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di N-O 
(%) 
7.3 
10.5 
13.8 
17.4 
21.2 
30.2 
43.9 
di N-O 
(%) 
18.6 
25.7 
33.1 
41.6 
56.3 
Temp-
erature 
(0 C) 
-40 
+20 
+37 
Table 3.12 
Relative Proportions of N-oxides Formed by 
Fluphenazine at Various Temperatures 
m-chloroperbenzoic 
acid added 
(molar equiv.) 
0.20 
0.40 
0.60 
0.80 
1.00 
1.30 
1.60 
0.20 
0.40 
0.80 
1.00 
1.30 
0.20 
0.40 
0.60 
0.80 
1.00 
1.30 
1.60 
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Mono N-O A 
% 
4.8 
2.5 
1.8 
0.9 
0.8 
0.3 
16.4 
11.0 
4.8 
2.9 
1.3 
17.6 
13.5 
10.2 
7.5 
5.0 
2.5 
Mono N-O B 
% 
81.0 
78.6 
76.6 
73.6 
69.2 
58.2 
41.0 
65.6 
67.6 
63.7 
60.3 
48.6 
66.7 
65.9 
64.9 
63.4 
61.0 
54.5 
43.7 
di N-O 
% 
14.2 
18.9 
21.6 
25.5 
30.0 
41.5 
59.0 
18.0 
21.4 
31.5 
36.8 
50.1 
15.7 
20.6 
24.9 
29.1 
34.0 
43.0 
56.3 
m-chloroperbenzoic 
acid added 
(ml) 
o (InitiaI) 
5 
10 
15 
25 
30 
45 
55 
65 
Table 3.13 
Oxidation of Fluphenazine Mono N-O 
Mixture at 200 C 
Mono N-O A Mono N-O 8 
(%) (%) 
41.3 58.7 
31.8 59.0 
22.3 58.4 
14.4 56.5 
3.4 50.0 
44.8 
23.8 
9.3 
1.3 
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di N-O 
(%) 
9.2 
19.3 
29.1 
46.6 
55.2 
76.2 
90.7 
98.7 
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Fig. 3.13 - Relative Proportious of N-Oxides Formed During 
Oxidation of Fluphenazine Acetate with 
m -Chloroperbenzoic Acid 
A = mono N-oxide Ai B = mono N-oxide Bi 
C = di N-oxide. 
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Fig. 3.14 - Relative Proportions of N-Oxides Formed During 
Oxidation of Fluphenazine Enanthate with 
m-Chloroperbenzoic Acid. 
A = mono N-oxide A; B = mono N-oxide B; 
C = di N-oxide. 
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F~g. 3.15 - Relative Proportions of N-~des Formed During 
Oxidation of Fluphenazine Decanoate with 
m-Chloroperbenzoic Acid 
A = mono N-oxide Ai B = mono N-oxide Bi 
C = di N-oxide. 
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Fig.3.l6 - Relative Proportions of N-Oxides Formed During 
Oxidation of Perphenazine Acetate with 
m-Chloroperbenzoic Acid 
A = mono N-oxide Ai B = mono N-oxide Bi 
C = di N-oxide. 
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Fig.3.l7 - Relative Proportions of N-Oxides Formed Durinq 
Oxidation of perphenazine with 
m -Chloroperbenzoic Acid 
A = UDno N-oxide A; B = UDno N-oxide B; 
C = di N-oxide. 
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Fig.3.l8 - Relative Proportions of N-Oxides Formed During 
Oxidation of Trifluperazine with 
m-Chloroperbenzoic Acid 
A = mono N-oxide A; B = mono N-oxide B; 
C = di N-oxide. 
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Fig.3.l9 - Relative Proportions of N-Oxides Formed 
During Oxidation of Perazine with 
m -Olloroperbenzoic Acid 
A = mono N-oxide A; B = mono N-oxide B; 
C = di N-oxide. 
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Fig.3.20 - Relative Proportions of N-Oxides Formed 
During Oxidation of Fluphenazine with 
m-Chloroperbenzoic acid 
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A = mono N-oxide Ai B = m:mo N-oxide Bi 
C = di N-oxide. 
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3.2.5 Discussion of Results 
The above results demonstrate that the compounds examined may be 
divided into two distinct groups: 
CD Esterified piperazino-phenothiazines, which form approximately equal 
quantities of each of the two mono N-oxides. 
(ii) Non-esterified piperazino-phenothiazines, which form mainly mono N-
oxide B with small amounts of mono N-oxide A (approximate ratio 90:10). 
A recent paper by Rowell et al211 has described evidence to support the 
theory of conformational recognition by antibodies (originally postulated by 
Horn and Snyder212) which requires that the phenothiazine side-chain is 
orientated toward the phenothiazine ring 2-substituent and held in this 
preferred conformation by Van der Waals forces. 
A similar interaction between the 2-substituent and the side-chain was 
suggested by Underberg et al77 to account for the change in the pattern of 
degradation products observed with respect to the electronegativity of the 2-
substi tuent. 
However, introduction of an electronegative substituent at the 2-position 
in the phenothiazine ring has little effect on the ratio of the A and B mono 
N-oxides formed during oxidation, suggesting that molecular conformation is 
unimportant in this case. 
Other minor molecular alterations also have no apparent effect on the 
ratio of A:B formed. Thus extending the ester chain-length from acetate to 
decanoate does not affect the approximate 1:1 ratio of mono N-oxides 
produced on oxidation of the esters. Similarly, varying the terminal group 
attached to the piperazine ring in the non-esterified phenottliazines has little 
effect on the 9:1 ratio of N-oxides A:B formed. 
The influence of the basicity of the piperazine t-amino groups can be 
excluded as the published pKa values for fluphenazine and fluphenazine esters 
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are similar (Table 3.14). 
Table 3.14 
pKa Values of Some Piperazino-Phenothiazines 
Compound Ring 2- pKa l pKa2 Reference substi tuent 
Perazine H 3.95 5.20 213 
Prochlorperazine CI 4.05 6.BO 213 
Trifluperazine CF3 4.13 7.23 213 
Fluphenazine CF3 3.90 B.IO 214 3.60 7.BO 215 
Fluphenazine CF3 3.29 7.70 216 
enanthate 3.50 8.20 1 
. 
Within the group of non-esterified piperazino-phenothiazines, introduction 
of an electronegative substituent at the 2-position in the aromatic ring 
system causes a distinct increase in pKa2 value (Table 3.14), but has little 
effect on the ratio of mono N-oxide A:B formed during oxidation (Tables 3.4 
to 3.13). The apparent relationship between pKa2 value and electronegativity 
of the ring substituent maybe further evidence supporting the conformational 
theory of Hom and Synder212• The electronegative influence of the 
phenothiazine ring substituent would not normally be transmitted through the 
length of a propyl carbon-chain to influence the piperazine t-amino groups; 
thus a spatial effect is indicated. 
With further regard to the ratio of A and B oxides produced, the 
alternative possibility of protonation of the basic amino groups by the acidic 
oxidant was also considered. Thus oxidation of fluphenazine was performed 
after addition of excess carboxylic acid m-chlorobenzoic acid}. The results 
(Fig. 3.20) demonstrate that this facet had little or no effect on the ratio of 
A:B formed and may therefore be dismissed as a non-contributory factor. 
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The most important factor in this respect was the temperature at which the 
oxidation reaction was conducted. A reduction of the reaction temperature 
from 200 C to _400 C considerably reduced the amount of N-oxide A produced 
(Fig.3.2l) Such an effect may be considered as indicative of steric hinderance 
in the region of the 4-position of the piperazine-ethanol moiety within the 
side-chain. 
A further demonstration of the preferential oxidation of the piperazine-
ethanol moiety at the I-position was obtained by observing the oxidation of 
approximately equimolar quantities of mono N-oxides A and 8 under identical 
conditions to those used in previous experiments. The results (Fig.3.22) 
unambiguously demonstrate that N-oxide A is preferentially converted to the 
di-N-oxide. Indeed, the observed preference is of such magnitude that N-
oxide A is selectively oxidised in the initial stages of the reaction. Hence, all 
available oxygen is consumed by N-oxide A until the concentration of A faUs 
to a relatively low value (A:8;15:55) whence both compounds (A and 8) are 
oxidised to the di-oxide at approximately equal rates. 
The means by which the introduction of an ester carbonyl group into the 
piperazino side-chain causes a modification of the behaviour of the pheno-
thiazines toward oxidation cannot be envisaged from the results obtained to 
date. Further experimental work will be required before a satisfactory 
explanation of this phenomenon can be proposed. 
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CHAPTER 4 
CHARACTERISA nON OF PREPARED COMPOUNDS 
4.1. Purity 
4.1.1 Experimental 
The purity of the isolated compounds was assessed using HPLC, 
based upon systems described previously (Section 3.1.2.1). A 20cm column 
of SAS-Hypersil together with a mobile phase of methanol-acetontrile-1 % 
aqueous ammonium carbonate in the ratio of 1:1:1 proved to be adequate 
for the examination of the majority of ester-related oxidation products. 
However, for complete resolution of compounds 0 and E (or V and W) it 
was necessary to adjust the ratio of the mobile phase components to 1:1:2. 
Similarly, a mobile phase of methanol-acetonitrile-10% aqueous 
ammonia containing 1% potassium chloride (ratio 0.5:0.5:1) was utilised 
for the examination of the majority of isolated fluphenazine oxidation 
products, but for complete resolution of compounds 0' and E' (or V' and 
W') the ratio was altered to 0.5:0.5:2. 
4.1.2 Results 
Results are summarised in Table 4.1. 
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Table 4.1 
Estimated Purity(HPLC) of Isolated Oxdiation Products 
Compound Estimated Purity Identi t Y of Impuri ti es 
A (Prep.HPLC) 99% 
B (Prep.HPLC) 99% Compound A(1%) 
C (recrystallised) 99% Compound D(1%) 
D 98% Compound E(2%) 
E 99% 
F 98% Fluphenazine 
decanoate(l %); 
Compound E(l %) 
V 95% Fluphenazine 
sulphoxide(4%); 
Unknown(I%) 
W 99% Compound V(I%) 
X (Prep.HPLC) 99% Compound Y(I%) 
V (Prep.HPLC) 99% 
Z 95% Unknown(5%) 
A' 95% Fluphenazine(5%) 
B' 98% Flu'phenazine(2%) 
C'(recrystallised) 99% Compound D'(1%) 
D' 96% Compound C'(3%); 
Compound E'(l %) 
E' 99% Compound D'(1%) 
F' 98% Fluphenazine(2%) 
V' 95% Compound W'(3%) 
W' Not isolated Unknown (2%) 
X' Not prepared 
V' 96% Compound 8'(4%) 
Z' 99% 
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4.2 Infra-red Spectrophotometry 
4.2.1 Experimental 
The infra-red spectrum of each isolated compound was determined on a 
Pye-Unicam SP 1000 IR spectrophotometer as a compressed disc (1% 
dispersion in KBr). To ensure homogeneity of the mix, the compound being 
examined was added to the potassium bromide as a solution in dichloro-
methane (decanoate series) or methanol (fluphenazine series). The solvent 
was evaporated under vacuum prior to pressing the disc at a pressure of 10 
tons. 
4.2.2 Results 
Salient features of the spectra obtained are listed in Tables 4.2 and 4.3. 
The full spectrum of each compound is reproduced in Appendix 3. Spectra of 
fluphenazine decanoate, fluphenazine hydrochloride and fluphenazine base 
are included for comparison. 
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Compound 
A 
B 
C 
D 
E 
F 
V 
W 
X 
y 
Z 
Table 4.2 
Main Features of IR Spectra 
(Fluphenazine Decanoate Oxidation Products) 
Diagnostic a~sorption Assignment 
band (cm- ) 
960 aliphatic N-oxide 
960 aliphatic N-oxide 
975 aliphatic N-oxide 
975 aliphatic N-oxide 
1030, 1060 sulphoxide 
975 aliphatic N-oxide 
1180 & 1305 sulphone 
1170 & 1310 sulphone 
975 aliphatic N-oxide 
1180 & 1310 sulphone 
975 aliphatic N-oxide 
1035, 1060 sulphoxide 
960 aliphatic N-oxide 
1030, 1055 sulphoxide 
960 aliphatic N-oxide 
1040, 1060 sulphoxide 
1030, 1055 sulphoxide 
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Fig.No. 
(Appendix 3) 
A3.2 
A3.3 
A3.4, A3.5 
A3.6, A3.7 
A3.8, A3.9 
A3.10 
·A3.11 
A3.12 
A3.13 
A3.14 
A3.15 
Compound 
A' 
B' 
C' 
D' 
E' 
F' 
V' 
V' 
Z' 
Table 4.3 
Main Features of IR Spectra 
(Fluphenazine Oxidation Products) 
Diagnostic ~sorption Assignment 
band(cm- ) 
960 aliphatic N-oxide 
940 aliphatic N-oxide 
970 aliphatic N-oxide 
955 aliphatic N-oxide 
1025 sulphoxide 
970 aliphatic N-oxide 
1709 & 1300 sulphone 
1170 & 1300 sulphone 
970 aliphatic N-oxide 
1170 & 1300 sulphone 
950 aliphatic N-oxide 
1050, 1060 sulphoxide 
1050, 1060 sulphoxide 
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Fig.No. 
(Appendix 3) 
A3.1S 
A3.19 
A3.20 
A3.21 
A3.22, A.23 
A3.24 
A3.25 
A3.26 
A3.27 
4.2.3 Discussion 
In the I.R. spectra of phenothiazine Nand 5 oxidised species, four 
b 'b d ' t t f d' t' 102,197 a sorption an s are Impor an or lagnos IC purposes: 
950 - 970 cm -1 N - 0 stretching vibration 
1030 - 1070 
1120 - 1160 
1300 - 1350 
N - 0 and 5 = 0 
5=0 stretching vibration 
~o 5~ 0 symmetrical stretching vibration 
5 ~O asymmetrical stretching vibration ~O 
stretching frquencies are readily observed as the 
spectrum of the unoxidised parent shows no interfering bands in the 
appropriate region. The expected absorption frequency of the sulphone 
symmetrical stretching vibration however, overlaps other frequencies present 
in the spectrum of t~e parent molecule and the presence of this band must be 
inferred from the observed changes in intensity. 
The pattern of absorption bands in the 1600cm -1 region, associated with 
the aromatic ring system, clearly indicate those compounds where oxidation 
has occurred in the phenothiazine nucleus. Thus observed absorption bands 
relating to oxidation of the phenothiazine 5 atom are accompanied by a 
concurrent change in the pattern of the spectrum in the 1600 cm-1 region 
(C = C in-plane stretching vibration). One unexpected feature of the IR 
spectra of the fluphenazine decanoate N-oxidised species (as bases) was an 
observed broad absorption band in the 3500 cm -1 region. 5uch an absorption 
band was anticipated for fluphenazine oxidation products (alcoholic OH 
group), but in the case of the oxides derived from the ester, the absorption 
band is believed to be indicative of the suspected hydrated nature of these 
compounds. 
The main conclusions to be drawn from the IR data are included in Tables 
4.2 and 4.3. It is also apparent from these tables that fluphenazine and the 
decanoate ester yield a similar sequence of oxidation products and that 
compound A' is related to compound A by addition of a decanoyl ester group. 
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Conversely, hydrolysis of compound A should yield A' and this relationship 
was confirmed by HPLC. A similar relationship was demonstrated for all the 
other compounds; therefore B is hydrolysed to B' etc. 
Combining IR data and earlier evidence from HPLC and oxidation 
experiments with m-chloroperbenzoic acid, the following tentative conclu-
sions may be made concerning the identi ty of the oxidation products: 
Compounds A, A' 
Compounds B, B' 
Compounds C, C' 
Compounds 0, 0' = W, W' 
Compounds E, E' = V V' 
Compounds F, F' 
Compounds X, X' 
Compounds V, V' 
Compounds Z, Z' 
4.3 UV Spectrophotometry 
4.3.1 Experimental 
piperazino mono-N-oxide 
piperazino mono-N-oxide 
piperazino di N-oxide 
sulphoxide piperazino di N-oxide 
sulphone piperazino di N-oxide 
sulphone 
sulphoxide piperazino mono 
N-oxide 
sulphoxide piperazino mono 
N-oxide 
sulphoxide 
The UV spectra of the isolated compounds in methanolic solution were 
recorded on Perkin-Elmer 137 scanning spectrophotometer. Quantitative 
measurements were determined with a Varian model 634 spectrophotometer 
and the molar absorptivity calculated from the equation19B,199 
where 
A = E c I 
A = absorbance 
e = molar absorptivity 
c = concentration (mole/litre) 
1 = path-length of cell (cm) 
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4.3.2 Results 
The results obtained are summarised in Tables 4.4 and 4.5. 
Table 4.4 
UV Absorption Characteristics 
(Fluphenazine decanoate oxidation products) 
Compound 
(Fluphenazine decanoate 
A (base) 
B (base) 
C (base) 
o (HCI Salt) 
E (Hel Salt) 
E (base) 
F (base) 
V (base) 
W (base) 
X (base) 
Y (base) 
Z (base) 
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~max(nm) 
260 
258 
261 
258 
274 
300 
350 
270 
296 
335 
272 
298 
340 
274 
302 
343 
271 
295 
340 
275 
301 
349 
277 
305 
352 
276 
303 
350 
277 
305 
352 
e 
34500) 
32000 
32800 
31200 
10900 
7100 
4100 
13100 
6900 
4500 
Table 4.5 
UV Absoq~tion Characteristics 
(Fluphenazine Oxidation Products) 
Compound ~max(nm) 
Fluphenazine 260 
A'(base) 260 
B'(base) 261 
C' (HCI Salt) 258 
0' (HCI Salt) 274 
300 
348 
E' (HCl Salt) 272 
298 
340 
F'(base) 275 
302 
343 
V' (base) 272 
298 
340 
V' (base) 278 
305 
355 
Z' (base) 278 
304 
352 
Z' (HCI Salt) 276 
303 
352 
4.3.3 Discussion 
Numerous descriptions of the UV spectral characteristics of phenothiazine 
sulphoxides and sulphones are apparent in the literature200,201,202. All 
reports are in agreement that oxidation of the phenothiazine ring S atom 
results in a bathochromic shift of the ~max with respect to the parent 
phenothiazine, and that the spectra of the sulphoxides are characterised by 
the presence of three wavelengths of maximum absorption (at about 275, 300 
and 350 nm). On further oxidation to the sulphone, the characteristic triple 
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absorbtion-band pattern is retained but the three ). max show a small 
hypochromic (blue) shift with respect to the sulphoxide. Thus, the results 
given in Tables 4.4(and 4.5) for compounds D-F (0' - F') and V-Z (V' - Z') are 
consistent with the conclusions derived from interpretation of IR spectra 
(Section 4.2). 
No information concerning the spectral characteristics of the N-oxidised 
phenothiazine species could be found in the literature. However, the results 
given in the Tables for compounds A-C (A'-C') are consistent with the 
postulation that oxidation has occurred in the side-chain whence little change 
in ). max or Eo would be expected. 
4.4 Spectrofluorimetry 
4.4.1 Experimental 
Excitation and fluorescence spectra of the isolated compounds in 0.1% 
methanolic hydrochloric acid were recorded on a Perkin-Elmer model 204 
spectrofluorimeter. 
4.4.2 Results 
Tables 4.6 and 4.7 summarise the results obtained. 
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Compound 
Fluphenazine 
decanoate 
A 
B 
C 
D 
E 
F 
v 
W 
x 
y 
z 
Table 4.6 
Fluorimetric Properties of Fluphenazine Decanoate 
and its Oxidation Products 
Excitation A max Fluorescence ~ max 
(nm) (nm) 
V.Weak, 470 
V.Weak, 470 
V.Weak, 470 
V.Weak, 470 
27 5(shoulder) 
295 
345 Strong, 397 
27 5(shoulder) 
295 
337 Strong, 390 
285(shoulder) 
313 
353 Strong, 390 
275(shoulder) 
295 
337 Strong, 390 
275(shoulder) 
295 
345 Strong, 397 
27 5(shoulder) 
298 
347 Strong, 395 
275 
298 
347 Strong, 398 
275(shoulder) 
297 
345 Strong, 393 
-117-
Compound 
Fluphenazine 
B' 
C' 
0' 
E' 
F' 
V' 
V' 
Z' 
Table 4.7 
Fluorimetric Properties of Fluphenazine 
and its Oxidation Products 
Excitation ~ max Fluorescence ~ max 
(nm) (nm) 
V.Weak, 470 
V.Weak, 470 . 
V.Weak, 470 
27 5(shoulder) 
297 
346 Strong, 396 
273(shoulder) 
295 
336 Strong, 390 
27 5(shoulder) 
297 
338 Strong, 390 
27 3(shoulder) 
295 
336 Strong, 390 
275(shoulder) 
297 
345 Strong, 396 
300 
348 Strong, 398 
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4.4.3 Discussion 
Phenothiazines, which exhibit a weak native fluorescence, are converted 
into strongly fluorescent sulphoxides (or sulphones) by hydrogen peroxide. In 
addition, the fluorescence ~ max is shifted to shorter wavelengthi03• The 
intense fluorescence is believed to result from the extended conjugation of 
the aromatic nucleus formed by substitution of oxygen at the phenothiazine-
ring S atom. Tables 4.6 and 4.7 clearly indicate those compounds which 
~O 
possess S = 0 or S~O groups and are in agreement with the IR and UV data 
quoted in the previous sections. 
The further oxidation of a phenothiazine sulphoxide yielding a sulphone 
could alter the fluorimetric properties of the molecule, but no indications to 
this effect are to be found in the literature. The results given in Tables 4.6 
and 4.7 imply that those compounds shown by IR to be sulphones, exhibit a 
A max at slightly shorter wavelengths than the corresponding sulphoxide -
compare compounds 0 (0') with E (E') and F(F') with Z(Z'). 
Nc information regarding the fluorimetric properties of phenothiazine N-
oxide~ could be gleaned from the literature. However, if oxidation occurs at 
the side-chain piperazine N atoms, the molecule could be expected to retain 
the fluorimetric characteristics of the parent, ie. no extension of the 
conjugated system. Accordingly, compounds A, Band C (A', B' and C') are 
again intimated to be piperazino N-oxides. 
4.5 Proton N.M.R.Spectra 
4.5.1 Experimental 
4.5.1.1 Conversion of Hydrochloride Salts to Bases 
Compounds prepared as hydrochloride salts were converted to the 
corresponding bases prior to determining NMR spectra in order to avoid 
interference from the associated proton. 
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lOOmg Hydrochloride salt (fluphenazine decanoate oxidation 
products) was dissolved in 2ml methanol and excess 1M aqueous ammonium 
hydroxide added. The precipitated base was extracted with ethyl acetate 
(or dichloromethane). The separated organic fraction was washed wi th 
water then dried over sodium sulphate. Evaporation of the organic 
solvent yielded the required base which was dried overnight at 200 e in a 
freeze-drier. The purity of the isolated solid material was checked by 
HPLC. 
4.5.1.2 Determination of Spectra 
The PMR spectra of the oxidation products (decanoate ester series) 
were recorded by an external agency (PCMU, Harwell) on a Perkin Elmer 
f 
Model R 34 220MHz NMR spectrometer using deutrochloroform to solub-
!.v 
ilise the compounds, with TMS as reference. 
4.5.2 Results 
Figs A3.28 - A3.35 (Appendix 3) illustrate the spectra obtained for 
compounds A-F and Z together wi th a similar spectrum of fluphenazine 
decanoate for comparison. 
4.5.3 Discussion 
F or the purpose of this discussion, the proton signals of the parent ester 
will be labelled according to the interpretation of Florey204: 
7~S~3 ·~N~F. C c 9 1 3. 
I ,CH i"CH 2\ 
CH 2-CH 2-CH 2-N\ N-CH rCH rO-C-CH 2-(CH 2~-CH 3 
abe' CHi'CHl e" d &. f 9 
e c 
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/ 
I 
Protons Integral value 
-2E!!l 
aromatic 7, multiplet 6.8-7.2 
a 2, triplet 3.95 
b 2, triplet 1.9 
c c' cIt 12, broad singlet 2.5(broad band) 
d 2, triplet 4.2 
e 2, broad singlet 1.6 
f 14, broad singlet 1.3 
g 3, broad singlet 0.85 
Resonance signals for methylene groups c, c' and c" were not clearly 
resolved and thus assignment of individual values to the three groups of 
protons was not attempted. 
However, the 220 MHz spectrum of fluphenazine decanoate obtained in 
the present study distinctly resolves two triplets (integral value = 2) at 2.3 
and 2.6ppm which may be attributed to the methylene protons of c' and c". 
The chemical shift of methylene group e" would be expected to be greatest, 
since this group is situated p to an oxygen atom. Hence, in the 220 MHz 
spectrum, the following chemical shift values are tentatively assigned to the 
methylene groups associated with the piperazine ring: 
Protons 
c" 
c 
c' 
Integral value 
2, triplet 
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8, broad singlet 
2, triplet 
-EE!!! 
2.6 
2.45 
2.3 
i) Compounds F and Z 
The PMR spectra of compounds F and Z (Figs. A3.34 and A3.35) are, in 
general, similar to the spectrum of the parent ester the most important 
difference being the perturbation of the aromatic proton signals (which are 
also moved downfield to 7.2-8.2 ppm). The spectrum of compound Z exhibits 
two doublets at 7.9 and 8.0 ppm separated from the general aromatic signal 
whilst in the spectrum of compound F the two doublets are shifted still 
further down-field (8.1 and 8.2ppm). This spli tting of the aromatic proton 
signal is consistent with the introduction of an oxygen atom at the 5-position 
(S atom)202, the two doublets representing the 4H and 6H protons205• Thus 
compound Z contains a sulphoxide group and compound F, which exhibits the 
greatest shi ft of the 4H and 6H aromatic signals is indicated to possess a 
second oxygen atom ie. a sulphone group. The pattern of side-chain proton 
signals is unchanged implying no oxidatior. of the piperazine N atoms in these 
compounds. 
One interesting feature of the spectre of compounds Z and F is the down-
field shift of resonance values for methy ene groups a and b (4.4 and 2.1 ppm 
respectively). Such a shift will only be evident if the N-IO side-chain adopts 
the H-extra configuration205• 
ii) Compounds A and B 
From chemical evidence, compounds A and B are each indicated to 
contain I molar equivalent of oxygen. No splitting of the aromatic proton 
signal is observed in the spectrum of either of the compounds signifying that 
oxidation has occurred only in the side-chain. The main task therefore is to 
determine the position of N-oxidation within the piperazine-ring. 
Compound A 
The spectrum of compound A is difficult to interpret even though 
numerous chemical-shift changes are apparent relative to the parent-ester. 
The most easily recognised feature is the downfield &hi ft of the signal 
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associated with methylene group a (from 3.95 to 4.2ppm), whence the a and d 
protons resonate at similar values and suggesting that the oxygen atom in 
Compound A is substituted at the 4-position within the piperazine-ethanol 
group: 
Further interpretation of the spectrum is not possible without additional 
experimental work involving, perhaps, the use of spin-spin decoupUng tech-
niques. The non-availability of suitable instrumentation prevented com ple-
tion of this work. 
Compound B 
The most noticeable difference between the spectrum of compound Band 
that of the parent ester is the large down-field shift (from 4.2 to 4.8 ppm) 
associated with the protons of methylene group d. The shift in the resonance 
value of methylene group a is negligible in comparison (from 3.95 to 4.05 
ppm). Changes in the chemical shift values of the other methylene groups 
within the side chain are also evident. This pattern of chemical shifts is 
consistent with the postulation that oxidation has occurred at the I-position 
in the piperazine-ethanol moiety: 
r--\/O-
~-(CH '-N +N-(CHz)-OCC H l' ~3 \'! Z II 9 1. 
'--' 0 
The c' protons, however, resonate at approximately the same value as in 
the parent molecule which further supports the above structure. 
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iii)Compound C 
Compound C has previously been shown to contain two molar equivalents 
of oxygen. 
The main feature of the spectrum of compound C (Fig. A3.31) is the total 
change in the resonance values for the piperazine methylene groups suggest-
ing that both of the oxygen atoms are situated in the side-chain. This 
postulation is further supported by the unchanged aromatic proton pattern 
apparent when the spectrum of compound C is compared with that of 
fluphenazine decanoate (Fig. A3.28). 
i v) Compounds D and E 
The spectra of compounds D and E (Figs. A3.32 and A3.33) show a pattern 
of side-chain methylene group signals similar to compound C, indicating the 
substitution of 0 at each of the piperazine N atoms. 
The aromatic signals of compou~ D are similar to those observed with / 
" compound Z; likewise the spectrum of compound E is related to compound F. 
Thus, it was inferred that compound D is the sulphoxide di N-oxide and 
compound E the sulphone di N-oxide of fluphenazine decanoate, a conclusion 
which is in complete agreement with IR data. 
4.6 Carbon-13 NMR 
Further evidence for the assignment of the position of oxidation in 
compounds A (A') and B (8') was sought using 13C NMR. To simplify the 
spectra, use of the ester (decanoyl chain) was avoided and the equivalent 
fluphenazine compounds examined (ie. compounds A' and B'). 
4.6.1 Experimental 
Spectra were determined at the University of Bath, School of Pharmacy, 
on a Joel NMR Spectrometer. The compounds were dissolved in deutero-
chloroform and TMS used as reference. 
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4.6.2 Results 
The spectra obtained are illustrated in Figs. A3.37 and A3.38 (Appendix 3) 
together with a similar spectrum of fluphenazine base for comparison (Fig. 
A3.36). 
4.6.3. Discussion 
The 13C NMR spectra of fluphenazine and the corresponding N-oxidised 
metabolite have been interpreted previously by So fer and Zeigler125• The 
main diagnostic features of the spectra were reported to be the resonance 
peaks at 25 and 59ppm, which were attributed to the methylene group P to 
the N-propyl piperazine nitrogen atom and the methylene group P to the N-
ethanol piperazine nitrogen atom respectively. Because of the gamma effect 
of oxygen, substitution of oxygen at a piperazine N atom will cause the 
resonance signal of the appropriate methylene group ( p to N, therefore 
y to the 0 atom) to move up field. 
In the 13C NMR spectra of compounds A' and B', the signal representativp 
of the methylene group p to the N-ethanol piperazine nitrogen atom (a~ 
59ppm) is difficult to identify because of the presence of other resonanC1 
signals in this region. In contrast, the alternative diagnostic resonance signal 
at 25ppm is easily distinguised. Comparing the spectra of compounds AI and 
B' with that of the parent molecule, only compound A' shows the upfield shift 
of the 25ppm signal (to 20ppm) and must therefore contain an oxygen atom 
substituted at the N-propyl piperazine nitrogen atom, a conclusion which is in 
complete agreement with the structural assignment based upon proton NMR 
spectra. 
4.7 Elemental Analysis 
All determinations were undertaken by an extemal agency (Butterworth 
Laboratories Ltd.). 
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4.7.1 Oxygen Determination 
Assay of the oxygen content of the oxides proved to be invalid because of 
interference from the fluorine present in the compounds. 
4.7.2 CHN Determination 
CHN determinations on the compounds (in the form of the base derived 
from the hydrochloride salt, Section 4.5.1.1) resulted in values which bore 
little resemblance to the theoretical values (Table 4.8) 
C 
H 
N 
Table 4.8 
CHN Analysis of Compound C (base) 
Theoretical % 
60.09 
6.88 
6.58 
Found % 
54.64; 54.59 
7.48; 7.43 
5.21; 5.52 
The high values obtained for the H content combined with the low values 
of C and N implied contamination of the sample by water. Subsequent work 
(Section 4.9) confirmed that water was indeed present in the sample. 
On the contrary, elemental analysis of the hydrochloride salt of compound 
C gave results close to theory: 
Table 4.9 
CHN Analysis of Compound C (HCI salt) 
Theoretical % Corrected Found % 
(anhydrous) for H 0 
conteht 
C 55.17 54.19 55.07 
H 6.69 6.73 6.17 
N 6.04 5.92 6.21 
CI 10.19 10.00 10.07 
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The above results, with the exception of the hydrogen value, are within 
the limits of allowable error (0.3% absolute) quoted by the manufacturer of 
the instrumentation. However, if the level of moisture present in compound 
C (1.8%, see Section 4.9) is taken into account, the values for determined 
carbon and hydrogen content deviate considerably from the theoretical figure 
(corrected values, Table 4.9). 
Because of the unreliability of the CHN values, alternative techniques 
were sought to confirm the suspected identity of the compounds. 
4.8 Mass Spectrometry 
4.8.1 Experi mental 
Spectra were recorded by various external agencies. 
Electron impact mass spectra (En were determined on a Kratos MS 25 
mass spectrometer,at the National Hospital, London. 
Chemical ionisation mass spectra (Cn were determined on a Finnigan 3000 
mass spectrometer using ammonia or butane as reagent gases. 
Desorption Chemical Ionisation (DCI) and Fast Atom Bombardment(F AB) 
mass spectra were determined using a VG Analytical 70-7OHS mass spectro-
meter coupled to a VG OS 20-50 data system (V.G. Analytical, Altrincham). 
The following conditions were employed: 
DCI 
Reagent-gas 
Ionisation energy 
Accelerating voltage 
Filament emmission 
ammonia 
70 eV 
4.0 KV 
ImA 
In negative chemical ionisation mode, Freon 113 was also introduced into 
the source as a supply of chlorine ions for chlorine adduction. 
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FAB 
Samples were introduced into the ion source by means of an axially 
mounted direct insertion probe fitted with a stainless-steel sample support. 
Xenon atom-beam source 
acceleration potential 7KV 
emmission current ImA 
accelerating voltage 4KV 
4.8.2 Results 
Tables 4.10 and 4.11 summarise the results obtained from the mass 
spectra. 
Compound 
A 
B 
C 
o 
E 
F 
X 
y 
z 
Table 4.10 
MS Examination of Fluphenazine Decanoate 
Oxidation Products 
Technique 
DCI 
DCI 
DCI 
FAB 
DCI 
DCI 
DCI 
EI 
DCI 
FAB 
DCI 
FAB 
EI 
Molecular Ion 
(m/z) 
607 
607 
623 
624(M+ +1) 
640(M+ +1) 
656(M+ +1) 
624(M+ +1) 
623 
624(M+ +1) 
624(M!1) 
624(M+ +1) 
624(M+ +1) 
607 
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Intensity (%) 
35 
10 
10 
10 
10 
100 
15 
10 
100 
15 
70 
5 
Fig.No. 
(Appendix 3) 
A3.39 
A3.40 
A3.41 
A3.42 
A3.43 
A3.44 
A3.46 
A3.45 
A3.47 
A3.48 
A3.49 
A3.50 
-
Table 4.11 
MS Examination of Fluehenazine Oxidation 
Products 
Compound Technique Molecular Ion Intensity Fig. No. 
(mlz) (%) (Aeeendix 3) 
B' DCI 454(M+ +1) 64 A3.51 
C' DCI 470(M+ +1) 20 A3.52 
FAB 470(M+ +1) 15 A3.53 
0' DCI 486(M+ +1) 40 A3.54 
FAB 486(Mtl) 50 A3.55 
E' DCI 502(M+ +1) 40 A3.56 
V' DCI 470(M+ +1) 10 A3.57 
FAB 470(M+ +1) 80 A3.58 
Z' DCI 454(M+ +1) 100 A3.59 
FAB 454(M+ +1) 100 A3.60 
4.8.3 Discussion of Results 
ElMS provided molecular ion information only for those compounds 'not 
containing an N-O group (as shown by IR). This phenomenom is probably a 
result of the thermolabile nature of N-oxides. For the ester N-O compounds 
a major fragment was m/z 591, which is the molecular ion of the parent, 
indicating that the N-oxide readily decomposed to the parent ester at the 
source-temperature. The thermally labile N-oxides may also undergo re-
arrangement according to defined rules. Cope elimination153 forms an aHyl 
derivative and it was by this means that original identification of the 
piperazino N-oxide as a degradation product of fluphenazine decanoate was 
h· d174 M· nh· t f h t 1· N ·d 206 ac leve • else elmer rearrangemen 0 e erocyc IC -OXI es 
involves the incorporation of the oxygen atom into the skeleton of the side-
chain. 
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Attempts to deduce the molecular structure of the compound from the 
observed fragmentation pattern were unsuccessful. 
Compounds Z and F however, the suspected sulphoxide and sulphone 
respectively, yielded small but observable peaks for the expected molecular 
ion. A comparison of the EI mass spectra of compounds Z, F and 
fluphenazine decanoate indicated that those fragments containing the intact 
phenothiazine ring occurred at 16 and 32 mass units higher in the spectra of 
compounds Z and F respectively. Fig. 4.1 summarises the observed intact-
ring fragments. m/z fragments at 325, 153, 139 and 125 are indicative of the 
side-chain. The presence of each of these fragments in all three spectra 
signifies that the side-chain is unchanged in each of compounds Z and F, and 
thus the spectra fully support the proposed structures for these oxidation 
products. 
Melikian et al207 have investigated the application of CIMS to pheno-
thiazine-oxides. The pseudo molecular ion (MH+) was observed as base-peak 
for all sulphoxides examined, but in the case of the side-chain N-oxide of 
chlorpromazine, the molecular ion (and pseudo molecular ion) were absent. In 
the latter case, MH+ of the Cope elimination product (allyl compound) was 
observed to be the base-peak. CI experiments wi th those oxidation products 
of fluphenazine and fluphenazine decanoate thought to be N-oxldes (IR data) 
were similarly unsuccessful. The situation was further complicated by the 
probable presence of two N-O groups in compound C thus allowing the 
possibility of two Cope elimination products. 
Because of these difficulties an alternative technique was sought in order 
to obtain useful molecular ion data by mass-spectrometry. The use of Field 
Desorption MS was briefly considered but the non-availability of suitable 
instrumentation hindered progress in this direction. Subsequent discussions 
with V.G. Analytical Ltd., revealed the existence of two new techniques 
which, at that time, were not generally available - DCI and F AB. DCI is 
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R 
I (D:SX) ~ I + I ~ N C~ 
" CHz 
r (XSX) ~ I + I ~ 
N Cfs 
Fluphenazine 
decanoate 
(R = -) 
m/z 591 
m/z 419 
m/z 405 
m/z 280 
m/z 266 
Fluphenazine 
decanoate 
sulphoxide 
(R = 0) 
m/z 607 
m/z 435 
m/z 421 
m/z 296 
m/z 282 
(V.weak) 
Fig. 4.1 - Intact Phenothiazine-ring Fragments 
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Fluphenazine 
decanoate 
sulphone 
m/z 623 
m/z 451 
m/z 437 
m/z 312 
(V.weak) 
m/z 298 
similar to the technique of Field Desorption, but the MS is operated in CI 
mode instead of the EI mode usually associated with Field Desorption. In DCI 
the sample is deposi ted on a probe having a heatable platinum wire tip. The 
probe is inserted into the CI plasma beam and the wire rapidly heated. Sy 
this means, the desorption of ions occurs with much reduced fragmentation. 
The technique of F AS uses the phenomenon of ion sputtering, employing a 
beam of fast neutral atoms of high energy, thus avoiding the use of heat to 
promote ionisation. 
The results (Table 4.10 and 4.11) established that DCI successfully 
produced the required molecular ion (or pseudo molecular ion) albeit in small 
quantities (approx. 10% intensity). The advantages of the mild experimental 
conditions used with FAS, particularly when applied to the heat labile N-
oxides, is also clearly demonstrated by the results. 
The information obtained by mass spectrometry confirmed the expected 
molecular weight of the isolated oxidation products and provided further 
evidence for the structures postulated in Section 4.2. 
4.9 Hydrated Nature of Oxides 
4.9.1 Introduction 
The samples of the oxide hydrochloride salts which were converted to the 
corresponding bases for NMR and MS examination were also subjected to 
elemental analysis (Section 4.6). However the CHN values obtained did not 
correspond to the expected values. In addition, a strong absorption band in 
the 3500 cm -1 region of the IR spectrum of the ester compounds could not be 
explained, except as water contamination. The hygroscopic nature of N-
oxides is a commonly reported feature of these compounds190,210, thus the 
determination of the water content of the samples pertinent to this study was 
undertaken. 
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4.9.2 Experimental - A Gas Chromatographic Method for 
Moisture Determination 
The procedure is based upon a method in current use within the Squibb 
Insti tute for Medical Research 208 • 
4.9.2.1 GC Conditions 
Column : glass, Sft x * in. 
Packing : Poropak Q, 100-120 mesh 
Oven : 120°C 
Injector heater : 194°C 
Carrier gas : Helium, 40ml/min 
Detector : Katharometer 
Bridge current, 230mA 
Attenuation, Xl 
4.9.2.2 Sample Preparation 
Jmg of the compound under examination were accurately weighed 
into a 1ml reactivial (Pierce Chemicals Ltd.) and dissolved in 100uI 
methanol. 
4.9.2.3Standard Preparation 
25uI of water were diluted to 5ml with methanol in a volumetric 
flask. 
4.9.2.4Analytical Procedure 
SuI aliquots of each of a solvent blank, the sample and the standard 
were injected in duplicate onto the GC and the resultant peak-height of 
the peak representing water was determined. A typical chromatogram is 
illustrated in Fig. 4.2. 
4.9.2.5Linearity 
Linearity of response was determined by preparing a series of 
standard solutions containing known amounts of water between 1 and 
5mg/ml (the proposed range of the procedure). A linear response for 
-133-
200 
e 
e 150 
rzl 
CIl 
Z 
0 
llo 
CIl 
rzl 
a:: 100 
50 
./ 
./ 
• 
5 10 15 20 25 
CONCENTRATION OF WATER (mg/ml) 
Fig. 4.2 - Linearity of Response, GC Determination 
of Water 
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Fig. 4J - GC Determination of 
Water, Typical 
Chroma togram 
peak-height versus concentration was obtained (Fig. 4.3). The scatter of 
the points about the average straight line may be attributed to the 
interference of atmospheric moisture with which the GC syringe is readily 
contaminated. 
4.9.3 Results 
Samples of the isolated compounds (bases and hydrochloride salts) were 
examined before and after treatment by various drying techniques. The 
results are tabulated overleaf:-
-136-
Table 4.12 
Water Content of N- and S- Oxides of Fluphenazine 
and Fluphenazine Decanoate 
a) Ester Oxide Bases (prepared from hydrochloride salts for NMR and MS 
examination). 
Compound Treatment H20 Content(%) 
C 'as is' from 3.7 
isolation 
0 procedure 3.5 
E (Section 4.5) 6 
0 Freeze-dried 4.5 
(2nd treatment) 
0 Solution dried 2.8 
over MgS04 
0 Dimethoxypropane 1.7 
reaction 
b) Original H~drochloride Salts (Ester oxides) 
Compound Treatment H20 Content(%) 
C 'as is' 1.8 
C Freeze dried 1.5 
16 hrs @ RT 
C Dried under 1.0 
vacu,&m, 16 hrs 
@55 C 
D 'as is' 3.0 
D Freeze dried 1.9 
c) Fluphenazinf'! Oxide Hydrochloride Salts 
Compound Treatment H20 Content(%) 
C' as isolated 4.5 
0' as isolated 7.1 
Z' as isolated 5.5 
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4.9.4 Discussion of Results 
The results clearly verify the expected presence of water in all the 
compounds examined. Furthermore, the difficulty experienced when attemp-
ting to dehydrate the samples is also adequately demonstrated. 
In the majority of cases, the moisture content does not represent a 
stoichiometric value. However, one exception may be noted. Compound 0 
(in methanol solution) dried over magnesium sulphate appears to form the 
monohydrate (2.7% theoretical water content). 
Reaction with dimethoxypropane, a reagent which has been reported to 
, , 1 ' h 209,227 d 1 til' 't . quantItatIve y react WIt water , oes not comp e eye Imina e mOls-
ture from compound D in dichloromethane solution. Instead, the moisture 
content is reduced to a value approximating to the hemihydrate (1.4% 
theoretical water content). 
4.10 Hydrolysis Rates of the Piperazino-Mono-N-oxides 
4.10.1 Introduction 
The mono N-oxides of fluphenazine decanoate Cie. compounds A and B) 
had been noted to hydrolyse to the corresponding oxides of fluphenazine at 
differing rates during earlier investigations with HPLC. Rate constants were 
thus determined for the hydrolysis of compounds A and B and compared wi th 
the hydrolysis rate of the parent ester (fluphenazine decanoate), determined 
under identical conditions. Hydrolysis was performed under alkaline 
conditions in order to avoid the alternative reactions that can occur with 
phenothiazines in acid solution; ego formation and subsequent decomposition 
of the cation radical. 
4.10.2 E xperi mental 
A solution containing 0.5mg/ml of the compound to be hydrolysed was 
prepared in methanol. 4.0ml (pipette) were transferred to a 5ml volumetric 
flask and the solution diluted to volume with water. A similar dilution was 
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prepared using O.5M aqueous ammonium hydroxide instead of water. Aliquots 
of the second (alkaline) solution were withdrawn at suitable intervals and 
injected directly into the HPLC (SAS-Hypersil column; mobile phase, 
methanol/acetonitrile/l% aqueous ammonium carbonate, 1-1-1; flow rate, 
l.5ml/min; detector, 260nm). The unchanged ester component of the solution 
was quantitated by integration of the peak area. (Spectra Physics, Mini-
grator). 
4.10.3 Results 
Tables 4.13 to 4.15 list the results obtained. 
Table 4.13 
Alkaline Hydrolysis of Compound A 
Time Compound A 
(min.) remaining(%) 
Initial 100.0 
5 95.6 
10 91.2 
25 85.9 
35 80.3 
45 75.7 
55 71.7 
65 67.9 
85 61.1 
105 55.1 
125 49.2 
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Table 4.14 
Alkaline Hydrolysis of Compound B 
Time Compound B 
(min.) remaining(%) 
Initial 100.0 
5 82.9 
15 60.7 
25 44.4 
35 32.0 
45 23.3 
55 16.8 
65 12.8 
Table 4.15 
Alkaline Hydrolysis of Fluphenazine Decanoate 
Time Ester 
(min.) remaining(%) 
Initial 100.0 
10 95.4 
30 87.1 
50 80.4 
70 74.4 
90 67.9 
III 62.5 
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In the presence of excess reagent, the hydrolysis reaction obeys 1st order 
kinetics (pseudo 1st order reaction)208 and reaction rate is represented by the 
equation 
- d [ester] = k' [ester] 
dt 
which, following integration becomes 
In [estert ] = In [estero] - k't 
or, In [estert ] = -k't 
[ estero] 
The above equation is of the general mathematical form y = mx. Thus a 
graph of In [ester JI (estero] versus t will produce a straight line, the slope of 
which represents thf; rate-constant k'. 
The result of plutting In [estert]/[ estero] against t for the compounds 
examined is shown in Fig. 4.4. Th~ rate-constant (ie. the slope) was 
calculated by linear regression and the results of this exercise are given in 
Table 4.16. 
Compound 
F luphenazi ne 
A 
B 
Table 4.16 
Rate-Constants for Hydroysis of Fluphenazine 
Decanoate and its mono N-oxides 
Rate-~onstant Correlation 
(min- ) coefficient 
0.416 x 10-2 0.9997 
0.556 x 10-2 0.9995 
3.146 x 10-2 0.9998 
-141-
r--"Q' 
~ 
Q) 
+J 
til 
&!,.., 
" r--:;t ~ 
Q) 
+J 
!II 
L!..J 
Z 
IV\ 
100 
90 ~~ .~ .. ~ 
80 . '. \ ,.~". 
70 
., " 
.", ." 
60 • . . ....... 
"'. 
50 "'. " 
• 
40 \ 
• 
30 
• 
20 
10~ ____ ~ ____ ~ ____ ~ ____ ~ ____ ~ ____ ~ __ __ 
20 40 60 80 100 120 
TIME (min) 
Fig. 4.4 - Rates of Hydrolysis of Fluphenazine 
Decanoate and Mono N-Oxides 
_.fluphenazine decanoate; 
decanoate mono N-oxide Ai 
decanoate mono N-oxide B. 
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• I fluphenazine 
.' fluphenazine 
4.10.4 Discussion of Results 
From the values of the rate constants given in Table 4.16 it .can be seen 
that the hydrolysis rate of compound A is of the same order as fluphenazine 
decanoate whereas that of compound B is greater by a factor of five. The 
difference can be readily explained if compound A is assumed to be the 4-
piperazine-ethanol mono N-oxide and compound B the I-piperazine-ethanol 
mono N-oxide. 
The enhanced rate of hydrolysis apparent for compound B may then be 
accounted for by an anchiomeric effect involving the ester carbonyl group 
and the formation of a stable 6-membered transition state (Fig. 4.5). The 
observed phenomenon provides further evidence to support the structures of 
compounds A and B proposed on the basis on NMR data. 
With compound A, no such transition state is possible and therefore the 
hydrolysis rate of A would be expected to be similar to that of the parent 
ester. 
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(i) fompound B 
CHrCH2 
r--\/ \ ~-(CH;)-N +N 0 
3 '--1\ / Q .C 
'-./. II'R (0 
(ii) Compound A 
r--\ ~-(CHJ-N+ N-(CH2) OCR 
3 /'--1 2 Il 
0_ ° 
no cyclic intermediate 
possible with this oxide 
products 
-OH 
products 
!ig. 4.5 - Postulated Cyclic Intermediate Formed 
During Hydrolysis of Ester Mono N-Oxides 
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CHAPTER 5 
OXIDA TION OF FLUPHENAZINE DECANOATE BY HYDROPEROXIDES 
5.1 Introduction 
5.1.1 Background 
The antioxidant properties of phenothiazines when added to lubricating 
oils were reported as early as 1955 and the product of the reaction was 
established as the corresponding phenothiazine sulphoxide60• The mechanism 
by which the oxidation of the phenothiazine occurred in oily solution was 
postulated to involve the hydroperoxides formed during autoxidation of the 
°161 01 • 
Identi fication of a phenothiazine N-oxide formed during the accelerated 
degradation of a sesame oil solution of fluphenazine decanoate resulted in a 
similar postulation ie. that the unsaturated triglycerides present in sesame oil 
were autoxidised to hydroperoxides which further reacted with fluphenazine 
decanoate producing the N-oxidised phenothiazine species179• Indeed, 
experiments with castor-oil, which contains almost 100% fully saturated 
triglycerides, established that the direct reaction of dissolved oxygen with 
fluphenazine decanoate was unlikely180. The nature of the reaction mechan-
ism is unknown. The reaction may involve radical species from the 
autoxidation process or, alternatively, may involve the nucleophilic attack of 
the peroxide species at the t-amine centre as described by Lewis1J7• An 
investigation of the reaction between fluphenazine decanoate and various 
hydroperoxides was therefore proposed. As few hydroperoxide species are 
available in a pure form commercially, it was decided to prepare the required 
hydroperoxide 'in situ' by autoxidation prior to addition of fluphenazine 
decanoate. The chemistry involved in the formation of hydroperoxides by 
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autoxidation is well-documented, thus the nature of the peroxide formed 
should be predictable with a moderate degree of confidence. 
5.1.2 Choice of Materials 
Two criteria limited the choice of materials: 
1. Material must contain at least one C = C 
double bond to enable autoxidation to 
readily proceed. 
2. Materials should be structurally related, however 
remotely, to sesame oil or its constituents. 
Sesame oil, the vehicle used in Modecate Injection, consists of triglycer-
ides composed mainly of oleic and linoleic esters (40 and 45% respectively). 
The chemical entities most closely related to the triglycerides and which are 
commercially available in a pure form are the simple esters of oleic and 
linoleic acids. The methyl ester was chosen arbitrarily. Fatty acids may 
occur as minor constituents of natural oils, thus oleic and linoleic acids were 
also included in the study. 
To further simplify the situation, the ester group may be eliminated from 
the molecule resulting in simple olefins. These materials too were readily 
available commercially in a variety of carbon chain-lengths. Olefins less 
than seven carbon atoms long are extremely volatile, a property that could 
cause problems during autoxidation. Use of olefins was thus restricted to 
those molecules having a carbon-chain of between seven and eighteen atoms. 
Two readily available hydroperoxides were also included in the study, t-
butyl hydroperoxide and hydrogen peroxide. 
5.2 Preparation of Autoxidised Media 
It is imperative that the level of peroxide present in each of the degrading 
fluphenazine decanoate solutions be standardised to ensure a valid compari-
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son of the rates of oxidation occurring in the various media. The concentra-
tion of fluphenazine decanoate in each solution must be identical to that in 
Modecate Injection ie. 25mg/ml. The level of peroxide required was defined 
as that required to achieve an equimolar ratio of peroxide: drug. On this 
basis, the concentration of peroxide was calculated to be 1.4mg of DOH/mI. 
The chosen ratio of peroxide: drug exhibits two particular advantages: 
a) Complete conversion of the drug to the 
di N-oxide would be prevented thus allowing 
the ratio of mono N-oxide A: mono N-oxide B 
formed during the reaction to be determined 
in solutions of differing polarity. 
b) In event of the oxidation reaction obeying 
2nd order kinetics, calculation of the 
reaction rate would be simpli fied. 
5.2.1 Determination of Peroxide Content of Autoxidising Material 
A titrimetric procedure based on methods similar to those described in 
the British and European Pharmacopoeias217,223 was adopted. 
5.2.1.1 Materials and Reagents 
Potassium iodide, saturated solution 
Glacial acetic acid/chloroform mixture, 3:2 
O.OlM Sodium thiosulphate, accurately standardised. 
1% starch solution. 
5.2.1.2 Procedure 
Pipette Iml of the sample under examination into a 250-ml conical 
flask and disperse in 25ml of glacial acetic acid-chloroform mixture. Add 
O.5ml potassium iodide solution and swirl to mix. After exactly I min. 
reaction time, titrate the liberated 12 with standard sodium thiosulphate 
solution using starch as indicator. 
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5.2.1.3 Calculation 
Iml O.OlM sodium thiosulphate=O.165mg hydroperoxide (DOH). 
5.2.2 Autoxidation Procedure 
Two procedures were designed for autoxidation of the chosen media: 
a) Volatile liquids (short-chain olefins) 
30ml of the sample were placed in a clear glass screw-top jar and 
the solution and headspace flushed with oxygen. Jars were stored 
in a south-facing window and autoxidation allowed to proceed. 
Samples were purged with oxygen at weekly intervals and the 
concentration of peroxide monitored by iodine titration. 
b) Non-volatile liquids 
30ml of sample were poured into a large test-tube in a thermo-
stated oil bath (BOoC) and air bubbled through at a rate of 
50ml/min. Formation of peroxide was monitored by iodine titra-
tion. 
In each case autoxidation was allowed to proceed until the peroxide 
content of the solution was in excess of 1.4mg DOH/mI. 
5.2.3 Preparation of Standardised Media 
Subsequent to autoxidation, each liquid required dilution in order to 
produce a solution containing the chosen standard value of peroxide O.4mg 
OOH/mI). The solutions were prepared in the following manner:-
a) The peroxide content of the original bulk material was determined. 
b) The peroxide content of the autoxidised portion of material was 
determined. 
c) The relative proportions of (a) and (b) necessary to produce a 
medium with the correct peroxide content was calculated. 
d) The calculated quantities of (a) and (b) were carefully pipetted into 
a suitable container and thoroughly mixed. 
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5.3 H P L C Method for the Determination of N- and S- Oxides in Oily Solution. 
Before investigations into the reaction of fluphenazine decanoate with 
hydroperoxides could begin, an analytical procedure was required for 
quantitation of the expected mixture of oxides. HPLC seemed a logical 
choice of technique as suitable systems for the separation of fluphenazine 
decanoate oxides had been partially developed (Chapter 3) and quantitation 
could readily be achieved. The technique also offered the additional 
advantage that individual components of the expected mixture could be 
determined. By this means the occurrence of any change in the oxidation 
pattern may be observed. 
5.3.1 Development of HPLC System 
Both the literature and previous work with hydroperoxides during the 
synthesis of fluphenazine decanoate oxide reference compounds indicated 
that formation of sulphone was improbable at 200 C, the proposed tempera-
ture at which oxidation would be performed. An HPLC system was thus 
sought that would provide a separation of the N-oxides, sulphoxide and mixed 
N-oxide sulphoxide of fluphenazine decanoate (Compounds A, B, C, D, X, Y 
and Z). 
A mobile phase of methanol-acetonitrile-l% aqueous ammonium carbonate 
(1:1:1) together with a 20cm column of SAS-Hypersil resulted in the separa-
tion of six out of the seven oxides (Fig. 5.1). Compounds C and Y, the eli N-
oxide and sulphoxide N-oxide, chromatographed together in this system. The 
ratio of methanol: acetonitrile was found to be critical, the most efficient 
separation being obtained with the two organic components present in a ratio 
of 1:1. 
The complete resolution of all seven compounds was achieved (Fig. 5.2) by 
altering the mobile phase to methanol-10% aqueous ammonia (2:1). The 
presence of ammonia was essential in order to prevent tailing. 
Subsequent work with the same column used in the above experiments 
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aqueous ammonium carbonate (1-1-1); column, 
SAS-Hypersi1; 
1 = mono N-oxide B; 2 = sulphoxide; 3 = mono 
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mono N-oxide B; 6 = sulphoxide mono N-oxide 
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implied that ageing of the column-packing modified the chromatographic 
characteristics and enabled a separation of compounds C and Y to be 
achieved with the original mobile phase of methanol-acetonitrile-1 % aqueous 
ammonium carbonate, 1:1:1. Compound Z (sulphoxide) eluted from the aged 
column between Compounds A and C. 
Further investigation demonstrated that on a newly-packed SAS-Hypersil 
column, compound Z (sulphoxide) is co-eluted with compound B (mono N-
oxide). As the column ages the relative position of compound Z changes until 
it is situated between compounds A and C. Probable reasons for this 
observed phenomenon are difficult to prove, but it is most likely that the 
ageing process is a result of the alkaline hydrolysis of the chemically-bonded 
reversed-phase leaving free silica sites on the surface of the column-packing 
particles. Under these modified conditions the adsorption characteristics of 
the sulphoxide (compound Z) and the N-oxides (compounds A and B) are 
altered, resulting in the changed elution pattern. 
Further evidence of the chemical stripping phenomenon is provided by the 
observation that a newly-packed SAS-Hypersil column can be converted to 
the modified form by a short treatment with methanolic ammonia. 
5.3.2 Effect of Ammonium Carbonate Concentration 
Increasing the ammonium carbonate concentration of the mobile-phase 
aqueous component has been reported to cause a decrease in the retention 
time of nortriptyline, although the effect was not observed with fluphen-
. 235 
azme 
The effect of varying the ammonium carbonate content with respect to 
the oxides of fluphenazine decanoate is illustrated in Fig. 5.3. Small 
variations in retention-time are apparent for mono N-oxides A and B and the 
sulphoxide. Each compound, however, was affected to a similar extent thus 
no overall change in the relative position of elution was observed and hence 
the ammonium carbonate concentration can be considered as non-critical. 
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5.3.3 Effect of Injecting Oil onto HPLC Column 
In order to simplify sample preparation it was proposed to dilute the oily 
sample with a chloroform/methanol mixture and inject the resulting solution 
directly onto the HPLC column. 
The effect of this treatment was to cause a small amount of peak-
broadening, although resolution of the oxides was not unduly affected. 
However, to compensate for this small effect, an equivalent amount of oil 
was added to the standard solution during quantitative studies. 
5.3.4 Choice of Detector Wavelength 
N-oxides were detected at the X max of the compounds (260nm) but 
attempts to monitor low-levels of the sulphoxide at the ~ max of 275nm were 
thwarted because of interference from a minor impurity ( ~ max, 260nm) 
present in the fluphenazine decanoate. The interference was reduced to 
negligible proportions, with minimal loss of sensitivity, by offsetting the 
detector wavelength to 280nm. 
5.3.5 Validation 
5.3.5.1linearity of Response 
lineari ty of response was determined over the range 0 to 5mg 
oxide per ml of formulation (equivalent to 0-20% degradation of fluphen-
azine decanoate) at wavelengths of 260nm (N-oxide) and 280nm 
(sulphoxide) after dilution in the manner proposed for sample preparation 
(Section 5.2.6.2). 
Linear responses were obtained in each case (Figs. 5.4 and 5.5). 
5.3.5.2 Reproducibili ty 
An oily solution of fluphenazine decanoate was spiked with each 
oxide at a level equivalent to 10% degradation and diluted according to 
the procedure described in Section 5.2.6. 
A SuI aliquot of each diluted solution was injected onto the HPLC 
column and the oxide content assayed against a standard solution contain-
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/ 
• 
0.25 
ing an equivalent amount of oil. 
The results are given in Table 5.1. 
Table 5.1 
Reproducibility of HPLC Assay for Fluphenazine 
Decanoate Oxides 
Assay 
(% theory) 
Average 
S.D. 
Mono N-oxide, 
Total A + B 
(Theoretical 2.50mg/ml) 
99.9; 99.1; 100.5 
101.3; 102.0; 100.5 
100.4; 100.0 
100.5 
:to.88 
Sulphoxide 
(Theoretical 2.50mg/ml) 
100.0; 102.3; 101.7 
100.6; 102.3; 
101.4 
~1.04 
5.3.6 Analytical Procedure for Determination of Fluphenazine Decan-
oate Oxides in Oily Solution 
5.3.6.1 Preparation of Standards 
Accurately weigh 1mg of each oxide (Cahn Micro balance) into 
separate 10-ml volumetric flasks. Dissolve in and dilute to volume with a 
50-50 mixture of methanol/chloroform. Further dilute the solution to the 
required level (ie. the approximate level of oxide expected in the 
degrading oily solution). Typical dilutions are given below: 
Compound 
Mono N-O 
di N-O 
S =0 
S = 0 N-O 
S = 0 N-O 
5.3.6.2 Preparation of Sample 
Dilution 
x2 
x 10 
x5 
x5 
x5 
Dilute Iml of oily fluphenazine decanoate solution to 25ml with a 
50-50 mixture of methanol/chloroform. 
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5.3.6.3 HPLC Procedure 
Column 
Mobile 
phase 
Detector 
wavelength 
Flow 
Injection 
volume 
Quantitation 
5.3.6.4 Calculation 
Oxide,mg/ml 
of formu-
lation 
= Sample response 
Std. response 
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SAS-Hypersil, 20cm 
Methanol-acetoni trile-
1 % aqueous ammonium 
carbonate, 1-1-1. 
N-oxide, 260nm; sulphoxide, 
280nm 
1-2ml/min, as required. 
5ul(syringe) 
Mono N-oxides ) Integration of 
di N-O ) peak area 
S =0 
S = 0 mono N-oxides 
S = 0 di N-Oxides 
x Std.wt 
Std.diln. 
x 25 
T 
) Peak height 
) measurement 
) 
5.4 Reaction of Fluphenazine Decanoate with t-Butyl Hydroperoxide 
5.4.1 Preparation of Samples 
.t-Butyl hydroperoxide was purchased from Aldrich Chemicals Ltd., as an 
aqueous solution (70% t-BuOOH). As this mixture is not miscible with 
organic hydrocarbons, the aqueous solution was partitioned with heptane and 
the organic layer separated by centrifugation. The hydroperoxide content of 
the heptane fraction was assayed by iodine titration then the solution diluted 
with heptane to produce the required standard value of hydroperoxide 
(l.4mg/mI). A saturat~d hydrocarbon was used as solvent to avoid alternative 
reactions that could possibly occur if an unsaturated hydrocarbon was 
employed. Eg. oxidation of the C = C double bond. 
A solution containing 25mg/ml fluphenazine decanoate was subsequently 
prepared with the t-BuOOH/heptane solution as solvent. It was necessary to 
gently warm the mixture (350 C) to aid dissolution of the fluphenazine 
decanoate (MP = 320 ). A similar solution omitting the peroxide was prepared 
as a control. The mixtures were then stored in the dark in an environment 
thermostated at 200 C. Storage under conditions of darkness was considered 
essential so that photoxidation reactions would be prevented. These 
conditions also simulate the normal manner of storage of Modecate Injection. 
Formation of fluphenazine decanoate oxides was monitored by assaying 
the oxidising solultions at suitable intervals using the HPLC procedure 
described in Section 5.3 
5.4.2 Results and Discussion 
The results obtained are summarised in Table 5.2. 
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Table 5.2 
Oxidation of Flu henazine Decanoate with 
t-Butyl Hydroperoxide Heptane Solution 
Oxide Content, um/ml 
Time of t BuOOH Solution Control 
storage 
(weeks) Mono N- DiN- Sulphoxide Mono N- Sulphoxide 
oxide oxide oxide 
(Total) (Total) 
0.731 Not 0.058 Not Not detected 
detected detected 
2 2.303 0.353 0.120 0.027 
3 2.893 0.517 0.171 0.035 
6 4.054 1.493 0.188 0.039 Not detected 
The most notable feature of the above results is the preferential oxidation 
of the piperazine t-amine centres. Oxidation of the phenothiazine ring S 
atom is almost negligible by comparison. 
5.5 Reaction of Fluphenazine Decanoate with Olefinic Hydroperoxides 
5.5.1 Preparation of Samples . 
Solutions of fluphenazine decanoate at a strength of 25mg/ml were 
prepared with each of the standardised olefinic hydroperoxide solutions 
resulting from the procedures described in Section 5.2. The solutions were 
gently heated OSoC) to dissolve the fluphenazine decanoate, then immediate-
ly cooled to RT and stored under conditions of darkness in a thermostated 
environment at 20oC. Samples were assayed for oxide content at regular 
intervals. 
5.5.2 Results 
The results obtained are given in Tables 5.3 to 5.8. 
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Time 
(Hours) 
5 
24 
46 
101 
168 
288 
Time 
(Hours) 
72 
144 
240 
312 
Table 5.3 
Oxidation of FluE!henazine Oecanoate with 
Autoxidised I-HeE!tene 
Oxide Content (um/ml) 
Piperazino Piperazino 
Mono N-oxides Oi N-oxide 
(Total) 
0.381 Not detected 
1.199 0.057 
1.916 0.152 
2.773 0.335 
3.880 0.703 
4.512 1.246 
Table 5.4 
Oxidation of FluE!henazine Oecanoate with 
Autoxidised 2-Heptene 
Piperazino 
Mono N-oxi des 
(Total) 
1.466 
2.204 
3.274 
3.582 
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Oxide Content(um/ml) 
Piperazino 
Oi N-oxide 
0.113 
0.266 
0.520 
0.704 
Sulphoxide 
Not detected 
0.067 
0.100 
0.154 
0.156 
0.239 
Sulphoxide 
0.048 
0.079 
0.163 
0.134 
Table 5.5 
Oxidation of FluEhenazine Decanoate with 
Autoxidised 1°-0ctene 
Oxide Content(um/ml) 
Time Piperazino Piperazino Sulphoxide 
(Hours) Mono N-oxides Di N-oxide 
(Total) 
24 1.331 0.088 0.107 
48 2.339 0.189 0.150 
120 3.689 0.579 0.208 
192 4.526 0.852 0.232 
Table 5.6 
Oxidation of FluEhenazine Decanoate with 
Autoxidised I-Decene 
Oxide Content(um/ml) 
Time Piperazino Piperazino Sulphoxide 
(Hours) Mono N-oxides Di N-oxide 
(Total) 
24 2.549 0.190 0.114 
48 3.872 0.422 0.170 
120 5.445 0.960 0.239 
192 6.361 1.464 0.254 
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Table 5.7 
Oxidation of FluQhenazine Decanoate with 
Autoxidised 1-Tetradecene 
Oxide Content(um/ml) 
Time Piperazino Piperazino Sulphoxide 
(Hours) Mono N-oxides Di N-oxide 
(Total) 
24 1.646 0.092 0.107 
48 2.545 0.267 0.150 
120 4.013 0.717 0.186 
196 4.703 1.006 0.226 
Table 5.8 
Oxidation of FluQhenazine Decanoate with 
Autoxidised l-Octadecene 
Oxide Content(um/ml) 
Time Piperazino Piperazino Sulphoxide 
(Hours) Mono N-oxides Di N-oxide 
(Total) 
24 2.305 0.218 0.134 
48 3.860 0.483 0.199 
120 5.025 1.320 0.262 
144 5.387 1.405 0.275 
192 5.710 1. 785 0.290 
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5.5.3 Application of Kinetics 
The degradation of fluphenazine decanoate calculated from the oxide 
assay results obeys no particular order of kinetics, the rate of degradation 
steadily decreasing with time. This effect is probably a result of the 
chemical nature of the drug. Because of the four potential oxidation sites 
within the molecule, hydroperoxides may further attack one of the oxidation 
products, effectively reducing the amount of peroxide available for reaction 
with the remaining drug ie. two parallel reactions occur viz. oxidation of 
fluphenazine decanoate and oxidation of the degradation (oxidation) product. 
A decrease in the degradation rate of fluphenazine decanoate is thus 
observed as oxidation proceeds. Although this phenomenon cannot be 
I 
prevented from occurring in practice, a mathematical correction can be 
made when calculating values for use with kinetic-equations. From the total 
amount of oxygen consumed (moles) during formation of the oxides, a 
theoretical value may be calculated for the concentration of fluphenazine 
decanoate that would remain had the drug contained only one oxidation site 
ie. the theoretical concentration of drug which would be present in solution if 
all available peroxide had reacted with the drug alone. Although this 
treatment is not valid for stability-prediction, it will allow a comparison of 
varying reaction parameters on a quantitative basis. 
The integrated forms of the kinetic equations are as follows:-
zero order 
1st order 
2nd order 
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kt = C - C o 
kt = InC 
-0 
C 
kt = 1 In b(a-x) 
a-b a(b-x) 
where C = Initial concentration of reactant 0 
C = Concentration of reactant at time t 
a = Initial concentration of reactant a 
b = Initial concentration of reactant b 
x = Concentration of product at time t 
F or the special case of both reactants being of equal intial concentration 
(a = b = Co) the 2nd order equation simplifies to 
kt = 1 1 
C Co 
A linear graph may therefore be obtained by plotting C (zero order), In C 
Ost order) or IIC (2nd order) against time. 
Treatment of the results in this manner failed to reveal an obeyance of 
anyone particular reaction order. Closest fit of the data was observed for 
2nd order kinetics. 
5.5.4 Discussion 
In all cases the results tabulated above show a similar selectivity to that 
exhibited by t-butyl hydroperoxide and thus oxidation of the piperazino t-
amine groups is observed in preference to oxidation of the phenothiazine ring 
heteroatoms. Although absolute reaction-rates could not be calculated from 
the results obtained, a plot of the reciprocal of the calculated theoretical 
drug concentration remaining versus time indicates an apparent relationship 
between the peroxide carbon-chain length and reaction-rate (Fig. 5.6). The 
autoxidised l-decene (C-IO) was a notable exception, the rate of oxidation of 
fluphenazine decanoate by this material being greater than that obtained 
with autoxidised l-octadecene (C-18). 
F ormation of secondary products from hydroperoxides is an established 
reaction which has been documented with particular regard to the autoxi-
dation of unsaturated fatty acids and esters177• Under conditions of elevated 
temperatures the hydroperoxides of fatty esters are known to decompose 
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producing saturated and unsaturated carbonyl compounds, and organic acids, 
which are believed to be responsible for the characteristic odour of rancid 
fats. 
If the autoxidised olefines used in the current experiments were to 
decompose to different extents during autoxidation, then varying levels of 
secondary reaction products would be formed which could possibly influence 
the reaction rate of the peroxide with fluphenazine decanoate. A viable 
explanation of observed differences (Fig. 5.6) could then be offered. 
Accordingly the olefins were examined by IR spectrophotometry and the 
materials before. and after autoxidation compared. A scan of the full IR 
spectrum (625-4000 cm -1) of a thin smear of each sample between NaCI 
plates revealed no obvious differences (Figs. 5.7 and 5.8). However, the IR 
spectra of a O.lmm layer (liquid-cell) provided useful information, particu-
larly in the 1700 cm -1 region (carbonyl stretching frequency). The spectra 
are reproduced in Figs. 5.9 and 5.10. In each case, the appearance of an 
absorption band at about 1700 cm -1 was observed in all materials following 
autoxidation which is attributable to the carbonyl compounds resulting from 
the secondary reaction of the hydroperoxides formed during autoxidation. 
Autoxidised I-decene contained the greatest amount of this impurity thus 
proffering a plausible explanation for the curiously enhanced rate of oxida-
tion of fluphenazine decanoate by this material. 
The possibility of other trace-impurities (eg. from manufacture of the 
olefins) influencing the rate of oxidation could not, however, be ignored. 
Consequently an alternative batch of I-decene was acquired (Sigma 
Chemicals) and autoxidised simultaneously with a second portion of the 
original batch. Solutions of fluphenazine decanoate were then prepared in 
accordance with the procedure described under 'Preparation of Samples', 
Section 5.5.1. The results of this experiment are given in Table 5.9. A 
graphical representation of the results (Fig. 5.11) clearly established that the 
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Table 5.9 
Original Batch New Batch 
Time Piperazin~ Piperazin~ Sulphoxide Piperazin~ Piperazin~ Sulphoxide 
(hours) Mono N-oxide di N-oxide Mono N-oxides di N-oxide 
I (Total) (Total) 
.... 
0\ um/ml um/ml um/ml um/ml um/ml um/ml 
-..,f 
I 
24 2.769 0.259 0.179 1.451 0.130 0.127 
48 4.521 0.566 0.200 2.531 0.165 0.220 
120 7.290 1.549 0.343 4.498 0.625 0.320 
1.3 
1.2 
1.1 
1.0 ~--------~--------~---------r--~ 
100 200 300 
TIME(hours) 
!ig. 5.6 - Oxidation of Fluphenazine Decanoate by 
Autoxidised Olefines (2nd order kinetics) 
~ = 2-heptene; _ = l-heptene; 0 = l-octene; 
A = l-tetradecene; C = l-octadecene; 
• = l-decene. 
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two batches of l-decene (after autoxidation) oxidised fluphenazine decanoate 
at different rates. Furthermore, comparison with the original results (Fig. 
5.6) demonstrated that the new batch of I-decene exhibited a rate of 
oxidation in approximate agreement with the postulated relationship with 
regard to carbon-chain length. 
The characteristics of the two lots of I-decene were thus closely 
compared. A most noticeable difference upon opening the bottles was the 
strongly rancid odour of the original batch. The rancid odour was apparent in 
the material as received from the manufacturer, and as this material 
contained very little peroxide (OOH = 0.28mg/ml) an impurity resulting from 
the manufacturing process was indicated. Such odours are typical of the 
higher fatty acids hence the acid value of each of the olefins was determined 
using the method described in the British Pharmacopoeia218• The results are 
tabulated below and unequivocally show the comparatively high acidity of the 
original batch of 1-decene. In addition, a considerable increase in acidity was 
noted following autoxidation. 
Table 5.10 
Acid Values of the Dlefins 
Material Acid Value 
I-heptene 
l-octene 
I-decene(originaI) 
Autoxidised I-decene 
1-decene{2nd lot) 
Autoxidised 
l-tetradecene 
Autoxidised I-tetradecene 
0.064 
0.031 
0.258 
1.272 
0.038 
0.121 
0.051 
0.116 
0.064 l-octadecene 
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5.6 Reaction of Fluphenazine Oecanoate with Autoxidised Fatty Acids 
As a logical extension to the previous section the rate of oxidation of 
fluphenazine decanoate by fatty acid hydroperoxides was determined. 
5.6.1 Preparation of Samples 
Oleic and linoleic acids were autoxidised as described in Section 5.2 then 
diluted to produce standardised hydroperoxide solutions. Fluphenazine dec an-
oate was dissolved in the prepared peroxide solutions to give a concentration 
of 25mg/ml and samples stored at 200 C in the dark. 
5.6.2 Results and Discussion 
Tables 5.11 and 5.12 list the results obtained. 
Table 5.11 
Oxidation of Fluphenazine Decanoate with 
Autoxidised Oleic Acid 
Time Oxide Content(um/ml) 
(Hours) 
piperazino Piperazino Sulphoxide 
Mono N-oxides Oi N-oxide 
(rotal) 
1 0.643 Not detected 0.338 
2 1.143 Not detected 0.647 
4 2.465 0.032 1.191 
5 3.031 0.052 1.325 
6 3.633 0.078 1.702 
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Table 5.12 
Oxidation of Flu~henazine Decanoate with 
Autoxidised linoleic Acid 
Time Oxide Content(um/mI) 
(Hours) 
1 
2 
3.5 
4.5 
5.5 
Piperazino Piperazino Sulphoxide 
Mono N-oxides Oi N-oxide 
(Total) 
1.613 Not detected 0.557 
2.832 Not detected 0.881 
4.002 0.114 1.303 
5.023 0.170 1. 712 
5.988 0.271 2.069 
The results given in the above tables, when treated as described in Section 
5.5.3 apparently obeyed both 1st and 2nd order kinetics equally well (Figs. 
5.12 and 5.13), the degree of scatter within the available data causing the 
orders of reaction to be indistinguishable. linear regression of the data also 
., 
failed to identify the reaction order. Further data is obviously required to 
determine the correct reaction order and corresponding reaction rate. 
However, the results are sufficient to demonstrate the enhanced oxidation 
rate of fluphenazine decanoate by the autoxidised fatty acids compared with 
the results of similar experiments using autoxidised olefins (Section 5.5). 
With the fatty acid hydroperoxides, formation of fluphenazine decanoate 
oxides is achieved in a matter of hours whereas the olefinic hydroperoxides 
required days to produce a similar level of oxidation products. Hence the 
suspected influence of acidity on the rate of fluphenazine decanoate oxida-
tion by autoxidised olefins appears to be further substantiated. It could not, 
however, be deduced at this stage of the work whether the influence of 
acidity was dependant on the presence of the corresponding acid hydro-
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TIME{hours) 
Fig. 5.12 - Oxidation of Fluphenazine Decanoate 
by Autoxidised Fatty Acids (1st order 
kinetics) 
o = oleic acid, ~ = linoleic acid. 
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Fig. 5.13 - Oxidation of Fluphenazine Decanoate by 
Autoxidised Fatty Acids (2nd order 
kinetics) 
a = ole i c a c i d , t::. = 1 i no 1 e i c a c i d • 
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6 
peroxide, or whether the effect was due to the acid acting in a catalytic role. 
Another feature of oxidation by the autoxidised acids is the increased 
amount of sulphoxide formed. Oxidation with autoxidised olefins (Section 
5.5) had shown almost negligible proportions of sulphoxide to be produced. 
The effect of acidity in this respect may be related to either of two 
previously noted facts: 
(i) Hydrogen peroxide oxidation of fluphenazine in a protonated form (di 
hydrochloride salt) exclusively yields sulphoxide (Section 3.1.2.4) 
(in N-substituted phenothiazines in the presence of H+ form a protonated 
phenazathionium ion which is readily converted to sulphoxide by traces of 
water. 
5.7 Reaction of Fluphenazine Decanoate with Autoxidised Fatty Esters 
A small amount of acid present as impurity in I-decene, either naturally 
occurring or formed during autoxidation, had previously been intimated as a 
factor influencing the rate of oxidation of fluphenazine decanoate by the 
autoxidised material. In order to determine if a similar effect was evident 
with fatty esters, which contain small amounts of fatty acid impurities, 
similar experiments were conducted with methyl oleate and methyllinoleate. 
A procedure for deacidification of the esters was required so that 
oxidation by neutral materials could be compared with materials containing 
natural fatty acid impurities. Because of the likelihood of acid formation 
during the autoxidation step the deacidification procedure would have to be 
performed after autoxidation of the ester. Deacidification must therefore 
selectively remove acid material from the ester, allowing the hydroperoxide 
to remain in solution. 
procedure 218 • 
Acid values were determined by the B.P. 
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5.7.1Method for the Deacidification of Autoxidised Fatty Esters 
Using a technical grade of ethyl oleate for reasons of cost-efficiency, two 
procedures for the deacidification of autoxidised fatty esters were investi-
gated. 
a) Macrorecticular ion-exchange resins were successful only on a small scale 
with traces of acid impurity. At a realistic level of acid, results became 
erratic. 
b) Basic alumina. A short column (30mm x 10mm) of basic alumina (Merck) 
adsorbed acid impurities, allowing the majority of hydroperoxide to be 
eluted with the ester. To test the validity of the procedure stearic acid 
(90mg) was added to an aliquot (JOm!) of autoxidised ethyl oleate and the 
peroxide and acid contents determined before and after deacidification 
using a 30mm x 10mm alumina column. 
The results are given below and indicate the validity of the deacidifi-
cation procedure: 
Autoxidised Autoxidised 
Ester Ester after 
(as is) deacidi fication 
Peroxide 14.7 12.1 
(ml O.OlM Na2S203) 
Natural acid level )mI0.1M 0.36 zero 
)NaOH 
Added Stearic acid ) 1.45 0.05 
5.7.2 Preparation of Samples 
5.7.2.1Deacidified Esters 
Following autoxidation, the esters were deacidified as described 
above (Section 5.7.1) and diluted to the standardised value of hydro-
peroxide with deacidified original material. Fluphenazine decanoate was 
then dissolved in the peroxide solution to produce solutions containing 
25mg/ml of drug. 
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5.7.2.2' As is' Esters 
Standardised ester solutions containing 25mg/ml of fluphenazine 
decanoate were prepared as previously described for autoxidised olefins. 
All solutions were stored at 200 e (thermostated) in the dark. 
5.7.3 Modification of Assay Procedure for Oxides 
No interferences had been noted when injecting the prepared olefin and 
fatty acid samples, in chloroform/methanol solution, directly on-column. 
However, methyl linoleate caused interfering peaks to be co-eluted with the 
two fluphenazine decanoate mono N-oxides. The nature of the interferences 
was unknown. To overcome this problem the oxides were separated from the 
ester by extraction prior to chromatography. Thus the oily sample (lml; 
pipette) was dispersed in hexane (5mt) and the fluphenazine decanoate oxides 
extracted into an accurate volume (IO ml) of a mixture of methanol/a. 1M 
aqueous hydrochloric acid (50-50). 
Validation of the procedure was determined by dissolving a known amount 
of oxide in the hexane/methyl linoleate solution and after partition with 
methanol/O.IN Hel mixture the level of oxide extracted was determined. The 
following recoveries were obtained: 
Mono N-oxides (A +8) 
Di N-oxide 
Sulphoxide 
5.7.4 Results and Discussion 
97.7% recovery 
100.9% recovery 
98.1 % recovery 
Tables 5.13 to 5.16 summarise the results obtained. 
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Table 5.13 
Oxidation of Flu henazine Decanoate with 
Autoxidised Methyl Oleate - 'As is' Acid Value = 0.44) 
Time Oxide Content(um/mI} 
(hours) 
Piperazino Piperazino Sulphoxide 
Mono N-oxides Di N-oxide 
(rotal) 
24 0.366 No detected Not detected 
120 1.736 0.038 0.074 
192 2.297 0.046 0.082 
288 2.890 0.088 0.130 
Table 5.14 
Oxidation of Fluehenazine Decanoate with 
Autoxidised Methyl Oleate - Deacidified 
Time Oxide Content(um/mI} 
(days) 
Piperazino Piperazino Sulphoxide 
Mono N-oxides Di N-oxide 
(Total) 
7 0.345 Not detected Not detected 
14 0.743 Not detected Not detected 
21 1.129 Not detected 0.091 
26 1.251 Not detected 0.086 
42 1.761 0.027 0.119 
49 2.115 0.247 0.123 
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Table 5.15 
Oxidation of Flu henazine Oecanoate with 
Autoxidised Methyl Linoleate - 'As is' Acid Value = 0.19) 
Time Oxide Content(um/mI) 
(hours) 
Piperazino Piperazino Sulphoxide 
Mono N-oxides Oi N-oxide 
(rotal) 
72 0.611 0.093 0.064 
168 1.708 0.092 0.147 
240 1.951 0.154 0.138 
336 2.582 0.175 0.280 
Table 5.16 
Oxidation of FluQhenazine Oecanoate with 
Autoxidised Methyl Linoleate - Oeacidi fied 
Time Oxide ContentCum/mO 
(days) 
Piperazino Piperazino Sulphoxide 
Mono N-oxides Di N-oxide 
(Total) 
6 0.599 Not detected Not detected 
13 1.246 Not detected 0.142 
19 1.765 0.062 0.086 
34 3.089 0.147 0.203 
As found in previous experiments using olefinic hydroperoxides and t-butyl 
hydroperoxide, preferential oxidation of the piperazine ring was observed 
resulting in the almost selective formation of N-oxides. The results also 
confirm the enhancement of oxidation by acid which was suspected from 
earlier work. 
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S.B Influence of Acid on Rate of Oxidation 
S.B.l Effect of Acid Concentration 
S.B.l.IChoice of Materials 
Although the enhancement of fluphenazine decanoate oxidation 
rate in the presence of acid had been adequately demonstrated with both 
olefin and fatty ester hydroperoxides, the nature of the effect was 
unknown. Fatty acid hydroperoxides had been shown to oxidise fluphen-
azine decanoate at a much faster rate than the olefinic or fatty ester 
hydroperoxides implying one possible mechanism for the rate-enhance-
ment effect ie. that small amounts of fatty acid hydroperoxides are 
formed during the autoxidation process effectively increasing the rate of 
oxidation. Alternatively, the acid could be acting as a catalyst in similar 
manner to that described in the published literature referring to the 
oxidation of organic sulphides (See Section 1.2.1.1). 
Experiments were therefore designed in which oxidation of the acid 
could not readily occur. Stearic acid was chosen as it is a saturated fatty 
acid which would be unlikely to autoxidise at 200 C throughout the 
duration of the experiment. The acid is also of the same carbon-chain 
length as oleic/linoleic esters which would be used as the media and would 
thus be of a similar nature to the naturally occurring fatty acids present 
in the oleate and linoleate fatty esters. 
Oleate and linoleate esters were chosen as the solution media 
representative of the esters present in sesame oil, the vehicle used for' 
Modecate Injection. 
5.B.1.2Preparation of Samples 
Oleic and linoleic esters were autoxidised, deacidified then diluted 
to the standardised value of hydroperoxide with deacidified ester as 
described previously. 
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125mg Quantities of fluphenazine decanoate were weighed into a 
5ml volumetric flask and known amounts (between 0 and 50mg) of stearic 
acid added, representing 0 to 1% acid impurity relative to the fatty ester. 
The drug and acid were then dissolved in the standardised fatty ester 
hydroperoxide solution and warmed gently to dissolve. The solutions were 
cooled to 200 C as soon as the materials had completely dissolved. 
Samples were stored in the dark at 200 C (thermostated environment). 
Aliquots of each sample were assayed at regular intervals. Because of the 
limited volume (5mI) of each sample available O.4ml aliquots were diluted 
to 10ml in chloroform/methanol mixture (Section 5.3). 
Methyl linoleate samples again showed interfering peaks on the 
HPLC chromatograms if injected directly on-column and thus the oxides 
were extracted into methanol/O.1M HCl prior to injection into the HPLC. 
(See Section 5.7). 
5.8.1.3 Results and Discussion 
The results obtained with methyl oleate hydroperoxides are given 
in Table 5.17. 
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Table 5.17 
Influence of Stearic Acid on Oxidation 
of Fluphenazine Decanoate by Autoxidised Methyl Oleate 
a) Zero % aci d 
Time 
(Hours) 
17 
63 
165 
230 
336 
504 
672 
Piperazino 
Mono N-oxides 
(rotal) 
0.055 
0.078 
0.329 
0.502 
0.657 
0.865 
1.130 
b) 0.25% acid (0.045 mM) 
Time 
(Hours) 
Piperazin~ 
Mono N-oxides 
(Total) 
17 0.303 
63 0.815 
165 2.091 
230 2.974 
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Oxide Content(um/mO 
Piperazino 
Oi N-oxide 
Not detected 
" 
" 
" 
" 
" 
" 
Oxide Content(um/ml) 
Piperazino 
Oi N-oxide 
Not detected 
Not detected 
0.095 
0.100 
Sulphoxide 
Not detected 
" 
0.037 
0.052 
0.060 
0.075 
0.076 
Sulphoxide 
0.012 
0.056 
0.087 
0.094 
Table 5.17(Contd ••• ) 
c) 0.5% acid (0.089mM) 
Time Oxide Content(um/r'nl) 
{ROUrs) 
Piperazin~ Piperazin~ Sulphoxide 
Mono N-oxides Oi N-oxide 
(Total) 
17 0.504 Not detected 0.038 
63 1.563 0.029 0.080 
165 3.450 0.137 0.105 
230 4.908 0.233 0.155 
d) 0.75% acid (0.132mM) 
Time Oxide Content(um/mi) 
(Hours) 
Piperazin~ Piperazin~ Sulphoxide 
Mono N-oxides Oi N-oxide 
(Total) 
17 0.647 Not detected 0.038 
63 2.081 0.051 0.072 
165 4.675 0.263 0.161 
230 6.175 0.431 0.198 
e) 1.0% acid (0.177mM) 
Time Oxide Content(um/mI) 
(Hours) 
Piperazin~ Piperazin~ Sulphoxide 
Mono N-oxides Oi N-oxide 
(Total) 
17 0.825 Not detected 0.049 
63 2.651 0.073 0.104 
165 5.681 0.395 0.204 
230 7.278 0.631 0.241 
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The results were found to obey 2nd order kinetics (Figs. 5.14 and 
5.15). The enhanced rate of oxidation wi th increasing acid content is 
clearly demonstrated and in this controlled experiment is unlikely to be 
due to the presence of fatty acid hydroperoxides. The effect must thus be 
attributed to acid catalysis. 
To obtain confirmation of the reaction order, the experiment was 
repeated with a single level of acid. The results are given below:-
Table 5.18 
Oxidation of Fluphenazine Oecanoate by Autoxidised Methyl 
Oleate in the Presence of Stearic Acid 
Time Oxide Content(um/ml) 
(Hours) 
Piperazino Piperazino 
Mono N-oxides Oi N-oxide 
(Total) 
17 0.529 Not detected 
41 1.397 Not detected 
65 2.011 Not detected 
89 2.550 0.071 
168 4.585 0.168 
233 5.845 0.344 
Sulphoxide 
0.052 
0.059 
0.065 
0.116 
0.167 
0.191 
Graphical illustration of these results (Figs.5.16 and 5.17) confirms 
the 2nd order kinetics of the reaction. 
A combination of stearic acid and methyl linoleate hydroperoxides 
had a similar effect on the oxidation rate of fluphenazine decanoate. 
These results are given in Table 5.19. Reproducibility of the results was 
demonstrated by repeating the experiment with a separately autoxidised 
methyl linoleate (Table 5.19). 2nd order rate-constants in good agree-
ment, calculated as described in Section 5.5.3, were obtained (Table 5.20). 
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Time 
(Hours) 
Experiment 1 
72 
120 
168 
Experiment 2 
24 
72 
144 
192 
Experiment 
1 
2 
Table 5.19 
Oxidation of Fluphenazine Decanoate with 
Methyl Linoleate Hydroperoxides in the Presence 
of Stearic Acid 
Piperazino 
Mono N-oxides 
(Total) 
3.518 
5.041 
6.473 
1.081 
3.301 
5.395 
6.639 
Oxide Content(um/mI) 
Table 5.20 
Piperazino 
Oi N-oxide 
0.161 
0.263 
0.510 
Not detected 
0.114 
0.338 
0.548 
2nd Order Rate Constants for Oxidation of 
Fluphenazine Decanoate by Methyl Linoleate 
with Added Stearic Acid 
Sulphoxide 
0.176 
0.199 
0.283 
0.139 
0.136 
0.211 
0.230 
Rate Co~ta~t Correlation Coefficient (litre mole - hr - ) 
1.327 x 10-5 0.9987 
1.205 x 10-5 0.9994 
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4.6 
4.5 
4.4 
I 
4.3 
100 200 
TIME(hours) 
-e_ 
300 
Fig. 5.14 - Oxidation of Fluphenazine Decanoate by 
Autoxidised Methyl Oleate in the Presence 
of Stearic Acid (1st order kinetics) 
• :: zero, .. :: 0.045mM, C = O.089mM, 
o = 0.132 mM, Il. = 0.177mM of added stearic 
acid. 
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1.3 
1.2 
1.1 
-------.-
-.-
.----:.-------
1.0~---------------p--------------~--------------~~----~ 
100 200 
TIME(hours) 
300 
Fig. 5.15 - Oxidation of Fluphenazine Decanoate by 
Autoxidised Methyl Oleate in the Presence 
of Stearic Acid (2nd order kinetics) 
• = zero, ~ = 0.045mM, 0 = 0.089mM, 
o = 0.132mM, ~ = 0.177mM of added stearic 
acid 
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4.6 
4.5 
4.4 
, 
, 
4.3~--------------~--------------'---------------~ 100 200 
TIME(hours) 
Fig. 5.16 - Oxidation of Fluphenazine Decanoate 
by Autoxidised Methyl Oleate in the 
Presence of O.lmM Stearic Acid (1st 
order kinetics) 
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300 
1. 
1.2 / 
• 
• 
1.1 
1.0~ ____________ ~ ______________ ~ ____________ ~ 
100 200 
TIME(hours) 
Fig. 5.17 - Oxidation of Fluphenazine Decanoate 
by Autoxidised Methyl Oleate in the 
Presence of O.lmM Stearic Acid (2nd 
order kinetics) 
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300 
5.8.2 Effect of Different Carboxylic Acids 
5.8.2.1 Choice of Materials 
Use of stearic acid had successfully veri fied the catalytic effect of 
acidity on the oxidation rate of fluphenazine decanoate by hydro-
peroxides. The effect of varying the nature of the acid was next 
investigated. Materials were chosen to represent some of the typical 
carboxylic acids that may be encountered in a Modecate Injection 
formulation. The following acids were thus selected: 
Acid 
Oleic 
Linoleic 
Decanoic 
Benzoic 
Possible origin in formulation 
)Mono and di unsaturated 
)acids from hydrolysis of 
)sesame oil triglycerides. 
Hydrolysis of fluphenazine 
decanoate 
Autoxidation of benzyl 
alcohol(preservati ve) 
Acetic acid was also included in order to determine the effect (i f 
any) of the carbon-chain length. Stearic acid was used as 'control~. 
5.8.2.2 Sample Preparation 
Autoxidised methyl oleate was used as the oxidising medium and 
samples prepared in the same manner as in Section 5.8.1.2 with the 
modification that each acid was added at a concentration of O.lmM per 
5ml of solution. Samples were then stored under conditions identical to 
those used in all other experiments. 
5.8.2.3 Results and Discussion 
Tables 5.21 to 5.26 summarise the results obtained. 
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Time 
(Hours) 
96 
168 
264 
Time 
(Hours) 
96 
168 
264 
Table 5.21 
Oxidation of Fluphenazine Oecanoate with 
Autoxidised Methyl Oleate in the Presence 
of stearic Acid 
Piperazino 
Mono N-oxides 
(Total) 
3.025 
4.542 
5.777 
Oxide Content(um/mI) 
Table 5.22 
Piperazino 
Oi N-oxide 
0.076 
0.173 
0.350 
Oxidation of Fluphenazine Oecanoate with 
Autoxidised Methyl Oleate In the Presence 
of Oleic Acid 
Oxide Content(um/mI) 
Piperazin~ Piperazin~ 
Mono N-oxides Oi N-oxide 
(Total) 
2.806 0.065 
4.270 0.147 
5.847 0.393 
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Sulphoxide 
Not detected 
0.195 
0.199 
Sulphoxide 
Not detected 
0.186 
0.208 
Time 
(Hours) 
96 
168 
264 
Time 
(Hours) 
96 
168 
264 
Table 5.23 
Oxidation of Fluphenazine Oecanoate with 
Autoxidised Methyl Oleate in the Presence 
of linoleic Acid 
Piperazino 
Mono N-oxides 
(Total) 
2.901 
4.475 
5.704 
Oxide Content(um/ml) 
Table 5.24 
Piperazino 
Oi N-oxide 
0.053 
0.169 
0.362 
Oxidation of Fluphenazine Decanoate with 
Autoxidised Methyl Oleate in the Presence 
of Benzoic Acid 
Oxide Content(um/mI) 
Piperazino Piperazino 
Mono N-oxides Di N-oxide 
(Total) 
4.074 0.124 
5.938 0.251 
7.606 0.713 
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5ulphoxide 
Not detected 
0.195 
0.208 
5uiphoxide 
Not detected 
0.242 
0.272 
Time 
(Hours) 
96 
168 
264 
Time 
(Hours) 
96 
168 
264 
Table 5.25 
Oxidation of Fluphenazine Oecanoate with 
Autoxidised Methyl Oleate in the Presence 
of Oecanoic Acid 
Piperazino 
Mono N-oxides 
(rotal) 
2.977 
4.327 
6.054 
Table 5.26 
Oxide ContentCum/mI) 
Piperazino 
Oi N-oxide 
0.075 
0.163 
0.430 
Oxidation of Fluphenazine Oecanoate with 
Autoxidised Methyl Oleate in the Presence 
of Acetic Acid 
Piperazino 
Mono N-oxides 
(Total) 
2.997 
4.433 
6.012 
Oxide Content(um/mI) 
Piperazin~ 
Oi N-oxide 
0.077 
0.170 
0.479 
Sulphoxide 
Not detected 
0.186 
0.217 
Sulphoxide 
Not detected 
0.186 
0.208 
From the results the 2nd order rate constants were calculated by linear 
regression. The calculated values are given below: 
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Acid 
Table 5.27 
2nd Order Rate Constants for the Oxidation of Fluphenazine 
Decanoate by Autoxidised MethAI Oleate in the Presence 
of Various cids 
Rate Con!tanf Correlation Coefficient (litre mole- hr- ) 
Stearic 7.12 x 10-6 0.9928 
Stearic, 2nd expt. 6.92 x 10-6 0.9981 
7.30 x 10-6 0.9992 
Oleic 7.29 x 10-6 0.9991 
Linoleic 7.11 x 10-6 0.9949 
Benzoic 10.64 x 10-6 0.9983 
Benzoic, 2nd expt. 9.62 x 10-6 0.9948 
10.18 x 10-6 0.9941 
Decanoic 6.76 x 10-6 0.9920 
Acetic 7.69 x 10-6 0.9988 
. 
The aliphatic carboxylic acids all give similar values for the rate constant 
of the reaction. The obvious exception in the list is benzoic acid whi<?h 
causes an increase in the rate of reaction by a factor of approximately 2. 
Consequently the reaction in the presence of benzoic acid was repeated in 
duplicate (Expt. 2) and yielded rate constants in good agreement with the 
original results, confirming the greater rate of reaction. Stearic acid was 
again used as 'control'. Minor differences in duplicate rate constants may be 
attributable to small deviations from the chosen O.lmM acid concentration, 
caused by the method of sample preparation. 
The most obvious di fference between benzoic and the other acids utilised 
in this investigation was the aromaticity of the benzoic acid, the delocalising 
effect of which causes an increase in the dissociation constant (pKa). To 
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substantiate the influence of pKa on the oxidation rate, a series of acids of 
known pKa value were investigated. 
5.8.3 Effect of Acid Dissociation Constant 
5.8.3.1 Choice of Materials 
Choice 'of acids for use in this experiment was dictated by the 
commercial availability of material and published values of the dissocia-
tion constant. The following range of pKa values was eventually chosen. 
Acid pKal71 
o-Iodobenzoic 2.85 
m-Chlorobenzoic 3.82 
Benzoic 4.19 
Caprylic 4.89 
Autoxidised methyl oleate, adjusted to the standardised value of 
hydroperoxide was used as the oxidising media so that the results obtained 
would be comparable with the previous set of results (Section 5.8.2). 
5.8.3.2 Preparation of Samples 
Samples were prepared in a manner identical to that described in 
the previous experiment (Section 5.8.2). 
5.8.3.3 Results and Discussion 
The results obtained are summarised in Tables 5.28 to 5.31 and 
illustrated graphically in Fig. 5.18. 
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Table 5.28 
Oxidation of Flu[!henazine Decanoate with 
Autoxidised Meth~l Oleate in the Presence 
of o-Iodobenzoic Acid 
Time Oxide ContentCum/mO 
(Hours) 
Piperazino Piperazino Sulphoxide 
Mono N-oxides Oi N-oxide 
(Total) 
17 1.265 Not detected 0.052 
41 2.929 Not detected 0.092 
65 4.041 Not detected 0.093 
89 5.132 0.213 0.155 
Table 5.29 
Oxidation of Fluehenazine Oecanoate with 
Autoxidised Meth~l Oleate in the Presence 
ofm-Chlorobenzoic Acid 
Time Oxide Content(um/mI) 
(Hours) 
Piperazin~ Piperazin~ Sulphoxide 
Mono N-oxides Oi N-oxide 
<rotaD 
17 0.996 Not detected 0.039 
65 3.063 Not detected 0.112 
89 3.770 0.118 0.141 
168 6.695 0.251 0.198 
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Time 
(Hours) 
17 
41 
65 
89 
168 
Time 
(Hours) 
17 
41 
65 
168 
Table 5.30 
Oxidation of Fluphenazine Decanoate with 
Autoxidised Methyl Oleate in the Presence 
of Benzoic Acid 
Oxide Content(um/mO 
Piperazino Piperazino 
Mono N-oxides Oi N-oxide 
(Totan 
0.945 Not detected 
2.064 Not detected 
2.994 Not detected 
3.071 0.118 
6.504 0.326 
Table 5.31 
Oxidation of Fluphenazine Oecanoate wi th 
Autoxidised Methyl Oleate in the Presence 
of Caprylic Acid 
Oxide Content(um/mI) . 
Piperazino Piperazino 
Mono N-oxides Oi N-oxide 
(TotaD 
0.588 Not detected 
1.338 Not detected 
1.982 Not detected 
4.634 0.186 
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Sulphoxide 
Not detected 
0.086 
0.084 
0.129 
0.244 
Sulphoxide 
Not detected 
0.086 
0.056 
0.167 
1.3 
1.2 
/ 
1.1 
1.0~--------~~--------~--------~~--------~---
so 100 150 200 
TIME(hours) 
Fig. 5.18 - Oxidation of Fluphenazine Decanoate by 
Autoxidised Methyl Oleate - Effect of 
pKa of Added Acid(2nd order kinetics) 
• = Caprylic acid, pKa = 4.89; 0 = benzoic 
acid, pKa 4.19; c = m-ch1orobenzoic acid, 
pKa 3.82; .... O-iodobenzoic acid, pKa 2.85. 
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Acid 
Table 5.32 
2nd Order Rate Constants for Oxidation 
of Fluphenazine Decanoate by Autoxidised 
Methyl Oleate in the Presence of Acids 
K 171 Rate Const"nt 1 p a (litre mole- hr- ) 
Correlation 
Coefficient 
o-iodobenzoic 2.85 17.20 x 10-6 0.9982 
m-chlorobenzoic 3.82 12.49 x 10-6 0.9996 
benzoic 
caprylic 
4.19 12.50 x 10-6 0.9992 
4.89 8.29 x 10-6 0.9996 
The results clearly demonstrate that an increase in the pKa of 
added acid is accompanied by a decrease in oxidation rate. The similarity 
of oxidation rates exhibited by fluphenazine decanoate in the presence of 
m-chlorobenzoic acid (pKa 3.8) and benzoic acid (pKa 4.2) is probably a 
combination of experimental design and closeness of the two pKa values. 
Errors during the addition of the acid to the samples by weight may be 
controlled but not completely eliminated, and thus acids with a greater 
difference in pKa value would have been more suitable. Small errors 
during sample preparation would then be negligible in comparison to the 
degree of rate-enhancement. However, when considered with the rates of 
oxidation attributable to the other acids used, the results are sufficient to 
verify the suspected effect of pKa. 
5.9 Influence of Benzyl Alcohol on Rate of Fluphenazine Decanoate Oxidation by 
Fatty Ester Hydroperoxides 
Benzyl alcohol is added to Modecate Injection as a preservative and thus 
the influence of this material on the rate of fluphenazine decanoate oxidation 
was investigated. Autoxidised fatty esters were selected as the solution 
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media in order to simulate typical conditions which would be apparent in the 
product. 
5.9.1 Preparation of Samples 
Freshly distilled benzyl alcohol was obtained from a suitable supplier 
(B.D.H.) and checked for benzaldehyde content (Squibb & B.P. limit 0.2%) by 
HPLC (See Chapter 6). The material was deacidified before use in order to 
remove possible traces of benzoic acid. 75mg of the alcohol was added to 
125mg of fluphenazine decanoate (equivalent to the level of preservative in 
the product) in a 5ml volumetric flask. Deacidified standardised autoxidised 
fatty ester was added to the flask contents which were diluted to volume 
when the components had completely dissolved. 
A second series of samples containing a known amount of stearic acid 
(O.lmM per 5ml) were also prepared. 
All samples were stored under conditions identical to those used in 
previous experiments. 
5.9.2 Results and Discussion 
For convenience, this series of experiments was conducted concurrently 
wi th the investigations described in Sections 5.7 and 5.8. Although the 
results of experiments 5.7 and 5.8 have already been quoted, the relevant 
results are reproduced in Tables 5.33 to 5.36 so that the effect of adding 
benzyl alcohol to the oxidation reaction mixture may be conveniently 
assessed. 
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Table 5.33 
Oxidation of Flu Autoxidised Methvl 
Time Oxide Content - Absence of Benzyl Alcohol Oxide Content - Presence of Benzyl Alcohol 
(dam (um/mI) (um/mI) 
Piperazino Piperazino Sulphoxide Piperazino Piperazino Sulphoxide 
Mono N- di N-oxide Mono N- di N-oxide 
oxide oxide 
(Total) (Total) 
I 
to.) 
& 7 0.345 Not detected Not detected 0.442 Not detected Not detected 
I 
14 0.743 Not detected Not detected 0.901 Not detected Not detected 
21 1.129 Not detected 0.0913 1.289 Not detected 0.0913 
27 1.251 Not detected 0.0859 1.752 Not detected 0.103 
42 1.761 0.027 0.119 2.162 Not detected 0.132 
49 2.115 0.247 0.123 2.420 0.210 0.167 
Time 
(days) 
I 
IV 
~ 
I 96 
168 
264 
Table 5.34 
Oxidation of Fluphenazine Decanoate by Autoxidised Methyl Oleate, 
with Added Stearic Acid 
Oxide Content - Absence of Benzyl Alcohol Oxide Content - Presence of Benzyl Alcohol 
(um/mO (um/ml) 
Piperazino Piperazino Sulphoxide Piperazino Piperazino Sulphoxide 
Mono N- di N-oxide Mono N- di N-oxide 
oxide oxide 
(Total) (Total) 
2.589 Not detected 0.108 2.542 Not detected 0.108 
3.774 0.152 0.149 3.819 0.135 0.158 
5.541 0.375 0.238 5.718 0.489 0.220 
Time 
(da~ 
I 
I\) 
0 
...... 
I 6 
13 
19 
34 
Table 5.35 
Oxidation of Fluphenazine Decanoate by Autoxidised Methyl Linoleate 
'Deacidified' 
Oxide Content - Absence of Benzyl Alcohol Oxide Content - Presence of Benzyl Alcohol 
(um/ml) (um/mI) 
Piperazino Piperazino Sulphoxide Piperazino Piperazino Sulphoxide 
Mono N- di N-oxide Mono N- di N-oxide 
oxide oxide 
(Total) (Total) 
0.599 Not detected Not detected 0.615 Not detected Not detected 
1.246 Not detected 0.142 1.303 Not detected 0.213 
1.765 0.0620 0.086 1.928 0.054 0.129 
3.089 0.147 0.203 3.269 0.144 0.347 
Table 5.36 
Oxidation of Flu I Linoleate 
Time Oxide Content - Absence of Benzyl Alcohol Oxide Content - Presence of Benzyl Alchol 
(hours) (um/mI) (um/mO 
Piperazino Piperazino Sulphoxide Piperazino Piperazino Sulphoxide 
Mono N- di N-oxide Mono N- di N-oxide 
oxide oxide 
(Total) (Total) 
I 
,.." 
0 72 3.518 0.161 0.176 3.343 0.134 0.176 en 
I 
120 5.041 0.263 0.199 4.621 0.280 0.196 
168 6.473 0.510 0.283 6.397 0.586 0.251 
From the results, the 2nd order rate constants were calculated by linear 
regression and are given in Table 5.37. 
Table 5.37 
2nd Order Rate Constants for Fluphenazine 
Decanoate Oxidation in the Presence of Benzyl Alcohol 
Oxidant Conditions/ Rate Const~nt 1 
Additives (li tre mole - hr - ) 
Deacidified 0.55 x 10-6 
Deacidified + 0.64 x 10-6 
Methyl Benzyl alcohol 
oleate 
6.85 x 10-6 hydroperoxi de Stearic acid 
Stearic acid + 7.33 x. 10 -6 
Benzyl alcohol 
Deacidified 1.14 x 10-~(ExPt.I) 
0.96 x 10- (Expt.2) 
Methyl Deacidified + 1.26 x 10-~(EXPt.I) 
linoleate Benzyl alcohol 1.07 x 10- (Expt.2) 
hydroperoxide 
Stearic acid 13.27 x 10-~(ExPt.I) 
12.05 x 10- (Expt.2) 
Stearic acid + 13.19 x 10-~(EXPt.I) 
Benzyl alcohol 11.46 x 10- (Expt.2) 
Correlation 
Coefficient 
0.9892 
0.9974 
0.0993 
0.9970 
0.9994 
0.9990 
0.9993 
0.9993 
0.9987 
0.9994 
0.9964 
0.9996 
The results demonstrate that benzyl alcohol has little influence on the 
oxidation rate of fluphenazine decanoate. 
5.10 Reaction of Fluphenazine Decanoate with Hydrogen Peroxide 
Use of hydrogen peroxide as oxidant in this series of studies was proposed 
at the beginning of the programme, hydrogen peroxide being the simplest of 
the commercially available hydroperoxides. However, alternative investi-
gations had meanwhile indicated that the autoxidation of benzyl alcohol (the 
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preservative in Modecate Injection) would ultimately result in the formation 
of hydrogen peroxide (See Chapter 6). To simulate the typical conditions 
apparent in a degraded product, the reaction was conducted in fatty ester 
solution. The unsaturated fatty esters could not be used in this case, because 
of possible side-reactions between the C=C double bond and the added 
peroxide. Of the saturated fatty esters methyl myristate (C14) is the highest 
of the series which are liquid at room temperature. Thus methyl myristate 
was selected as solvent for the reaction. 
5.10.1 Preparation of Sample 
Methyl myristate (Sigma Chemicals) was deacidi fied through alumina then 
partitioned with an equal volume of 50% aqueous hydrogen peroxide (SOH 
Chemicals) and the organic layer separated by centrifugation. Deacidif-
ication was necessary prior to addition of hydrogen peroxide since the 
alumina column effectively adsorbs the total hydrogen peroxide content of 
the methyl myristate solution. 
After drying the peroxide/methyl myristate solution over magnesium 
sulphate, the hydroperoxide content of the solution was determined iodometr-
ically and subsequently diluted with deacidified methyl myristate in order to 
obtain a solution containing the standardised amount of DOH (1.4mg/mI). 
Fluphenazine decanoate was dissolved in the prepared solution at a 
concentration of 25mg/ml and the final sample stored as in previous 
experiments. 
5.10.2 Results and Discussion 
The results obtained are summarised in Table 5.38 and again show prefer-
ential oxidation of the piperazine ring. In common with the olefinic 
hydroperoxides the results could not be fitted to any particular reaction 
order, although the application of 2nd order kinetics gave the shallowest 
curve. (Fig. 5.19). 
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Time 
(Hours) 
Piperazino 
Mono N-
oxides 
(Total) 
I 
N 
.... 24 0.790 
.... 
I 
144 2.550 
216 3.846 
310 4.550 
Table 5.38 
Oxidation of Fluphenazine Decanoate by Hydrogen peroxide in 
Methyl Myrlstate Solution 
____ ~~ ____ ~ ___ ---9_xiciej:ont~nt(um/mI) 
Piperazino Sulphoxide Sulphoxide 
Di N-oxide mono N-
oxides 
Not detected Not detected not detected 
0.253 0.259 0.253 
0.212 "0.484 0.370 
0.225 0.379 0.338 
Sulphoxide 
di N-oxide 
Not detected 
0.208 
0.190 
0.427 
1.3 
1.2 
1.1 
1.0 
100 
• 
200 
TIME(hours) 
~ig. 5.19 - Oxidation of Fluphenazine Decanoate 
....... 
300 
by Hydrogen Peroxide in Methyl Myristate 
(2nd order kinetics) 
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Re-examination of the standardised methyl myristate/peroxide solution 
remaining after sample preparation revealed that the peroxide originally 
present had decomposed: 
original titre(ml O.OlM Na2S203) 
Ti tre after I week @ R T 
(sealed amber bottle) 
7.5 ml 
2.0 ml 
These figures indicate the instability of the myristate/peroxide solution 
and may explain the deviation of the oxidation reaction from standard 
reaction kinetic laws. Reasons for this observed instability are unknown. 
A second feature of the reaction was the formation of mixed sulphoxide-
N-oxides which were not noted in previous experiments. Interestingly, only 
one of the two possible sulphoxide-mono-N-oxides was produced (Compound 
V). No evidence for the presence of the alternative sulphoxide-mono-N-oxide 
(Compound X) was obtained but the sulphoxide di N-oxide (Compound D) was 
observed. It is thus feasible that compound Y is converted to compound D 
during degradation. 
Formation of the mixed oxides may be associated with the presence of 
water resulting from either the sample preparation (incomplete drying by 
magnesium sulphate) or from the decomposition of hydrogen peroxide which 
evidently occurs during storage. 
5.11 Conclusions 
In all the experiments described in this Chapter, the ratio of mono· N-
oxides A and 8 formed during oxidation of fluphenazine decanoate varied little 
from the approximate 1:1 ratio noted in Chapter 3, regardless of the solvent (oil). 
Although N-oxidation was noted to be the primary degradative route, some 
sulphoxide was also formed. The only notable difference in the pattern of 
oxidation products observed in each of the oily solutions was the increased 
formation of sulphoxide in fatty acid solution. 
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The presence of small amounts of acid caused an increase in the 
oxidation rate of the drug, enhancing the formation of both N- and 5- oxides; N-
oxidation was enhanced to a far greater extent than 5- oxidation. The catalytic 
effect of acid on the oxidation of t-amines by hydroperoxides is contrary to 
previously published data192, though the acid-catalysed oxidation of dialkyl 
sulphides under similar conditions is well established128• 
A comparison of the 2nd order rate constants obtained during the course 
of the work clearly demonstrates that methyl linoleate hydroperoxides oxidised 
fluphenazine decanoate approximately twice as fast as methyl oleate hydro-
peroxides, in both acid and deacidified solution. Reasons for this observed 
phenomenon are not understood but three possibilities may be presented for 
further consideration: 
(i) formation of secondary oxidation products which affect the reaction of 
the hydroperoxide with the drug to a greater or lesser degree. 
(ii) presence of positional isomers (four from methyl oleate, viz. 8-, 9-, 10-
and 11- hydroperoxide; three from methyl1inoleate, viz. 9-, 11- and 13-
hydroperoxide) which may react with the drug at different rates. The 
ratio of isomers present in the autoxidised materials used for the 
described experiments is unknown. An HPLC procedure for the separa-
tion and quantitation of such mixtures has been reported.235 
(iii) Oxidation of unsaturated fatty esters is accompanied by stereomutation 
of the cis double-bond system177 thus altering the spatial arrangement 
of the mo1.ecules. 
Factors (ii) and (iii) could be of considerable importance because of the 
bulky nature of both the oxidant and the drug. 
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CHAPTER 6 
AUTOXIDA nON OF BENZYL ALCOHOL AND ITS INFLUENCE 
ON THE OXIDATIVE DEGRADATION OF FLUPHENAZINE DECANOA TE 
6.1 Effect of Benzyl Alcohol on the Oxidative Degradation of Fluphenazine 
Decanoate in Sesame Oil 
6.1.1 Introduction 
The preservative efficacy of benzyl alcohol has been well documented219 
and it is thus included in the Modecate formulation to ensure a sterile 
product, particularly where the package is designed to be a multidose 
container. 
Preliminary experiments (Section 5.9), which compared the rate of flu-
phenazine decanoate oxidation by fatty ester hydroperoxides, had demon-
strated that the addition of benzyl alcohol had relatively little influence on 
the oxidation rate. However, the data obtained may be insufficient to enable 
a true estimate of the effect of benzyl alcohol to be determined. The results 
were obtained over a period of six weeks - which is perhaps unrealistic in 
comparison to the product shelf-li fe (2 yrs). 
To assess the potential of benzyl alcohol to affect the stability of the 
product a series of laboratory-prepared samples of Modecate Injection, with 
and without the preservative, were formulated using materials of normal 
Squibb quality. 
As an alternative approach, the effect of increasing the benzaldehyde 
level in the preservative was also assessed since benzaldehyde has been 
reported to react directly with molecular oxygen forming the powerful 
oxidant perbenzoic aCid187• In order that these experiments could be 
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directly compared with the former, solutions were prepared in sesame oil to 
normal product specifications. Two forms of benzyl alcohol/benzaldehyde 
mixture were used: 
a) Naturally aged benzyl alcohols which contained benzaldehyde at 
varying levels. 
b) Accurately prepared mixtures of pure benzyl alcohol and pure 
benzaldehyde. 
a) provides conditions which are more closely-related to those expected in a 
degrading product, whereas (b) is an ideallised mixture which would enable 
the true effect of the benzaldehyde impurity to be assessed. 
6.1.2 Materials 
Sesame oil 
and fluphenazine 
decanoate 
Benzyl alcohol 
Degraded benzyl 
alcohol 
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Obtained from Squibb Q.C.Dept. 
and tested according to the 
current Squibb Testing Standards. 
The materials complied in all 
respects. 
Redistilled benzyl alcohol was 
was obtained from a suitable 
supplier(BDH) and tested in 
accordance with the current 
Squibb Testing Standard. The 
material complied in all 
respects(Note - benzaldehyde 
level = 0.012%; limit 0.2%) 
Naturally aged batches of 
benzyl alcohol were selected 
from various laboratories 
wi thin the Squibb laboratory 
complex and chosen to represent 
increasing levels of benzal-
dehyde impurity. Actual 
levels of benzaldehyde were 
as follows:-
Benzaldehyde 
Benzyl alcohol! 
benzaldehyde 
mixtures 
6.1.3 Preparation of Samples 
PhCHO Original 
(%) Supplier 
Batch A 0.17 Von Heyden 
(Germany) 
Batch B 0.56 BDH 
Batch C 1.12 BDH 
Batch D 1.27 BDH 
Analar material was obtained 
from BDH Chemicals and 
stored at 40 C under N2• 
Analar benzaldehyde was 
added to pure benzyl 
alcohol(absence of benzal-
dehyde impurity confirmed) 
at levels of 0.1, 0.5, 1.0, 
5.0, 10.0 and 50% v/v. 
2g Fluphenazine decanoate was dissolved in 80mI sesame oil by gently 
heating (350 C). The preservative, or benzyl alcohol/benzaldehyde mixture, 
was then added to 5ml aliquots at a concentration of 1.5% by weight, 
simulating the product formulation. A 5ml aliquot was reserved as control. 
Solutions were stored under a headspace of air to hasten oxidative 
decomposition. (Modecate product is N2 purged during manufacture and 
packing). Storage under conditions of darkness at temperatures of 200 C and 
400 C were utilised. 
Samples were assayed for N-oxide content at intervals using the HPLC 
procedure described in Section 5.3. 
6.1.4 Results and Discussion 
Results are summarised in the following tables: 
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Table 6.1 
Decanoate 
c 
Sample Total N-oxide(mg/g formulation) 
Initial 1 week 2 weeks 3 weeks 6 weeks 12 weeks 20 weeks 25 weeks 
Control Not detected 0.042 0.070 0.077 0.132 0.235 0.388 
I + pure PhCH20H Not detected 0.045 0.079 0.086 0.140 0.257 0.440 
"" t-' Q) 
+ Aged PhCH OH Not detected 0.056 0.565 I 
(Batch A, 0.11% pHCHO) 
+ Aged PhCH OH 
(Batch B, 0.5~ PhCHO) Not detected 0.258 
+ Aged PhCH OH 
(Batch C, 1.11% PhCHO) 
Not detected 0.463 0.660 0.778 0.847 0.928 
+ Aged PhCH OH 
(Batch 0, 1.21% PhCHO) 
Not detected 0.724 
+ pure benzaldehyde Not detected 0.035 0.096 0.090 0.128 0.193 0.321 
Sample 
Control 
I 
N 
+ pure PhCH20H ~ 
'" I 
+ Aged PhCH OH 
(Batch C, 1.12% PhCHO) 
+ pure benzaldehyde 
Table 6.2 
Effect of Benzyl Alcohol/Benzaldehyde on Fluphenazine Decanoate 
Oxidation in Ageing Sesame Oil Solution @ 406 C 
Total N-oxide (mg!g formulation) 
Initial 1 week 2 weeks 3 weeks 6 weeks 
Not detected 0.140 0.280 0.278 0.421 
Not detected 0.139 0.340 0.313 0.508 
Not detected 0.769 0.980 0.949 1.035 
Not detected 0.146 0.280 0.331 0.428 
12 weeks 25 weeks 
0.723 1.042 
0.880 1.522 
1.308 
0.709 1.175 
Table 6.3 
Effect of Benzyl Alcohol/Benzaldehyde 
Mixtures on Fluphenazine Decanoate Oxidation in Sesame Oil 
Sample N-oxide{mg/g formulation) 
Initial I Week 
(20°C) 
Control . Not detected 0.009 
+ Benzyl alcohol Not detected 0.028 
containing 0 • .1 % PhCHO 
+ Benzyl alcohol Not detected 0.036 
containing 0.5% PhCHO 
+ Benzyl alcohol Not detected 0.019 
containing 1.0% PhCHO 
+ Benzyl alcohol Not detected 0.042 
containing 5.0% PhCHO 
+ Benzyl alcohol Not detected 0.020 
containing 10.0% PhCHO 
+ Benzyl alcohol Not detected 0.025 
containing 50.0% PhCHO 
+ PhCHO alone Not detected 0.023 
Comparison of the results obtained for the Control sample and that 
containing added benzyl alcohol (pure) establishes an enhanced rate of N-
oxide formation in the presence of the alcohol at both 200 C and 40oC. The 
effect is conveniently illustrated by plotting the di fference in N-oxide level 
evident between the control and the sample with added benzyl alcohol against 
time (Fig. 6.1). The difference can be seen to increase steadily, implicating 
benzyl alcohol to be a contributory factor in reducing the potential stability 
of Modecate. 
By contrast, replacing benzyl alcohol with an equivalent amount of 
benzaldehyde has an apparent stabilising effect at 20oC, whereas at 400 C a 
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Fig. 6.1 - Effect of Adding Benzyl Alcohol to 
Fluphenazine Decanoate in Sesame 
Oil, Demonstrating the Enhanced 
Formation of N-Oxides in the Presence 
of the Preservative. 
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25 
- , 
small increase in fluphenazine decanoate degradation is noted in comparison 
to the Control. However, assay values for N-oxide formed in the presence of 
benzaldehyde alone are less than those observed in the presence of pure 
benzyl alcohol, thus signifying that the direct reaction of oxygen with 
benzaldehyde, yielding perbenzoic aCid187, would be of little importance 
under the normal conditions of the product pack. 
Addition of aged benzyl alcohols to the sesame oil solution of fluphen-
azine decanoate has considerable influence on the oxidation rate of the drug. 
The only known variable between the batches of aged benzyl alcohols was the 
concentration of benzaldehyde present in each. Table 6.1 indicates that the 
amount of fluphenazine decanoate N-oxide present after 1 week at room 
temperature is seemingly related to the benzaldehyde concentration, yet 
benzaldehyde alone had been shown to exert little effect on the oxidation of 
fluphenazine dec ana ate. 
The improbable requirement of benzaldehyde and benzyl alcohol together 
being necessary for enhanced fluphenazine decanoate oxidation to occur was 
investigated using mixtures of pure benzyl alcohol and pure benzaldehyde. 
The results (Table 6.3) verify the remoteness of this possibility. 
Consequently, the enigma of the large amounts of fluphenazine decanoate 
N-oxides formed in the presence of aged benzyl alcohol remained to be 
explained. A logical explanation of the effect is that an unidentified 
degradation product of benzyl alcohol was causing the observed enhancement 
of fluphenazine decanoate oxidation. 
Work was thus orientated toward the identification of the oxidation factor 
present in aged benzyl alcohol and is described in Section 6.2. 
6.2 Autoxidation of Benzyl alcohol 
6.2.1 - Introduction 
Before commencing a detailed examination of the naturally aged benzyl 
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alcohols used in Section 6.1 above, a Ii terature search was undertaken in 
order to determine the extent of knowledge concerning the natural degrada-
tion of benzyl alcohol ie. autoxidation. Surprisingly little information was 
gleaned from the wealth of published material connected with benzyl alcohol. 
Only one directly relevant report, by Howard and Korcek220, was discovered. 
These authors determined the absolute rate constants for the oxidation of 
some -substituted toluenes, including benzyl alcohol. The autoxidation was 
described as proceding via an cx-hydroxybenzylperoxy radical, PhCH(OH)OO·. 
The formation of benzaldehyde following the autoclaving of a parental 
solution containing 0.9% benzyl alcohol as preservative has been noted221 
and was attributed to the oxidation of the benzyl alcohol by the oxygen 
present in the vial headspace. No mechanism for the reaction was consider-
ed. 
An alternative possibility that benzaldehyde (formed from benzyl alcohol 
by an unknown mechanism) is autoxidised to benzoic acid via perbenzoic 
°d222 al °d °fO d aCI was so I entl Ie • 
Each of the above intermediate species (cx-hydroxybenzyl peroxy radical 
and perbe:nzoic acid) are powerful oxidants and would readily oxidise fluphen-
azine decanoate. Thus the batches of naturally aged benzyl alcohols were 
studied in an attempt to quantitate and identify the nature of the suspected 
oxidant. 
6.2.2 Examination of Naturally Aged Benzyl Alcohol 
6.2.2.1Peroxide Values 
The peroxide value (P.V.) of each of the aged benzyl alcohols was 
determined by the iodometric procedure described in the British Pharma-
copoeia, 1980217• The results (Table 6.4) .clearly established the oxidising 
nature of the materials. 
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Table 6.4 
Peroxide Values of Some Naturally Aged Benzyl Alcohols 
Batch 
A 
B 
C 
o 
Peroxide Value 
11.4 
113.8 
203.4 
345.8 
By comparison, a freshly purchased benzyl alcohol (obtained from 
B.D.H. Chemicals) had a P. V. of zero, indicating that the oxidation factor 
present after ageing was attributable to a degradation product. 
6.2.2.2 HPLC 
An HPLC procedure reported for the determination of benzoic acid 
in syrups and elixirs224 was adapted to the examination of benzyl alcohol 
and used in a search for the presence of perbenzoic acid in the naturally 
aged samples. 
Experi mental Condi tions: 
Column 
Mobile phase 
ODS-Hypersil, 20cm 
Citrate buffer (pH4.2)-
acetonitrile (9:1) 
Perbenzoic acid was synthesised from benzaldehyde by photoxida-
tion (sunlight) in an acetone solution saturated with oxygen225• The 
separation of the perbenzoic acid from benzyl alcohol and benzaldehyde 
under the proposed HPLC conditions was demonstrated (Fig. 6.2) prior to 
examination of the aged benzyl alcohols. Chromatography of each of the 
naturally aged materials failed to reveal the occurrence of perbenzoic 
acid. 
To verify this observation SOul aliquots of each aged benzyl alcohol 
were injected onto the HPLC column and the fractions of eluate repre-
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I 
20 
I 
15 
I 
±::-o 
10 
TIME(min) 
Fig. 6.2 - HPLC Separation of Perbenzoic Acid, 
Benzaldehyde and Benzyl Alcohol 
1 - benzyl alcohol; 
3 = benzaldehyde. 
-225-
2 = perbenzoic acidJ 
senting a positive recorder response were collected and tested for the 
presence of peroxide with potassium iodide/acetic acid solution. The 
peroxide known to be present in these materials (Section 6.2.1) was shown 
to be eluted within the solvent-front, indicating the highly polar nature of 
the peroxide. No other potassium iodide-positive fractions were observed 
conclusively demonstrating the absence perbenzoic in the aged samples of 
benzyl alcohol. 
6.2.2.3Titration with Ceric Sulphate 
Ce 4+ is reduced by hydrogen peroxide according to the equation: 
4+ 3+ + 2Ce + H202 .. 2Ce + 2H + 02 
Organic hydroperoxides also react with ceric sulphate226; per-
acids, however, will not react. Hence the procedure has been utilised for 
the determination of hydrogen peroxide in the presence of peracetic acid. 
To prevent diacyl and dialkyl peroxides reacting the titration is normally 
conduct~d at O_SoC226• 
Procedure: Approximately 2g of benzyl alcohol was accurately weighed 
into a 2S0-ml conical flask and dissolved in lOml methanol. 50ml of 2M 
sulphuric acid was added, the mixture cooled to OoC and the peroxide 
titrated with O.05M ceric sulphate (BDH, Volucon) using Ferroin as 
indicator. 
ImIO.05MCe(S04)2 = O.825mg OOH 
Validation: The reactivity of Ce4+ with chloroperbenzoic acid, benzal-
dehyde and freshly distilled benzyl alcohol was determined. In each case, 
19 of material resulted in a titre value of zero, confirming the non-
reactivity of these materials, which will thus not interfere if present 
during the titration of the aged benzyl alcohols. 
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Each of the naturally aged benzyl alcohols was subjected to the 
titrimetric procedure described above and the peroxide content calculated 
in terms of hydroperoxide (DOH). The results are given in Table 6.5 to-
gether with the results of the iodometric titre (Peroxide Value, Section 
6.2.2.3) transposed from peroxide values to mg of hydroperoxide (OOH). 
Table 6.5 
Peroxide Content of Some Aged Benzyl Alcohols 
Aged Benzyl Alcohol 
A 
B 
C 
D 
Ce4+titre(00C) 
0.198 
1.898 
3.415 
5.817 
DOH mglg 
12titre 
0.188 
1.878 
3.366 
5.702 
The results of the Ce 4+ titre are in excellent agreement with the 
values obtained iodometrically indicating that all of the peroxide present 
is in the form of a hydroperoxide. These results confirm the absence of 
peracid (which is readily determined iodometrically229) thus discounting 
the possibili ty of a direct reaction between benzaldehyde and oxygen. 
Each sample of aged benzyl alcohol was also titrated with Ce4+ at 
20°C. Identical results were obtained at both OOC and 20°C implying the 
absence of diacyl and dialkyl peroxides. 
6.2.2.4TLC 
The samples of aged benzyl alcohol were examined by TLC to 
determine the impurity profile. Benzaldehyde and benzoyl peroxide were 
used as markers. 
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TLC Condi tions: 
Plate 
Mobile phase 
Sample 
Visualisation: 
Merck Silica Gel F60254 
dichloromethane 
50% solution of benzyl alcohol 
in dichloromethane. 20ul of 
solution was streaked onto the 
base-line of the TLC plate 
across a 2cm channel. 
a) UV lamp, 254nm 
b) potassium iodide/2M 
sulphuric acid spray. 
All samples produced similar impurity profiles but with the impur-
ities present in varying degrees. A typical chromatogram is shown in Fig. 
6.3. Three important observations were noted: 
1. Benzoyl peroxide was present in only trace amounts. 
2. Two KI positive zones were present, one of which was less polar 
than benzyl alcohol and present in nagligible proportions. 
3. The majority of peroxide was pres mt in the form of highly polar 
compound, R f = zero. 
6.2.2.5 Comparison of Benzaldehyde and Peroxide Levels 
The benzaldehyde content of the aged benzyl alcohols were deter-
mined by an HPLC method227 and compared with the level of peroxide, as 
determined by 12 titration. (Section 6.2.2.3) 
HPLC procedure 
Column 
Mobile phase 
Sample 
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ODS-Hypersil, 20cm. 
Acetonitrile - water (60 - 40) 
19 of benzyl alcohol, accurately 
weighed, was diluted to 100ml 
wi th methanol. 
Benzal- Aged benzyl Benzoyl 
dehyde alcohol peroxide 
solvent 
front 
~J "' .............. ", e . . . . . . . '" ......... ' 
0 C 
= 
) 
-~~ 
~~ 
l 
'-- ~ 
ba •• 1(:::::----~) 
line 
Fig. 6.3 - TLC Examination of Naturally Aged 
Benzyl Alcohol 
Mobile phase, dichloromethane; layer, 
silica gel GF 254 • 
0= visible under UV254 
~ = +ve to KI spray reagent. 
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Standard 10ul of benzaldehyde were diluted 
to 100ml with methanol. 5ml of 
this solution were further 
diluted to 25ml with methanol. 
The results are given in the following Table. 
Batch 
A 
B 
C 
D 
Table 6.6 
Comparison of Benzaldehyde and Peroxide Levels 
of Some Aged Benzyl Alcohols 
Benzaldehyde(mg/ g) 
1.72 
5.56 
11.20 
12.70 
Hydroperoxide(mg/g) 
0.19 
1.88 
3.36 
5.70 
A graphical representation of the above results (Fig. 6.4) indicates 
that the levels of peroxide and benzaldehyde are related. 
6.2.2.6 Discussion 
The extensive examination of the aged samples of benzyl alcohol, 
described above, ascertained the formation of a hydroperoxide during 
ageing which is highly polar in nature. In addition a possible relationship 
between the benzaldehyde and hydroperoxide autoxidation products was 
identified. 
Both of these observations are in agreement with the work of 
Howard and Korcek220 who have suggested that benzyl alcohol does not 
oxidise directly to an organic hydroperoxide, as do other alcohols, but 
forms instead hydrogen peroxide and an aldehyde. The authors also 
postulated that the intermediate species is represented by a-hydroxy-
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a) 
b) 
benzylhydroperoxide and thus the following reactions were suggested to 
account for the formation of benzaldehyde. 
H 
I 
2Ph - C-OH 
I 
00· 
a-hydroxybenzy I 
peroxy radical 
H 
I 
------.. ~ Ph COOH + Ph - C-OH 
I 
OH 
~ 
PhCHO + H20 
Ph CH(OH)OOH 
Each of these mechanisms require the a-hydroxybenzylperoxy 
radical to be the chain propagating species and indeed the existence of 
this radical was confirmed by radical trapping experiments. Based on the 
observation that the total yield of carbonyl-compounds (IR measurements) 
was always in excess of the stoichiometric amount calculated from the 
concentration of oxygen absorbed during the autoxidation process, the 
authors concluded that carbonyl-compounds must also be formed in the 
radical termination step as in (a) above. If reaction (b) was the sole mode 
of aldehyde formation then the peroxide: aldehyde molar ratio present in 
the autoxidised material would be I : 1. rrom the results given in Table 
6.6 the molar ratio of hydroperoxide: benzaldehyde for the samples of 
naturally aged benzyl alcohol was calculated to be: 
Batch A OOH: PhCHO= 1:2.82 
B 1:0.96 
C 1:1.04 
0 1:0.69 
The ratio obtained for batches B and C is evidence for only 
reaction (b) occurring during degradation whereas the greater than 
stoichiometric concentration of aldehyde present in Batch A suggests that 
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reaction (a) has occurred within this particular material. The anomalous 
results obtained for Batch 0 cannot be explained by reactions (a) or (b). 
The nature of the peroxide formed during autoxidation of a-substi-
tuted toluenes was also considered in the paper by Howard and Korcek 220• 
To differentiate between organic hydroperoxide and hydrogen peroxide an 
aqueous partition method was adopted, whence the organic hydroperoxide 
remained in the organic phase but hydrogen peroxide parti tioned into the 
aqueous phase. By this means the authors demonstrated that the peroxide 
present in autoxidised benzyl alcohol was hydrogen peroxide. However, 
the failure to consider the aqueous-solubility of benzyl alcohol renders the 
conclusions suspect. Benzyl alcohol is soluble in water to the extent of 
4% at 200 C. It may therefore be reasonably expected that a-hydroxy~ 
benzylhydroperoxide, which is a more polar molecule than benzyl alcohol, 
would have a considerable aqueous solubility. Hence the "identification" 
of the peroxide present in autoxidised benzyl alcohol based on the aqueous 
solubility of the material must be seriously questioned. 
Two facets of benzyl alcohol autoxidation therefore warranted 
further investigation: 
(0 the nature of the peroxide formed. 
(ii) the reaction mechanism involved in the formation 
of benzaldehyde. 
6.2.3 Mechanism of Benzaldehyde Formation 
6.2.3.1 Benzoic Acid Content of Naturally Aged Benzyl Alcohol 
The published literature had indicated two possible mechanisms by 
which benzaldehyde could be formed from benzyl alcohol during autoxi-
dation (Section 6.2.2.6). If benzaldehyde is formed by the interaction of 
two a-hydroxybenzyl peroxyl radicals (radical termination step), then 
formation of benzaldehyde will be accompanied by formation of benzoic 
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acid (equation (a) Section 6.2.2.6) and the molar ratio of the two 
components will be 1:1. The benzoic acid content of the naturally aged 
benzyl alcohols was thus determined. A suitable analytical procedure was 
devised by modification of the HPLC method utilised previously for the 
determination of perbenzoic acid (Section 6.2.2.2). By substituting 
acetate buffer for the original mobile phase containing citrate buffer and 
increasing the pH to 4.5, an improved separation of benzoic acid from the 
other components present (benzaldehyde and benzyl alcohol) was 
achieved. 
HPLC column: 
Acetate buffer: 
Mobile phase: 
Standard: 
Sample: 
ODS-Hypersil, 20cm 
3.86% sodium acetate solution 
adjusted to pH 4.5 wi th 
acetic acid. 
pH 4.5 acetate buffer! 
acetonitrile (3 - 1) 
50mg benzoic acid was 
dissolved in and diluted 
to volume with methanol. 
A further x 5 dilution 
was prepared. 
Oi luted as necessary wi th 
methanol (typically x 2) 
A typical sample chromatogram is shown in Fig. 6.5. The benzoic 
acid content of the samples examined is given in Table 6.7. 
Batch 
A 
C 
F 
Table 6.7 
Benzoic Acid Content of some 
Naturally Aged Benzyl Alcohols 
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Benzoic Acid Content 
mg!g 
0.062 
1.455 
0.214 
uM 
0.57 
11.93 
1.75 
, 
o 
TIME(min) 
Fig. 6.5 - HPLC Determination of Benzoic Acid -
Typical Chromatogram 
Mobile phase, pH 4.5 acetate buffer -
acetonitrile (3-1); column, ODS-Hypersil. 
1 = benzoic acid; 2 = benzyl alcohol; 
3 = benzaldehyde. 
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Assuming that the radical termination step postulated by Howard 
and Korcek is the only means of benzoic acid formation, equimolar 
quantities of benzoic acid and benzaldehyde would be produced simul-
taneously. The fraction of benzaldehyde formed during radical termin-
ation can therefore be predicted from the benzoic acid results. A 
comparison of this value with the total benzaldehyde content (determined 
previously) is given in Table 6.8. 
Table 6.8 
Comparison of Benzaldehyde Contents 
Batch 
of 
benzyl 
alcohol 
Total PhCHO Content Predicted PhCHO formed during 
radical termination 
A 
C 
F 
1.72 
11.20 
0.77 
uM 
16.23 
105.66 
7.26 
0.062 
1.455 
0.186 
uM 
0.51 
11.93 
1.75 
% of 
Total 
-
3.14 
11.30 
24.10 
The figures above indicate that relatively little aldehyde is formed 
by this route in Batches A and C. Batch F however may be indicative that 
the mechanism is feasible in some benzyl alcohols. 
6.2.3.2Forced Autoxidation of Benzyl Alcohol - Ratio of Benzaldehyde 
and Peroxide 
The value of the benzaldehyde: peroxide ratio is important since a 
reliable figure for this molar ratio could be used to confirm, or reject, the 
direct relationship between the two entities postulated by Howard and 
Korcek220 ie. that both are formed as a result of the decomposition of . 
the intermediate autoxidation product, a-hydroxybenzylhydroperoxide. 
PhCH(OH) DOH .. 
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The aldehyde/peroxide ratio of four naturally aged benzyl alcohols 
(examined previously) had varied considerably. As the history of these 
samples was unknown, it was considered likely that different modes and 
times of ageing could have contributed to the observed variability. Thus 
it was proposed to study the autoxidation of benzyl alcohol under rigidly 
controlled conditions. Two sets of experimental conditions were chosen 
to represent varying degrees of severity and can be classed as 
(i) static autoxidation 
{ii) dynamic autoxidation 
Experimental Conditions 
en Static autoxidation 
A pure benzyl alcohol (SOH Chemicals) was tested for the absence 
of benzaldehyde and peroxide. lOOml of the material was transferred to a 
250-ml conical flask and the liquid and headspace sparged with oxygen. 
The stoppered flask was then stored in the dark in a thermostated 
environment at 400 C. Aliquots of the alcohol were withdrawn at intervals 
and the benzaldehyde and peroxide contents determined simultaneously. 
The headspace above the alcohol was flushed wi th oxygen following the 
removal of an aliquot for assay to ensure that an atmosphere of oxygen 
was above the alcohol at all times. Oxygen was chosen in preference to 
air in order to accelerate the autoxidation reaction. 
(ii) Dynamic Autoxidation 
50ml of pure benzyl alcohol was transferred to a large test-tube 
and suspended in a thermostated oil-bath at SOoC. Compressed air was 
bubbled through the alcohol via a sintered-bubbler at a constant flow-rate 
of 50ml/min. The flow-rate was continually monitored with a flow-meter. 
Aliquots of benzyl alcohol were withdrawn at intervals and the benzal-
dehyde and peroxide levels determined simultaneously. 
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Benzaldehyde was determined by HPLC (Section 6.2.2.5) and per-
oxide by iodometric titration (Section 6.2.2.5 and 5.2.1). 
Results and Discussion 
The results obtained are summarised in Tables 6.9 and 6.10. At 
each sampling station, under either static or dynamic conditions, the ratio 
of peroxide to benzaldehyde is extremely close to the 1:1 value required 
for the direct formation of the two entities by dissociation of a-hydroxy-
benzylhydroperoxide. 
Furthermore, benzoic acid levels in naturally aged benzyl alcohols 
(Section 6.2.3.1) indicated that the alternative route for benzaldehyde 
formation postulated by Howard and Korcek220 is likely to be of minor 
importance. Hence both experiments provide evidence in support of the 
theory that benzaldehyde is formed mainly via an a-hydroxybenzyl-
hydroxperoxide moiety during the autoxidation of benzyl alcohol. 
6.2.4. Identity of Peroxide Formed During Benzyl Alcohol Autoxidation 
Reaction of fluphenazine decanoate with a variety of autoxidised media 
has demonstrated the variable rate at which the drug is oxidised by differing 
hydroperoxides. (Chapter 5). Thus it is important to identify the peroxide 
present in autoxidised benzyl alcohol so that the rate of fluphenazine 
decanoate oxidation by this entity can be determined. The rate may then be 
compared with similar rates obtained for other hydroperoxides and the 
relative importance of the reaction, with respect to product stability, can be 
assessed. 
The hydroperoxide formed initially during benzyl alcohol autoxidation has 
been reported as a-hydroxybenzylhydroperoxide but is ultimately believed to 
dissociate into hydrogen peroxide and benzaldehyde220,230. The equilibrium 
constant for this reaction is unknown and hence the relative proportions of 
the two peroxides present in ageing benzyl alcohol cannot be predicted. 
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Table 6.9 
Autoxidation of Benzyl Alcohol - Static Conditions, 400 C 
Time Benzaldehyde Content Hydro~eroxide Content Molar Ratio 
(days) mg/ml mM mg/ml mM OOH: PhCHO 
Initial 0.039 0.368 0.0132 0.40 1: 1.09 
22 0.273 2.57 0.066 2.00 1: 0.78 I 
IV 
IN 27 0.422 3.98 0.155 4.70 1: 1.18 \0 
I 
33 1.088 10.26 0.317 9.60 1: 0.93 
36 1.44 13.60 0.561 17.00 1: 1.25 
42 3.00 28.30 1.007 30.50 1: 1.08 
Table 6.10 
Autoxidation of Benzyl Alcohol - Dynamic Conditions, 800 C 
Time Benzaldehyde Content H:tdroeeroxide Content Molar Ratio 
(hours) mg/ml mM mg/ml mM OOH: PhCHO 
Initial 0.092 0.868 0.023 0.696 1: 1. 24 
1 0.113 1.066 0.037 1.000 1: 1.06 
.... 
2 0.148 1.396 0.040 1.212 1: 1.15 
I ,.., 
~ 4 0.324 3.066 0.086 2.616 1: 1.18 0 
I 
5 0.719 6.783 0.224 6.788 1: 1.00 
6 1.649 15.56 0.475 14.393 1: 1.08 
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Without a quantity of the pure a-hydroxy compound, it is impossible to 
determine a value for the equilibrium constant. Indeed, the material may be 
unstable, spontaneously decomposing to hydrogen peroxide and benzaldehyde 
and thus be impossible to isolate. As an alternative means of determining the 
position of equilibrium existing, the ratio of benzaldehyde: peroxide may be 
determined. However, the assay procedures used to quantify this value must 
not affect the equilibrium so that a true value of the ratio may be obtained. 
Dissociation of a-hydroxyalkylhydroperoxides occurs in aqueous solution 
and is catalysed by acid and alkali 230. Consequently the presence of water in 
the HPLC mobile phase utilised for assay of benzaldehyde, and of water and 
acid in the titrimetric procedure for peroxide determination could be the 
explanation of the consistent 1:1 ratio of peroxide: benzaldehyde noted in 
Section 6.2.3. The effect of sample diluent on the value obtained for 
benzaldehyde was thus invesJigated. In addition alternative assay procedures 
for determining benzaldehyde, which did not require use of water, acid or 
other highly polar solvents such as methanol, were sought. 
6.2.4.1 Effect of Sample Preparation on Benzaldehyde HPLC Assay 
Water is present in the HPLC mobile phase and could, if dissocia-
tion of a-hydroxyalkylhydroperoxide is a fast reaction, be converted to 
hydrogen peroxide and aldehyde upon injection of the organic solution 
onto the column. To overcome any effect which could be attributable to 
the mobile phase aqueous component, autoxidised benzyl alcohol (natur-
ally aged, Batch A) was diluted with water during sample preparation. 
The benzaldehyde content of this solution was compared with similar 
solutions diluted with 1M sulphuric acid and with methanol. 
The benzaldehyde content of the aqueous dilution was noted to be 
identical to that of a dilution prepared in methanol (Table 6.11). In 
contrast the benzaldehyde level of the acid dilution steadily increased 
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over a period of 20 min., subsequently decreasing in value until approxi-
mately equal to the initial figure (Table 6.11 and Fig. 6.8). Such an 
increase would be expected if the acid caused dissociation of the (X-
hydroxyalkylhydroperoxide to occur, but the subsequent decrease in 
benzaldehyde value is difficult, if not impossible to explain on these 
resul ts alone. 
6.2.4.2 Aqueous Extraction of Naturally Aged Benzyl Alcohol 
Methanolic and aqueous dilution of naturally aged benzyl alcohols 
resulted in identical values for benzaldehyde upon assay. In order to 
determine whether the peroxide present in the aqueous solution was in the 
form of a-hydroxybenzylhydroperoxide or hydrogen peroxide, the peroxide 
was extracted from the benzyl alcohol with water and the benzaldehyde 
level before and after acidification of the aqueous extract determined. If 
a-hydroxybenzylhydroperoxide is present, the addition of acid will cause 
dissociation and a corresponding increase in benzaldehyde concentration. 
Experimental 
Naturally aged benzyl alcohol was extracted with an equal volume 
of water and the aqueous layer separated by centrifugation. Absence of 
peroxide in the benzyl alcohol layer was established using a test solution 
of potassium iodide and sulphuric acid. The aqueous fraction was washed 
(X2) with dichloromethane to remove residual benzyl. alcohol, again 
separating the layers of centrifugation. The concentration of benzalde-
hyde in the aqueous extract was determined by an HPLC method before 
and after the addition of acid. Total peroxide content was determined 
iodometrically. 
Results and Discussion 
No benzaldehyde was detected in the aqueous extract before 
acidification. Following the addition of acid, benzaldehyde concentration 
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Methanol 
solution 
2.29 
Table 6.11 
Benzaldehyde Content of Some Aged 
Benzyl Alcohols(mg!mI) 
Aqueous 1M sulphuric acid 
solution solution 
2.37 Initial* 
S.O min. 
8.4 min. 
12.2 min. 
16.0 min. 
20.2 min. 
27.4 min. 
36.0 min. 
* Immediately after dilution. 
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was determined to be 0.029 mg/ml. From this increase in benzaldehyde 
content, the equivalent concentration of a-hydroxybenzylhydroperoxide 
was calculated at 0.039mg/ml, which is equivalent to O.0091mg/ml of 
hydroperoxide (DOH). The total hydroperoxide content of the aqueous 
extract, calculated as DOH, was O.301mg/ml thus the amount of peroxide 
attributable to a-hydroxybenzylhydroperoxide is approximately 3% of the 
total. The majority of peroxide present in the aqueous extract is 
therefore represented by hydrogen peroxide. 
6.2.4.3 Alternative Assay for Benzaldehyde - UV Spectrophotometry 
As an alternative means of assessing the true level of benzaldehyde 
in aged benzyl alcohol, and hence the extent of dissociation of a-
hydroxybenzylhydroperoxide, an assay procedure was sought which would 
be free from influences affecting the natural equilibrium present in the 
alcohol. A simple UV spectrophotometric procedure for determining the 
benzaldehyde content of commercial benzyl alcohol has been described in 
the literature231 and was applied to the batches of naturally aged benzyl 
alcohol. The method is valid only in the absence of other impurities or 
degradation products which absorb UV radiation at 283nm. 
Experimental Conditions 
Naturally aged benzyl alcohol was diluted with various solvents and 
the UV absorption of the solution determined at 283nm. Quantitation of 
benzaldehyde was achieved by comparing the sample with a standard 
solution prepared in the same solvent. 
Results and Discussion 
The results of assay are given in Table 6.12. 
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Benzyl Alcohol 
Batch A 
C 
E 
F 
Table 6.12 
Benzaldeh de Content(m /m!) of Some Naturall 
Aged Benzyl Alcohols Spectrophotometric Assay 
Diluent 
Methanol! Methanol/ 
Water 2M H;S04 
Hexane (50-50) (50- 0) 
3.36 3.08 3.18 
12.47 12.00 14.86 
0.41 0.41 
2.37 2.16 
During the HPLC determination of benzaldehyde following acidifi-
cation of a benzyl alcohol solution (Section 6.2.4.1), benzaldehyde concen-
tration was observed to increase, then subsequently decrease in value over 
a period of 35 min. The UV absorbtion measurements above were thus 
determined at intervals throughout a 35 min. period. After 15 minutes 
only Batches Band E exhibited an increase in absorption. Batch B 
retained the new absorption value throughout the 35 minute interval 
whereas the absorbance of Batch E slowly decreased to the original value. 
Batches A and C, in contrast exhibited no change in absorbance with 
respect to time. The variable effect of acid addition observed in this and 
previous experiments suggests that a reaction is occurring which is 
related to an unknown impurity or degradation product present in only 
occasional batches of benzyl alcohol. 
The true value of benzaldehyde concentration is most likely to be 
that obtained by assay of the benzyl alcohol diluted with hexane, since 
this non-polar inert solvent is unlikely to influence the dissociation of the 
a-hydroxyalkylhydroperoxide species, if present. The similar assay values 
apparent for hexane and methanol/water solutions of benzyl alcohol 
indicates that the addition of water, has had little effect on any 
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equilibrium that may exist within the aged benzyl alcohol. By analogy the 
assay values for benzaldehyde obtained via the HPLC procedure would be 
unaffected by the mobile-phase aqueous component and therefore also 
represent actual values for benzaldehyde content. 
6.2.4.4Determination of Benzaldehyde by an IR Spectrophotometric 
Procedure 
To obtain further evidence that the HPLC assay gives a true value 
for the benzaldehyde content ie. the assay procedure has no influence on 
the equilibrium concentration, an IR assay for total carbonyl compounds 
was developed. Although benzoic acid will interfere, the level of this 
compound present in Batches A and C of the aged benzyl alcohols 
(determined by an HPLC method; Section 6.2.3.1) was known to be 
negligible in comparison to the benzaldehyde content (about 5%). A high 
bias may thus be expected but the procedure will be of sufficient 
preCision for the envisaged purpose. 
Experimental 
Hexane was initially investigated as diluent for the benzyl alcohol 
samples, but was ultimately found to possess a high background absorption 
(Imm cell) in the 1600-1800cm -1 region (carbonyl stretching frequency). 
Dichloromethane was subsequently chosen, being almost free from back-
ground absorption in the required spectral region. 
Lineari ty of response for benzaldehyde was determined by adding 
aliquots (O-lOu!) of benzaldehyde to 5ml (volumetric flask) of a 50% 
solution of freshly distilled benzyl alcohol in dichloromethane. The IR 
spectrum of each solution was recorded and the response of the carbonyl 
stretching frequency at about 1700 cm -1 measured in terms of % 
transmission. Absorbance values were then calculated from the relation-
ship 
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absorbance = log 1 
T 
where, T = transmission 
A plot of absorbance against concentration (Fig. 6.9) indicated that 
a deviation from linearity was apparent beyond a benzaldehyde 
concentration of 1.25mg/ml solution (equivalent to 2.5mg!ml 
benzaldehyde in the original benzyl alcoho!). 
Sample preparation was therefore adjusted by dilution so that the 
final concentration of benzaldehyde present in solution was within the 
linear range of the assay. A standard calibration graph was constructed 
concurrently with sample examination. A typical sample spectrum is 
illustrated in Fig. 6.10. 
Results and Discussion 
The results are tabulated below, where they are also compared 
with HPLC assay values (methanol solution) determined on the same day. 
Table 6.13 
Comparison of IR and HPLC Assay Values for the 
Benzaldehyde Content of some Naturally Aged 
Benzyl Alcohols 
Benzyl Benzaldeh~de Content (mg/ml) 
Alcohol IR HPLC 
A 1.92 2.27 
C 11.45 10.46 
E 0.32 0.23 
F 1.49 0.77 
The IR results are in good agreement with HPLC values with the 
exception of Batch F. The fractionally higher results for the IR assay of 
batches A and C were not unexpected since these materials were known 
to contain small amounts of benzoic acid. 
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The vastly different assay values noted for Batch F is probably due 
to the relatively high level of benzoic acid present in this material 
(approx. 25% of benzaldehyde content). Comparison of the IR spectrum 
obtained for Batch F with the spectra of the other aged benzyl alcohols 
clearly shows an interfering absorption adjacent (1720cm -1) to the 
aldehyde carbonyl stretching frequency (l70Scm -1) which may be 
attributable to benzoic acid. (Fig. 6.10) 
6.2.4.5 GC Assay for Benzaldehyde 
For this determination a Squibb Q.C. procedure232 was utilised. 
Experimental Conditions 
GC column 
Temperature 
Injection heater 
Detector 
Gases 
Sample preparation 
Standard preparation 
Results and Discussion 
15% carbowax on Universal 
support. 
IS00 C 
2000C 
F.I.D. 
N2(carrier gas),60ml/min 9" 600ml/min Hi, 60ml/min 
Naturally aged benzyl 
alcohols 'were diluted 
with cyclohexane. 
50mg benzaldehyde was 
dUuted to 50ml with 
cyclohexane. 
The results obtained are compared with HPLC assays of the same 
materials in Table 6.14. A typical chromatogram is illustrated in Fig. 
6.11. 
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Benzyl 
Table 6.14 
Comparison of GC and HPLC Assay Values for 
Benzaldehyde Content of Aged 
Benzyl Alcohol 
Benzaldeh~de Content mg/ml 
Alcohol GC HPLC 
Batch A 4.98 2.27 
C 17.16 10.46 
E 0.87 0.23 
F 2.20 0.77 
The most striking feature of the results is that the GC procedure 
produces values which are approximately twice as high as those obtained 
by HPLC. Two postulates can be offered to account for this phenomenon: 
(i) that a- hydroxybenzylhydroperoxide is thermally decomposed at 
the injection point yielding increased benzaldehyde values. 
(ii) that the hydrogen peroxide present in the aged benzyl alcohol 
reacts in the gaseous phase at the injection point, oxidising benzyl 
alcohol to benzaldehyde via a mechanism other than that which 
requires formation of cx- hydroxybenzylhydroperoxide. (Howard 
and Korcek220). 
The results of Section 6.2.2.6 suggest that peroxide and benzal-
dehyde are present in equimolar quantities in Batch C, thus all peroxide 
must be present as hydrogen peroxide if the Howard & Korcek relationship 
is valid: 
PhCH(OH)OOH ~ PhCHO + H202 
Batch A contains a greater molar concentration of benzaldehyde than 
peroxide, thus again all peroxide present should be in the form of H20 2• 
Assuming that the results of Section 6.2.2.6 are not influenced by the assay 
procedure, as seems improbable from subsequent work (Section 6.2.4.3), then the 
additional amount of benzaldehyde found during GC assay cannot result from th~ 
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decomposition of an a-hydroxyalkylhydroperoxide since this entity is apparently 
absent. The most favourable explanation of the observed phenomenon must 
therefore be that of (ij). 
6.2.4.6 TLC of Peroxide 
A TLC procedure for the chromatography of hydrogen peroxide233 
was applied to the samples of naturally aged benzyl alcohol. 
Experimental Conditions 
Plate 
Mobile phase 
Visulisation 
Merck, Cellulose F 254 
Water/n-butanol/ether 
(1-10-10) 
a) UV lamp, 254nm 
b) KI/H2S04 spray 
The results are shown in Fig. 6.12. Only one peroxide zone was 
observed with an Rf value identical to that of hydrogen peroxide. 
6.2.5 Conclusions 
The formation of benzaldehyde in autoxidising benzyl alcohol probably 
occurs via an a-hydroxybenzylhydroperoxide intermediate, as postulated by 
Howard and Korcek220• An investigation of the peroxide present in the 
autoxidising material provided evidence that hydrogen peroxide is the major 
form of peroxide produced. The existence of small quanti ties of the a-
hydroxybenzylhydroperoxide cannot be entirely excluded on the available 
evidence, but results indicate that this entity must be > 95% dissociated to 
benzaldehyde and hydrogen peroxide. 
An alternative route of benzaldehyde formation via radical termination 
involving two a-hydroxybenzylperoxy radicals was shown to be unlikely to 
occur. 
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Naturally aged Hydrogen 
benzyl alcohol peroxide 
---
solvent front 
"( y/ 
W~ ® 
bas. lin. 
Fig. 6.12 - TLC of Naturally Aged Benzyl Alcohol 
Mobile phase, water-n-butanol-diethyl ether 
(1-10-10); layer, cellulose F 254 " 
0= visible under UV 254 
@ = +ve to KI spray reagent 
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Thus the identity of the peroxide which would be available to attack 
fluphenazine decanoate, if autoxidation of benzyl alcohol occurred within the 
Modecate product, is concluded to be hydrogen peroxide. 
6.3. Relative Oxidation Rates of Benzyl Alcohol, Fatty Esters and Fatty Acids 
Autoxidation of Modecate Injection could proceed via five possible intermed-
iaries since there are five potential receptors of oxygen present in the formula-
tion: 
(i) fluphenazine decanoate (active) 
(H) oleate triglycerides )sesame oil 
(iii) linoleate triglycerides ) 
(iv) benzyl alcohol (added preservative) 
(v) traces of unsaturated (natural impurities 
fatty acids. of sesame oil) 
Of these possible intermediaries, the direct reaction of the drug with 
molecular oxygen (i) has been shown to be unlikely180, though confirmatory 
evidence has still to be produced. Thus in this investigation only mechanisms (ii), 
(iii) (iv) and (v) were considered. A knowledge of the oxidation rate of each of the 
materials would enable prediction of the mechanism most likely to occur in the 
product. Autoxidation rates however are difficult to quantify in absolute terms 
because of the complex reactions occurring. A typical autoxidation follows the 
general pattern234 
a) initiation period 
b) increasing rate of oxidation as radical propagation pro-
ceeds. 
Hence the overall reaction does not obey simple kinetic laws. The common-
est method of determining the relative autoxidation rates of a series of materials 
is to oxidise each sample under identical conditions (carefully controlled) and to 
compare the results graphically. Quantitation of the data is not possible, but the 
procedure will enable a knowledge of the relative potential for autoxidation to be 
gained. 
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6.3.1 Materials 
Ideally the rates of autoxidation of the triglycerides should be determin-
ed, but these materials are not available in the pure form in the quantities 
required by the experimental technique. Methyl esters of oleic and linoleic 
acid were therefore used, these compounds being the most closely related 
entities available in pure form. (Sigma Chemicals). 
Pure unsaturated fatty acids (oleic and linoleic) were also obtained from 
Sigma Chemicals. Benzyl alcohol was obtained from BDH Chemicals. 
6.3.2 Autoxidation Procedure 
20ml of the material to be oxidised was transferred to a large test-tube 
and suspended in a thermostated bath at BOoC. Compressed air was allowed 
to bubble through the sample at a constant rate of 50ml/min, the flow rate 
being monitored with a suitable flow-meter (range, O-lOOml/min). Air was 
introduced into the liquid sample via a sintered tube. 
Aliquots of the sample were withdrawn at intervals and assayed for 
peroxide by an iodometric procedure (Section 5.2.1). 
Each material was vacuum-distilled immediately prior to autoxidation so 
that all samples were of an identical nature at the beginning of the 
experiment Ie. free from peroxide. 
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6.3.3 Results and Discussion 
Time 
(hrs) 
0 
2 
4 
6 
8 
Time 
(hrs) 
o 
0.5 
1.0 
1.5 
1.75 
2.0 
2.25 
Table 6.15 
Autoxidation of Methyl Oleate 
Table 6.16 
Autoxidation of Methyl Linoleate 
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OOH Content 
(mg/mI) 
0.05 
0.30 
0.61 
0.94 
1.39 
OOH Content 
(mg/mI) 
o 
0.64 
1.67 
3.33 
4.21 
5.38 
7.10 
Time 
(hrs) 
o 
1 
2 
4 
6 
7 
8 
Time 
(hrs) 
o 
0.25 
0.5 
0.75 
1.0 
1.25 
Table 6.17 
Autoxidation of Oleic Acid 
Table 6.18 
Autoxidation of Linoleic Acid 
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OOH Content 
(mg/mI) 
0.03 
0.30 
0.56 
1.24 
1.75 
2.10 
2.48 
OOH Content 
(mg/ml) 
o 
0.94 
1.93 
2.97 
4.39 
5.68 
Time 
(hrs) 
o 
1 
2 
4 
5 
6 
Table 6.19 
Autoxidation of Benzyl Alcohol 
6.3.4 Discussion and Conclusions 
DOH Content 
(mg/ml) 
0.023 
0.037 
0.040 
0.086 
0.224 
0.475 
A graphical comparison of the autoxidation rates (Fig. 6.13) illustrates the 
relatively faster rate at which the diunsaturated fatty ester (linoleate) is 
oxidised and is in agreement with previously published data177• Fatty acids, 
which follow a similar profile to the esters, have a marginally greater rate of 
oxidation than the corresponding ester. In contrast, benzyl alcohol possesses 
the slowest rate of autoxidation. 
Thus in a mixture of the components the diunsaturated compounds can be 
expected to preferentially autoxidise. As only trace amounts of fatty acid 
are present in a typical formulated product, the majority of oxidation can be 
predicted to occur with the diunsaturated ester. Autoxidation of the mono 
unsaturated ester (oleate) may occur to a limited degree. Benzyl alcohol, 
which exhibits the slowest rate of autoxidation and is al80 present in only 
small amounts (1.5%) would not be expected to oxidise to any great extent 
based on the above results. Hence the role of the preservative in enhancing 
degradation of the drug (Section 6.2) is still unclear. 
However, two criteria must be borne in mind when attempting to 
extrapolate these results to Modecate formulation: 
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(i) sesame oil contains natural antioxidants such as sesamolin 
(ii) interaction of the peroxides (formed during autoxidation) with other 
components of the product. 
The presence of antioxidant will undoubtedly prolong the first stage of 
autoxidation ie. the initiation period. The degree to which sesamolin may 
influence subsequent rates of oxidation is totally unknown and future work could 
usefully be directed towards determining the effect of antioxidants in this 
respect. 
The second criteria can be predicted with more certainty. Peroxides formed 
during autoxidation will probably react directly with the active, fluphenazine 
decanoate, since the drug has demonstrated a ready willingness to react with 
hydroperoxides, even at room temperature (Chapter 5). 
-264-
RECOMMENDATIONS FOR FURTHER WORK 
1. That the difference in the pattern of oxidation products exhibited by 
piperazino-phenothiazines and by piperazino-phenothiazine esters respective-
ly during reaction with chloroperbenzoic acid be further investigated. 
2. That the 13C NMR spectra of piperazino-phenothiazines be studied and, with 
the aid of. model compounds, absolute assignments of the chemical shifts be 
made. 
3. That the hygroscopic nature of the phenothiazine oxides be investigated. 
4. That the reaction of fluphenazine decanoate with olefinic hydroperoxides be 
assessed following deacidification in order to determine the true effect of 
the carbon-chain length. 
5. That the parameters affecting the rate of reaction of fluphenazine decanoate 
with oleate and linoleate hydroperoxides be investigated so that the differ-
ence in reaction rates, observed in the current work, be explained. 
6. That the effect of antioxidants on the reaction of fluphenazine decanoate 
with hydroperoxides be assessed. 
7. That a-hydroxybenzylhydroperoxide be synthesised and its absence in natur-
ally autoxidised benzyl alcohol be confirmed. 
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APPENDIX I 
METHODS FOR THE PREPARATION AND ISOLATION 
OF FLUPHENAZINE DECANOA TE OXIDES 
-Al-
AI.I. General Notes 
AI.I.I Reagents and Materials 
Analar reagents and solvents were used wherever possible. In the absence 
of Analar material, Reagent Grade chemicals were substituted. 
a) Purity of m-chloroperbenzoic acid, in terms of available oxygen, was 
found to decrease with age. In order to obtain the closest control over the 
oxidation with this reagent, the amount of available oxygen must be known. 
This value is readily determined for peracids by a simple iodometric 
t Ot to 193 1 ra Ion • 
Accurately weigh approximately 200mg of m-chloroperbenzoic acid into a 
250ml iodine flask (duplicate). Dissolve in 10ml of glacial acetic acid, add 
2g of potassium iodide and allow to stand for five minutes. Titrate the 
liberated iodine with O.IM sodium thiosulphate solution using starch 
solution as indicator. 
A reagent blank determination should be performed simultaneously. 
1ml of O.IM sodium thiosulphate solution :: 8.629mg m-chloroperbenzoic 
acid. 
b) Fluphenazine Decanoate 
Pharmaceutical grade fluphenazine decanoate (purity 99.5%) was 
used as received from the manufacturers (Linson Ltd. Eire). 
AI.I.2 Equipment 
HPLC equipment comprised of an Altex 110A reciprocating pump 
(Anachem Ltd.) and a Cecil 212 variable wavelength UV detector (Cecil 
Instruments Ltd.) coupled to a Perkin-Elmer Model 56 chart recorder. 
Operating the HPLC under preparative conditions overloaded the UV 
detector because of the relatively high concentrations of product being 
eluted from the column. To overcome this problem, a less sensitive 
refractive-index detector (Waters Associates Ltd.) was substituted for the UV 
detector. 
-A2-
AI.2. Synthesis of Fluphenazine Decanoate Mono N-Oxides (Compounds A and 8) 
AI.2.10xidation of Fluphenazine Decanoate 
Dissolve Ig fluphenazine decanoate (l.69mM in 25ml of dichloro-
methane contained in a 250ml conical flask. Add a teflon-coated 
magnetic-stirrer bar and place the flask on a magnetic stirrer. Add 
dropwise from a burette (approx. I drop per sec.) with constant stirring a 
solution of 0.29g m-chloroperbenzoic in 25ml of dichloromethane. Evap-
orate the resulting mixture to about lOml on a rotary film evaporator. 
Al.2.2. Separation of A and 8 from Reaction Mixture 
Prepare a 200mm x 25mm column of freshly activated CII00 C) 
Kieselgel 60 (70-230 mesh, Merck) dispersed in chloroform. Transfer the 
reaction mixture, prepared as in AI.2.1 above, to the top of the column 
and allow the solution to percolate through the silica gel. Elute the 
compounds from the column with a mobile-phase of methanol-cyclo-
hexane-methyl acetate (40 - 70 - 100). The progress of the compounds 
through the column may be conveniently monitored with a hand-held UV 
lamp (366nm), whence the fluphenazine decanoate-related bands appear 
bright-blue. Discard the first band eluted from the column (fluphenazine 
decanoate) and collect the second band (mixture of compounds A and 8) in 
a round-bottom flask. Evaporate the solution to dryness on a rotary 
evaporator with gentle heat (35-400 C); an oily residue remains which 
slowly solidifies when stored at -200 C, resulting In a pale yellow waxy 
solid. 
Al.2.3. Isolation of Pure A and 8 by Preparative HPLC 
Prepare a solution of the A/8 mixture at a concentration of 
500mg/ml in methanol. 
Using a 20cm x 3/8" HPLC column packed with SAS-Hypersil and a 
mobile phase of methanol-acetonitrile-l% ammonium carbonate (1-1-1) 
-A3-
inject 50ul aliquots of AlB solution onto the column. Collect the eluted 
fractions containing compound A and compound B in separate round-
bottom flasks. Repeat the injection of the solution and collection of the 
respective fractions as necessary. Treat the flasks containing separated 
A and B as follows: 
Evaporate under vacuum to remove the majority of the organic 
phase. Add about 20ml of ace toni trite and again evaporate on a rotary 
evaporator at about 700 C. Transfer the largely aqueous solution into a 
separating funnel, add an equal volume of water and extract with ethyl 
acetate or dichloromethane. 
Separate the organic layer and dry over magnesium sulphate. 
Evaporate to dryness on a rotary evaporator. Final traces of solvent can 
be removed in a freeze-drier. The resulting oil slowly solidifies on 
storage at _200 C yielding a pale yellow waxy solid. 
AI.3 Alternative Synthesis of Compound A 
Prepare the mixture of compounds A and B as detailed in Sections AI.2.1 
and AI.2.2 above. Dissolve the mixture in methanol and add 20ml of 
ammonium hydroxide (SG, 0.88). Allow to hydrolyse at room temperature 
until compound B comprises about 5% of the AlB mixture (about 48 hrs) using 
HPLC (SAS-Hypersil column; mobile phase, methanol-acetonitrile-l % 
ammonium carbonate solution, 1:1:1) to monitor the reaction. 
Isolate compound A (approx. 95% pure) from the reaction mixture by the 
method described in Section AI.2.2. 
A1.4. Synthesis of Fluphenazine Decanoate di N-Oxide (Compound D) 
Dissolve 0.5g fluphenazine decanoate (O.85mM) in 25ml ethyl acetate 
contained in a 250-ml conical flask. 
-A4-
Prepare a solution of 0.44g of m-chloroperbenzoic acid (2.55 mM available 
oxygen) in 75.0ml ethyl acetate. 
To the solution of fluphenazine decanoate at 20oC, add 48.0ml of oxidant 
dropwise from a burette, with constant stirring. Continue to add the oxidant 
in 0.5ml quanti ties moni toring the progress of the reaction by HPLC (SAS-
Hypersil column; methanol-acetonitrile-l % ammonium carbonate solution, 
1:1:1 as mobile phase, detector 260nm) after each addition. Cease the 
addition of oxidant as soon as compound 0 is seen to be formed. Evaporate 
the reaction mixture to dryness with a rotary film-evaporator and re-dissolve 
in diethyl ether. Add an etheral solution of hydrogen chloride dropwise from 
a graduated pipette until the precipitant is just present in excess (pH paper). 
Separate the precipitated hydrochloride salt by centrifugation and wash the 
solid twice with ether to remove excess hydrogen chloride. Dry the material 
in a vacuum oven at 60oC. 
If necessary, the material may be recrystallised from a mixture of dry 
ether and dry absolute ethanol. 
AI.5 Synthesis of Fluphenazine Decanoate Sulphoxide di N-Oxide (Com-
pound D) 
Dissolve 0.5g fluphenazine. decanoate (0.85mM) in 25ml ethyl acetate in a 
250-ml conical flask. 
Prepare a solution of 0.59g m-chloroperbenzoic acid (3.42 mM available 
oxygen) in 100mi ethyl acetate. 
To the solution of fluphenazine decanoate at 200 C, add 73.0ml of oxidant 
dropwise from a burette ensuring that the reaction mixture is stirred 
constantly. Continue to add the oxidant in O.5ml quantities monitoring the 
progress of the reaction by HPLC after addition of each O.5ml aliquot. (SAS-
Hypersil column; methanol-acetonitrile-l % aqueous ammonium carbonate, 
1:1:1 as mobile phase; detector 260nm). Cease addition of oxidant when the 
-AS-
level of compound C is reduced to approximately 2% of the reaction mixture. 
Evaporate the reaction mixture to dryness on a rotary evaporator and re-
dissolve the residue in diethyl ether. Add an ethereal solution of hydrogen 
chloride dropwise from a graduated pipette until the precipitant is just 
present in excess (pH paper). Separate the precipitated hydrochloride salt by 
centrifugation and wash the solid twice with ether. Dry the material in a 
vacuum oven at 600 C. 
AI.6 Synthesis of Fluphenazine Decanoate Sulphone di N-Oxide (Com-
pound E) 
Dissolve 0.5g fluphenazine decanoate (0.85mM) in 25ml ethyl acetate in a 
250-ml conical flask. Add 1.0g m-chloroperbenzoic acid (5.8mM available 
oxygen) and swirl to dissolve. Allow to react at room temperature (200 C). 
Monitor the reaction by HPLC (SAS-Hypersil column; methanol-acetonitrile-
1 % aqueous ammonium carbonate, 1:1:1; detector 275nm). Compound D is 
formed immediately and then slowly converted to Compound E. When 
conversion to compound E is complete, evaporate the reaction mixture to 
dryness on a rotary evaporator. Re-dissolve the residue in diethyl ether and 
precipitate the hydrochloride salt by drop wise addition of an ethereal solution 
of hydrogen chloride until in excess (pH paper). Separate the precipitate by 
centrifugation and wash the solid twice with ether. Dry the material in a 
vacuum oven at 600 C. 
AI.7 Synthesis of Fluphenazine Decanoate Sulphone (Compound F) 
Prepare Compound E as described in Section Al.6 but omitting the 
isolation of the hydrochloride. 
To the reaction mixture (20°C) in ethyl acetate add 10ml of ethyl acetate 
saturated with hydrogen chloride and pieces of granulated zinc. Monitor the 
reaction by HPLC (SAS-Hypersil column; methanol-acetonitrile-1 % aqueous 
-A6-
ammonium carbonate, 1:1:1; detector 260mm). When reduction of compound 
E is complete add excess 1M aqueous ammonium hydroxide and mix well. 
Separate the ethyl acetate layer, dry over magnesium sulphate, then evapor-
ate to dryness on a rotary evaporator. Add 10-ml acetonitrile and again 
evaporate to dryness in order to remove residual water. Compound F remains 
in the flask as a light-brown oil. 
The above product will be contaminated with a small amount of fluphen-
azine decanoate. If necessary, compound F may be purified by preparative 
layer chromatography: 
Streak a methanolic solution of compound F onto the base-line of a 40 x 
20cm silica-gel preparative layer plate (Merck; 2mm layer). Develop the 
plate in a mobile phase of acetone-cyclohexane-O.88 ammonia (80:30:5). 
Evaporate the mobile phase from the surface of the plate by placing in an 
oven at 1000 e for 5 mins. Scrape the main band from the plate, transfer the 
silica gel to a glass column and elute with methanol. Evaporate the solution 
to dryness with a rotary film evaporator. Remove any residual water by 
adding acetonitrile and again evaporating to dryness. Drying may be 
completed in a freeze-drier. 
A1.8 Synthesis of Fluphenazine Decanoate Sulphoxide (Compound Z) 
Two procedures are available for the preparation of Compound Z, either 
of which may be adopted: 
a) Oxidation of fluphenazine decanoate yielding the impure sulphoxide, 
which may be purified by preparative layer chromatography. 
b) Conversion of flu~enazine decanoate to the hydrochloride salt which, 
after isolation and dissolution in glacial acetic acid, may be selectively 
oxidised to the sulphoxide yielding Compound Z in almost 100% purity. 
The former method only has been used: 
Dissolve 0.5g fluphenazine decanoate in 5ml glacial acetic acid. Add 
-A7-
0.5ml of hydrogen peroxide (l00 volume) and allow to react at 20oC. 
Monitor the reaction by HPLC (SAS-Hypersil column; methanol-aceto-
nitrile-1 % aqueous ammonium carbonate, 1:1:1; detector 260nm). When all 
the fluphenazine decanoate has been oxidised isolate the crude sulphoxide by 
adding excess 10M sodium hydroxide whilst cooling the flask and contents in 
an ice-bath. Add 10mi dichloromethane to extract the sulphoxide and 
separate the organic layer. Dry over magnesium sulphate. Evaporate to low 
volume then streak the solution onto the base line of a silica gel preparative 
layer plate (Merck; 20 x 40cm, 0.2mm layer). Carry out the chromatographic 
procedure and method for the elution of the compound from the silica gel 
described under Al.7 above. A pale yellow viscous oil is obtained. 
Al.9 Synthesis of Fluphenazine Decanoate Sulphoxide mono- N-Oxides 
(Compounds X and Y) 
Al.9.1 Preparation and Isolation of the Mixture (Compounds X and Y) 
Prepare approximately 0.5g of crude fluphenazine decanoate sul-
phoxide and extract from the reaction mixture into dichloromethane by 
following the procedure described in section AI.7 above. Dry the 
dichloromethane solution over magnesium sulphate then filter through a 
No.3 sinter. Oxidise the resulting solution of crude sulphoxide with 
chloroperbenzoic acid solution (0.2g in 60ml dichloromethane) by adding 
the oxidant dropwise with constant stirring at 20oC. Monitor the reaction 
by HPLC (SAS-Hypersil column; methanol-acetonitrile-l % aqueous 
ammonium carbonate, 1:1:1, detector 275nm). Stop the reaction when 
compound W begins to be formed in preference to compounds X and Y (25-
30ml of oxidant). Evaporate to low volume on a rotary evaporator and 
transfer the concentrated solution to the top of a 10cm x 2.5cm column of 
freshly activated (nOoC) silica gel (Merck, 70-230 mesh) dispersed in 
chloroform. Allow the solution to run onto the column then elute with a 
-AS-
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mobile phase of methanol-cyclohexane-methyl acetate (40-70-100). 
Progress of the bands through the column may be conveniently followed 
using a hand-held UV lamp (366nm). Discard the first band eluted from 
the column (fluphenazine decanoate sulphoxide). Collect the second band 
in a round-bottom flask. Evaporate the eluate to dryness on a rotary 
evaporator. A pale yellow/brown viscous oil results. 
AI.9.2 Separation of Pure X and Pure V by Preparative HPLC 
Prepare a 50% solution of the mixture of C and V isolated in 
Section AI.B.I above. Operate the 20cm x 3/B" SAS-Hypersil column under 
the conditions described in Section AI.2.3, injecting 25ul aliquots of 
solution. Collect the fractions containing compounds X and Y in separate 
. flasks. Repeat the injection of the solution and collection of the 
respective fractions as necessary. Isolate X and Y from the mobile phase 
by the following procedure: 
Evaporate under vacuum at about 700 C to remove the majority of 
the organic phase. Add 20ml acetonitrile and repeat the evaporation at 
700 e. Transfer the largely aqueous solution to a separating funnel, add an 
equal volume of water and extract with dichloromethane. Separate the 
organic layer and dry over magnesium sulphate. 
Evaporate the solvent on a rotary evaporator, yielding a pale 
yellow viscous oil. Last traces of solvent may be removed by 'drying' in a 
freeze-drier. 
AI.I0 Synthesis of Fluphenazine Decanoate Sulphoxide di N-Oxide (Com-
pound W) 
Prepare approximately 0.5g of crude fluphenazine decanoate sulphoxide 
and extract from the reaction mixture into ethyl acetate by following the 
procedure described in Section AI.7 above. Dry the ethyl acetate solution 
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over magnesium sulphate then filter through a No. 3 sinter. Oxidise the 
resulting solution of crude sulphoxide with m-chloroperbenzoic acid solution 
(O.3g in 60ml ethyl acetate) by adding the oxidant dropwise with constant 
stirring at 200 C. Monitor the reaction by HPLC (SAS-Hypersil column; 
methanol-acetonitrile-l % aqueous ammonium carbonate, 1:1:1, detector 
275nm). 
Add the oxidant until compounds X and Y constitute about 10% of the 
reaction mixture. Continue to add the oxidant dropwise, but in O.5ml aliquots 
until X and Yare almost completely converted to compound W, ie. 2% 
reaction mixture. Wash. the ethyl acetate solution with 1M sodium hydroxide 
and with two successive volumes of water. Dry over sodium sulphate and 
concentrate to low volume. Place the solution in a freezer (_20oC) and allow 
preCipitation to occur. Separate the resulting amorphous solid by centrifug-
ation, wash with ether and dry in a freeze-drier or efficient vacuum oven at 
200 C. 
-AlO-
APPENDIX II 
METHODS FOR THE PREPARATION AND ISOLATION 
OF FLUPHENAZINE OXIDES 
-All-
A2.1 General Notes 
A2.1.1 Reagents and Materials 
Analar reagents and solvents were used wherever possible. In the event of 
unobtainability, Reagent Grade chemicals may be substituted. 
a) Puri ty of m-Chloroperbenzoic Acid 
For the closest control during oxidations with this reagent, it is 
necessary to know the precise value of purity (in terms of available 
oxygen). Determine by the iodometric method described in Section A.I.I.I. 
b) Purity of Fluphenazine Dihydrochloride 
The pharmaceutical grade material received from the manufac-
turers (Linson Ltd., Eire) has a purity of not less than 99.S%. 
c) Fluphenazine base is not available from the manufacturers and should be 
prepared from the hydrochloride by the following method: 
Dissolve 109 of fluphenazine dihydrochloride in lOamI water, add 
excess 10M sodium hydroxide solution and extract with SOml di-ethyl 
ether. Separate the ether layer, wash twice with water and dry over 
magnesium or sodium sulphate. Isolate fluphenazine base by evaporating 
the ether solution to dryness on a rotary evaporator. Finally, dry the base 
in a vacuum oven at 600 C for 16 hours. 
A2.2 Synthesis of Fluphenazine Mono N-Oxide (Compound B') 
A2.2.1 Oxidation of Fluphenazine 
Dissolve O.Sg fluphenazine base (l.l4mM) in 2Sml ethyl acetate contained 
in a 2S-ml conical flask. Cool the flask and contents in a card ice-acetone 
bath at _400 C. Add dropwise from a burette, SO.Oml of a solution of m-
chloroperbenzoic acid (0.296g dissolved in 7Sml ethyl acetate) ensuring 
constant stirring (magnetic stirrer), throughout. The temperature of the bath 
should be carefully monitored and kept at approximately -400 C by addition of 
small pieces of cardice during the reaction. When addition of the oxidant is 
-Al2-
complete, allow the reaction mixture to attain room temperature then 
evaporate to dryness on a rotary evaporator. Dissolve the residue in 5m! of 
dichloromethane. 
A2.2.2 Isolation of Compound st from Reaction Mixture 
Transfer the dichloromethane solution from (a) above onto the top of a 30 
x 2.5cm column of freshly activated (lIOoe) silica gel (70-230 mesh) 
dispersed in chloroform. Allow the solution to run onto the column then elute 
with a mobile phase of acetone-cyclohexane-ammonia, SG 0.88 (80-30-5). 
Use a hand-held UV lamp (366nm) to follow the progress of bands through the 
column. Discard the first eluted band (fluphenazine). Collect the second 
band to elute from the column. Isolate compound B by evaporating the eluate 
to dryness on a rotary film evaporator (700e). Add SOml acetonitrile and 
again evaporate to dryness. This last step will ensure the removal of residual 
water as a water/acetonitrile azeotrope. A pale yellow viscous oil results, 
which slowly solidifies if stored at -200 C. 
A2.3 Synthesis of Fluphenazine Mono N-Oxide (Compound A') 
Compound At cannot be. prepared in any reasonable quantity by normal 
oxidation methods. However, this material may be obtained by hydrolysis of the 
equivalent fluphenazine decanoate N-oxide (Compound A): 
Prepare Compound A from fluphenazine decanoate by the procedure describ-
ed in Section AI.3. Dissolve 0.5g compound A in methanol (20ml) and add 2ml of 
ammonia (SG 0.88). Allow to react at 200 C until compound A is completely 
hydrolysed (about 3 days). Evaporate to dryness on a rotary evaporator and 
dissolve the residue in a small volume of chloroform. Isolate compound A' using 
the column chromatographic procedure described in Section A2.2.2. 
A2.4 Synthesis of Fluphenazine di N-Oxide (Compound C') 
Dissolve 0.50g fluphenazine base (1.14mM) in 25ml dichloromethane In a 250-
-Al3-
ml conical flask. 
Dissolve 0.394g m-chloroperbenzoic acid (2.28mM available oxygen) in 50ml 
of dichloromethane. Add the oxidant dropwise to the solution of fluphenazIne, 
with constant stirring, until the total volume of oxidant has been consumed. Wash 
the final reaction mixture with water in order to remove the small amount of 
compound 0' produced during the reaction. Two or three washes should suffice -
use HPLC to monitor (SAS-Hypersil column; mobile phase, methanol-10% aqueous 
ammonia containing 1% potassium chloride, 1:1; detector 260nm). Dry the 
dichloromethane solution over magnesium sulphate, then evaporate to dryness on 
a rotary evaporator. Dissolve the residue in diethyl ether and add ethereal 
hydrogen chloride until present in a small excess (pH paper). Separate the 
precipitated hydrochloride salt by centrifugation and wash the solid with two 
successive volumes of ether. Dry in a vacuum oven at 600 C. 
If HPLC indicates the product to be contaminated with compound B', then the 
material should be recrystallised from a mixture of absolute ethanol and ether. 
A2.S Synthesis of Fluphenazine Sulphoxide di N-Oxide (Compound 0') 
Dissolve 0.5g fluphenazine (1.14mM) in 25ml ethyl acetate in a 25D-ml 
conical flask. 
Prepare a solution of 0.79g m-chloroperbenzoic acid (4.57 mM available 
oxygen) in lOOml ethyl acetate. 
To the solution of fluphenazine decanoate at 200 C, add 73.0mI of oxidant 
dropwise from a burette ensuring that the reaction mixture is stirred constantly. 
Continue to add the oxidant in 0.5ml quantities monitoring the progreea of the 
reaction by HPLC after addition of each O.5ml aliquot. (SAS-Hypersil column; 
mobile phase, methanol-10% aqueous ammonia containing 1% potasaium chloride, 
1:1; detector 260nm). Cease the addition of oxidant when compound E', which 
appears on the tail of the peak representing compound 0', begins to increase. 
Evaporate the reaction mixture to dryness on a rotary evaporator and re-
-Al4-
dissolve the residue in diethyl ether. Add an ethereal solution of hydrogen 
chloride dropwise from a graduated pipette until the precipitant is just present in 
excess (pH paper). Separate the precipitated hydrochloride salt by centrifugation 
o 
and wash the solid twice wi th ether. Dry the material in a vacuum oven at 60 C. 
A2.6 Synthesis of Fluphenazine SuI phone di N-Oxide (Compound E') 
Dissolve 0.5g fluphenazine (1.14 mM) in 25ml ethyl acetate in a 250-ml 
conical flask. Add 1.0g m-chloroperbenzoic acid (5.8 mM available oxygen) and 
swirl to dissolve. Allow to react at room temperature (200 C). Monitor the 
reaction by HPLC (SAS-Hypersil column; mobile phase, methanol-lO% aqueous 
ammonia containing 1% potassium chloride, 1:1; detector, 275nm). 
Compound 0' is formed immediately and then slowly converted to Compound 
E'. When conversion to compound E' is complete, evaporate the reaction mixture 
to dryness on a rotary evaporator. Re-dissolve the residue in diethyl ether and 
precipitate the hydrochloride sdt by dropwise addition of an ethereal solution of 
hydrogen chloride until in e) ~ess (pH paper). Separate the precipitate by 
centrifugation and wash the soli i twice with ether. Dry the material in a vacuum 
oven at 600 C. 
A2.7 Synthesis of Fluphenazine Sulphone (Compound F~ 
Prepare 0.59 of Compound E' as the hydrochloride salt using the method 
described in Section A2.6. 
Dissolve the resulting product in 1M aqueous hydrochloric acid (20mJ) and add 
pieces of granulated zinc. Allow the reaction to proceed at room temperature, 
monitoring the progress with HPLC (SAS-Hypersil column; mobile phase, 
methanol-lO% aqueous ammonia containing 1% potassium chloride, 1:1; detector 
26Onm). When conversion of compound E' to compound F' is complete, add 5M 
sodium hydroxide until the solution is alkaline and extract with dichloromettlane. 
Separate the layers by centrifu9B:tion and discard the aqueous layer. Wash the 
- AlS-
dichloromethane free from caustic soda using water, then dry the organic solution 
over magnesium sulphate. Isolate compound F' by evaporating the dichloro-
methane solution on a rotary film evaporator to yield a pale yellow viscous oil. 
Final traces of solvent may be evaporated in a freeze-drier at 200 C. 
A2.8 Synthesis of Fluphenazine Sulphoxide N-Oxide (Compound VI) 
Carry out the procedure described in Section A2.2.l (oxidation of fluphen-
azine at -400 C), but dissolve the final, residue in 10mi diethyl ether instead of 
dichloromethane. Add an ethereal solution of hydrogen chloride until present in 
excess then separate the precipitate by centrifugation. Wash the solid with two 
successive 10ml volumes of ether and dry in a vacuum oven at 200 C. 
Dissolve the mixture of hydrochloride salts in 10ml of glacial acetic acid, add 
1.0ml of hydrogen peroxide (100 volume) and allow to react at room temperature 
until the original components have been converted to the corresponding sulphox-
ides (about ~ hours) as shown by the HPLC chromatograms (SAS-Hypersil column; 
mobile phase, methanol-10% aqueous ammonia containing 1% potassium chloride, 
1:1; detector, 260nm). Stop the reaction by adding excess 10M sodium hydroxide 
and extract with dichloromethane. Concentrate the dichloromethane solultion to 
low volume (about 1m!) then streak the solution on to the base line of a silica gel 
preparative layer plate (Merck; 20 x 40cm, 2mm layer). Develop the plate in a 
mobile phase of acetone-cyclohexane-ammonia, SG 0.88 (80-30-5). View the plate 
under a UV lamp and mark the position of the main band. Scrape off the marked 
band and transfer to a glass chromatography column. Elute the compound VI with 
methanol. Carefully evaporate the solution to dryness on a rotary evaporator, 
without the use of heat. (Addition of aliquots of dichloromethane to the 
methanolic solution will help evaporate the methanol under vacuum at 200 C). A 
brown viscous oil results, which slowly solidifies at -200 C. 
-Al6-
A2.9 Synthesis of Fluphenazine SUlphoxide di N-Oxide (Compound VI) 
A2.9.1 Oxidation Reaction 
Dissolve 0.5g fluphenazine base in 5ml glacial acetic acid and add 0.5ml 
hydrogen peroxide (l00 volume). Heat the mixture on a water bath at BOoC, 
monitoring the reaction by HPLC (SAS-Hypersil column; mobile phase, 
methanol-lO% aqueous ammonia containing 1% potassium chloride, 1:1; 
detector 275nm). When the reaction is complete isolate the product by the 
following procedure. 
A2.9.2 Isolation of Compound VI 
Add 10M sodium hydroxide to the reaction mixture, cooled in an ice-bath, 
until the solution is alkaline. Allow the alkaline solution to percolate through 
a 20 x 25cm bed of Amberlite XAD2 resin. Wash the resin with water until 
the washings are neutral then draw excess water from the resin bed using a 
vacuum-line connected through a suitable trap. Elute the product from the 
resin with methanol (about 200mI) collecting the eluate in a round-bottom 
flask. Evaporate the majority of solvent On a rotary evaporator (700 C) then 
add two successive quantities of acetonitrile and evaporate in order to 
azeotrope the residual water. Dissolve the oily residue in dichloromethane 
and dry over magnesium sulphate. Finally, evaporate to dryness on a rotary 
evaporator to yield a white solid. Dry the resultant solid (compound V') in a 
freeze-drier or efficient vacuum oven at 200 • 
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APPENDIX III 
IR, NMR AND MS SPECTRA 
OF THE ISOLA TED OXIDES 
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Fig. A3.38 :3C NMR Spectrum of Compound BI (fluphenazine mono N-oxide B) 
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Fig. A3.39 - DCI Mass Spectrum of Compound A (fluphenazine 
decanoate mono N-oxide A) 
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Fig. A3.40 - DCI Mass Spectrum of Compound B (fluphenazine 
decanoate mono N-oxide B) 
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Fig. A3.41 - DCI Mass Spectrum of Compound C (fluphenazine decanoate 
di N-oxide) 
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Fig. A3.42 - FAB Mass Spectrum of Compound·C (fluphenazine decanoate 
di N-oxide) 
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Fig. A3.43 - DCI Mass Spectrum of Compound D (fluphenazine 
decanoate sulpho~ide di N-oxide) 
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Fig. A3.44 - DCI Mass Spectrum of Compound E (fluphenazine decanoate 
sulphone di N-oxide) 
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Fig. A3.45 - EI Mass Spectrum of 
a) Compound F(fluphenazine decanoate sulphone 
b) Fluphenazine Decanoate 
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Fig. A3.46 - DCI Mass Spectrum of Compound F (fluphenazine 
decanoate sulphone) 
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Fig. A3.47 - DCI Mass Spectrum of Compound X (fluphenazine decanoate 
sulphoxide mono N-oxide A) 
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Fig. A3.48 - FAa Mass Spectrum of Compound X (fluphenazine decanoate 
sulphoxide mono N-oxide A) 
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!ig. A3.49 - DCI Mass Spectrum of Compound Y (fluphenazine 
decanoate sulphoxide mono N-oxide B) 
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Fig. A3.S0 - EI Mass Spectrum of 
a) Compound Z(fluphenazine decanoate sulphox1de) 
b) Fluphenazine Decanoate 
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Fiq. A3.52 - DCI Mass Spectrum of Compound C' (fluphenazine 
di N-oxide) 
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Fig.A3.54 - DCI Mass Spectrum of Compound D' (fluphenazine 
sulphoxide di N-oxide) 
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Fig. A3.55 - !AB Mass Spectrum of Compound D' (fluphenazine 
sulphoxide di N-oxide) 
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!ig. A3.57 - DCI Mass Spectrum of Compound y' (fluphenazine 
sulphoxide mono N-oxide B) 
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Fig. A3.S8 - FAB Mass Spectrum of Compound Y' (fluphenazine 
sulphoxide mono N-oxide B) 
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